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ABSTRACT 
 
YU LEI: Biochemical and Functional Characterization of the 
Mitochondrial Immune Signaling Protein Complex 
(Under the Direction of Dr. Jenny P.-Y. Ting) 
 
The mitochondrion has emerged as a crucial organelle where key anti-viral 
responses including apoptosis, type 1 interferon (IFN-I) production and autophagy are 
regulated.  A prime example is the intersection of the mitochondrial protein MAVS 
with the RLR (RIG-I-like receptors) to induce IFN-I.  Here we show that MAVS is a 
pro-apoptotic protein independent of its function in initiating IFN-I production.  
Viral proteins such as NS3/4A encoded by HCV and NSP15 encoded by SARS-CoV 
inhibit this response.  MAVS-mediated IFN-I is tightly regulated by an NLR 
(nucleotide-binding domain, leucine-rich repeats containing) protein NLRX1.  More 
in-depth analysis utilizing cells from gene-deletion mice indicates that NLRX1 not 
only attenuates IFN-I production, it additionally promotes autophagy during viral 
infection.  This dual regulatory function of NLRX1 parallels the previously 
described functions of Atg5-Atg12, although NLRX1 does not associate with 
Atg5-Atg12.  High throughput quantitative mass spectrometry and biochemical 
analysis revealed a novel NLRX1-interacting partner, mitochondrial Tu translation 
iv 
 
elongation factor (TUFM/P43/EF-Tu/COXPD4/ EF-TuMT), which does interact with 
Atg5-Atg12.  Similar to NLRX1, TUFM potently inhibits RLR signaling and 
promotes autophagy during a viral infection.   This thesis demonstrates the dual 
roles of MAVS in controlling both IFN-I and apoptosis, and establishes the first link 
between an NLR protein and a viral-induced autophagic machinery via TUFM.   
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CHAPTER ONE 
 
INTRODUCTION 
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1.1 The evolution of mitochondria 
It was about one century ago when the serial endosymbiosis hypothesis was put forth 
to explain the origin of mitochondria 
1
, which has drawn support from numerous 
contemporary studies.  The prokaryotic origin of mitochondrion postulated in this 
hypothesis makes it the cellular power plant which also sustains three basic life functions: 
rapid response to insults (type 1 interferons and reactive oxygen species production) 
2, 3
, 
adaptation to the environmental nutrition supply (autophagy) 
4
 and active self-elimination 
to maintain homeostasis at an organismal level (apoptosis) 
5, 6
. 
It is postulated that when an ancient species of alphaproteobacteria became an 
endosymbiont, this novel organelle in eukaryotes is subjected to constant interactions 
with host factors.  Through co-evolution, the genetic material of bacterial ancestor of 
mitochondria has been transferred to host nucleus 
7
; similarly mitochondria incorporate 
the protein import system to integrate nucleus-encoded proteins 
8
.  The membranes of 
mitochondria  not only anchor a plethora of molecules engaged in bioenergetic functions, 
innate immune activation, metabolic balances and apoptotic signaling, but also sustain 
the biogenesis of other organelles, such as autophagosomes, mitochondria-associated 
endoplasmic reticulum membrane structure and peroxisomes 
4, 9, 10
.  Mitochondrial 
membrane fusion and fission as well as their continuity and fluidity with other membrane 
structures are emerging as potent regulatory factors of the host defense mechanisms. 
This review focuses on the immune-regulatory functions of mitochondria, which 
center on the cooperation between immune-activating mitochondrial adaptor proteins, 
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their upstream pathogen recognition receptors (PRRs) and the regulatory complexes.  
These regulatory proteins employ diverse mechanisms to keep the mitochondria-based 
immune signaling in-check. However, these mechanisms can be hijacked by various 
viruses to evade host immune surveillance.  
1.2 The functions of mitochondrial proteins in apoptosis 
Mitochondria are emerging as a critical signaling platform for apoptosis, 
dysregulation of which is closely associated with the pathogenesis of numerous diseases 
such as cancer, degenerative diseases and infectious diseases.  The central roles of 
mitochondria in apoptotic signaling have been defined by the process of mitochondrial 
outer membrane permeabilization (MOMP), leading to the release of proteins from the 
intermembrane space to the cytosol.  MOMP is closely associated with the dissipation of 
mitochondrial inner membrane potential (Δψm), which marks a point-of-no-return in 
apoptosis 
11, 12
.  A key event in the mitochondrial apoptotic signaling pathway is the 
release of cytochrome c (Cyt c), which was initially identified as an activator of the 
initiator caspase-9 
13
.  Indeed, Cyt c-deficient MEFs (mouse embryonic fibroblasts) are 
resistant to a variety of apoptotic stimuli 
14
.  In this process, released Cyt c is bound to 
Apaf-1 (apoptotic protease activating factors) via its WD40 domains, which oligomerize 
and recruit caspase-9 in the presence of ATP/dATP to form a wheel-shaped multimeric 
protein complex coined the apoptosome 
15
. 
Several models have been proposed for the pathogenesis of MOMP 
12
.  The first is 
mediated by the formation of permeability transition (PT) pores in the mitochondrial 
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inner membrane, which allows the passage of small molecules up to around 1.5kD 
16
.  
PT opening is triggered by either mitochondrial matrix swelling or Δψm collapse.  In 
some hypothetical models, the mitochondrial inner membrane protein, ANT (adenine 
nucleotide transporter), or the outer membrane protein, VDAC (voltage-dependent anion 
channel), may associate with multiple proteins to facilitate PT formation 
12
.  However, 
recent evidence also suggests either protein may be dispensable for PT-mediated 
apoptosis or preferentially plays a role in necrotic signaling 
17-19
.  The second is 
mediated by the Bcl-2 family members.  The ones with multiple BH (Bcl-2 homology) 
domains, such as Bax and Bak, are mediators of MOMP; and their deficiency results in 
the failure to respond to a variety of apoptotic stimuli 
20
.   
Although the two apoptotic mechanisms involve different components of 
mitochondrial membranes to induce the release of Cyt c, it has been noted that the 
secondary rupture of mitochondrial outer membrane also could lead to PT establishment; 
similarly Bax-dependent, PT-independent MOMP could result in Cyt c release, which is 
remarkably rapid and complete 
21
.  However, the mitochondrial intermembrane space 
only sequesters 15-20% of total Cyt c, while a large proportion of Cyt c resides in the 
tubular cristae located within the mitochondrial inner membrane 
21
.  Although it is 
possible that Cyt c stored on the cristae could be released to the intermembrane space 
with PT opening, however, significant amount of Cyt c could be detected in the cytosol 
before mitochondrial matrix swelling 
21
.  The complete extent of Cyt c release could be 
partially explained by the mitochondrial ultrastructure changes during apoptosis.  The 
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individual cristae could be fused together, resulting in the opening of inter-cristae 
junction.  Such morphological changes are PT-dependent, however, could occur before 
mitochondrial matrix swelling 
22
. 
1.3 Recognition of nucleic acid species 
One of the primary functions of the innate defense system is to differentiate “self” 
from “non-self”, which heavily relies on several classes of extracellular and intracellular 
sensors to detect pathogen-associated molecular patterns (PAMPs) and/or other danger 
signals.  Since Charles Janeway predicted the existence of pattern recognition receptors 
(PRRs) to engage their respective ligands and trigger immune activation 
23
, the body of 
knowledge in innate sensing has grown exponentially.  Toll-like receptors (TLRs) 
represent the first identified class of PRRs 
24
, which are type I integral membrane 
glycoproteins that share an N-terminal extracellular leucine-rich-repeats (LRR) domain 
and a C-terminal cytoplasmic Toll/IL-1R (TIR) signaling domain 
25, 26
.  TLRs detect 
both extracellular and endosomal/lysosomal microbial threats.  Among the 10 human 
TLRs and 12 mice TLRs, many demonstrate specificity to distinct repertoires of 
microbial products of bacteria, viruses and fungi.  TLR3, TLR7, TLR8 (human) and 
TLR9 recognize nucleic acids in the endolysosomal compartment.  TLR3 binds to 
double-stranded RNA (dsRNA), TLR7 (or human TLR8) binds to single-stranded 
(ssRNA) and TLR9 recognizes CpG-DNA 
26
.  However, as early as 2004, Lopez et al 
found that the dendritic cells (DCs) matured normally in the absence of TLR3, TLR7, 
TLR8 or TLR9 signaling.  In addition, these TLR-deficient DCs could prime efficiently 
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for Th1 responses against Sendai virus (SeV) infection or influenza A virus infection 
27
.  
Similarly, Tlr3
-/-
 mice displayed uncompromised antiviral responses to lymphocytic 
choriomeningitis virus (LCMV), vesicular stomatitis virus (VSV), murine 
cytomegalovirus (MCMV) and reovirus infection 
28
.  Bacterial DNA causes septic shock 
29
, and CpG DNA of Listeria monocytogenes can activate type 1 interferon (IFN) 
signaling, however, TLR signaling is dispensable for this response 
30
.  In addition, 
bacterial DNA activates B lymphocytes in a TLR9-independent fashion 
31
.  Finally, 
DNA viruses such as Herpes Simplex Virus type 1 induces type 1 IFN production in both 
TLR9-dependent and TLR9-independent pathways 
32
.  These compelling evidences 
suggest the existence of other nucleotides-sensing pathways.   
One of the early searches for novel nucleotides sensors was based on the screening of 
an expression cDNA library from IFN-β-treated human K562 cells, which respond poorly 
to viral infections unless the cells are treated with IFN-β 33.  One cDNA clone has been 
identified to significantly augment poly (I:C)-induced IRF promoter activation and this 
clone encodes the N-terminal residues of the RNA helicase retinoic acid inducible gene I 
(RIG-I) 
33
.  Together with the structurally similar proteins melanoma differentiation- 
associated gene 5 (MDA5) and laboratory of genetics and physiology 2 (LGP2), these 
proteins constitute the RIG-I-like receptors (RLRs) family.  RIG-I contains two 
N-terminal caspase activation and recruitment domain (CARD), a central DExD/H 
box-containing helicase domain and a C-terminal regulatory domain (CTD).  The 
CARD domain is critical in mediating a homotypic interaction with the central adaptor 
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molecule mitochondrial antiviral signaling protein (MAVS, also known as IPS-1, VISA 
and Cardif) 
34-37
.  The helicase domain endows the protein with ATPase activity to drive 
the unwinding of dsRNA with 3’-terminal overhang (>5nt) 38.  Although a mutation in 
this region leads to the disruption of its function in antiviral response, the K270A mutant 
protein still recognizes both dsRNA and 5’-triphosphate-bearing (5’-ppp) RNA 38.  
Recent structure analysis reveals that the CTD domain of RLR members forms a 
RNA-binding cleft despite that the binding capacity of MDA5 CTD is much weaker than 
that of RIG-I and LGP2 
38, 39
.  Importantly, RIG-I and MDA5 exhibit distinct 
preferences for the molecular features of RNA ligands and RNA viruses 
40
.  RIG-I binds 
to short 5’-ppp dsRNA while MDA5 recognizes long dsRNA 40-43.  Although it was 
shown that in vitro transcribed 5’-ppp ssRNA could also induce type 1 IFN activation 43, 
two recent reports show that T7 RNA polymerase leads to the generation of dsRNA 
44, 45
  
while synthetic 5’-ppp ssRNA has no immune activation effect 43.  This suggests only 
dsRNA could be recognized by RLRs.  The 5’-ppp moiety is the signature motif that 
activates RIG-I 
41, 43
, however, it has also been shown that 5’-p dsRNA and dsRNA 
bearing no 5’- triphosphate moiety could still potently induce type 1 IFN activation 38, 46.  
The source of dsRNA can be traced back to viral genomes, replication intermediates, 
viral transcripts or self-RNA generated by RNase L 
43, 46, 47
.  All these RNA species have 
been proposed to have immune stimulatory potential.  However, a recent study showed 
that only viral genome RNA could potently induce type 1 IFN activation during influenza 
A virus and SeV infection; and cleaved self-RNA does not induce type 1 IFN production 
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during the infection 
48
.  Further studies are essential to evaluate the respective 
contributions of dsRNA from various sources in inducing type 1 IFN production upon 
viral challenges.   
MDA5 recognizes higher-order structure of RNA complex involving dsRNA and 
ssRNA 
49
.  Due to the ligand binding properties of RIG-I and MDA5, they display 
specificity to different viruses.  RIG-I-deficient mouse fibroblasts and conventional 
dendritic cells (cDCs) fail to mount type 1 IFN activation in response to Newcastle 
disease virus (NDV), SeV, VSV, influenza A virus and Japanese encephalitis virus (JEV).  
However, MDA5-deficient cells respond normally to these viral challenges, yet fail to 
elicit immune activation upon infections by picornaviruses such as encephalomyocarditis 
virus (EMCV), Mengo virus and the Theiler’s virus 50.  Some flaviviruses such as 
Dengue virus and West Nile virus (WNV) can be recognized by both RIG-I and MDA5 
51, 
52
. 
RIG-I-mediated type 1 IFN signaling not only respond to certain RNA species but 
also to DNA.  Two groups have independently identified DNA-dependent RNA 
polymerase III as the cytosolic DNA sensor that generates 5’-ppp RNA, which engages 
RIG-I and activate downstream signaling 
53, 54
.  However, RIG-I-deficient cells still 
show competency in responding to cytoplasmic DNA, which raises the possibility that 
there are additional cytoplasmic DNA sensors.  To qualify as an intracellular DNA 
sensor, it should contain a DNA-binding domain.  The DNA-dependent activator of 
IFN-regulatory factors (DAI, also known as Z-DNA-binding protein) binds to dsDNA 
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and associates with TBK1 as well as IRF3.  DAI is an IFN-inducible protein, and could 
augment type 1 IFN induction by various DNA sources when overexpressed 
55
.  In 
addition, knockdown of DAI by RNA interference ablates immune activation by 
exogenous DNA 
55
.  The dimerization of DAI results in DNA-dependent type 1 IFN 
production 
56
.  DAI contains two receptor-interacting protein (RIP) homotypic 
interaction motifs (RHIMs) and binds to RIP1 and RIP3.  Knockdown of RIP1 or RIP3 
abrogates NF-κB activation induced by immunostimulatory DNA sequences 57, 58.  
However, DAI-deficient and wildtype control mice demonstrate no difference in 
DNA-dependent type 1 IFN activation in MEFs, GM-DC (bone-marrow-derived 
dendritic cells differentiated by GM-CSF) and FL-DC (bone-marrow-derived dendritic 
cells differentiated by Flt3) 
59
.  It is possible that additional intracellular DNA sensor 
exist so that redundant mechanisms provide host cells another layer of safe-guard against 
DNA stimuli.   
In order to identify novel DNA sensors, several high throughput biochemical 
screenings have been performed to seek DNA-interacting proteins.  One of the earliest 
identifications is the high-mobility group box (HMGB) protein family, which includes 
HMGB1, HMGB2 and HMGB3 and contributes to the initiation of type 1 IFN and 
proinflammatory cytokine responses to DNA stimuli 
60
.  Both HMGB1 and HMGB2 can 
be precipitated by immobilized B-DNA, and their deficiency results in impaired 
activation of NF-κB and IRF3.  Furthermore, the absence of HMGBs also compromises 
the activation of TLR3, TLR7 and TLR9 by their cognate ligands nucleic acids 
60
.   
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Another class of the intracellular DNA sensors is the PYHIN proteins, which contain 
two HIN DNA binding domains and one Pyrin domain.  Two members in this family, 
including IFI16 and AIM2, have been shown to be engaged with DNA and activate innate 
immune system 
61-65
.  Interestingly, IFI16 and AIM2 trigger separate signaling pathways 
despite their structural similarity and affinity to DNA.  IFI16 is essential for recruiting 
downstream adaptor proteins to mount type 1 IFN production in response to intracellular 
DNA.  Targeted knockdown of IFI16 results in the ablation of DNA-induced but not 
RNA-induced activation of both NF-κB and IRF3 61.  In contrast, AIM2 has no effect in 
modulating host type 1 IFN responses to DNA, rather it forms inflammasome with a 
critical adaptor molecule for procaspase-1 processing 
62-65
.   
The breadth of intracellular nucleic acid sensing system is also exemplified by the 
identification of two DExD/H-box helicases DHX36 and DHX9 in plasmacytoid 
dendritic cells 
66
.  Albeit these two proteins contain the DExD/H-box as RIG-I and 
MDA5 do, they exhibit different specificities.  DHX36 primarily binds to CpG-A via the 
DEAH domain, while DHX9 binds to CpG-B via the DUF1605 domain.  DHX36 is 
pivotal in activating IFN-α generation in response to CpG-A, while DHX9 preferentially 
activates NF-κB-dependent TNF-α and IL-6 production 66. 
Finally, the LRR (leucine-rich repeats) domain is postulated to function as ligands 
binding or protein-binding platforms 
26, 67
.  A screening in mouse peritoneal 
macrophages with a siRNA library targeting LRR-containing and LRR-interacting 
proteins-encoding mRNA leads to the identification of LRRFIP1, which recognizes both 
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exogenous RNA and DNA species to induce type 1 IFN production in a 
β-catenin-dependent fashion 68.  
1.4 The significance of immune adaptors trafficking in host innate antiviral 
responses 
Two mitochondria-based adaptors have been identified in the type 1 IFN responses to 
intracellular RNA or DNA threats, these are MAVS 
34-37
 and Stimulator of Interferon 
Genes (STING, also known as MITA, MPYS and ERIS) 
69-71
.  Both proteins are 
ubiquitously expressed and indispensable for transducing signals detected by upstream 
PRRs leading to type 1 IFNs production, albeit STING is less potent than MAVS in 
activating NF-κB or IRF3 when overexpressed 70.  Association between the two protein 
has been also identified 
70
.  Importantly the integrity of this adaptor core is critical since 
deletion of either of these two proteins results in ablated type 1 IFNs even though the 
other remains intact.  Some cell lines are exclusively dependent on MAVS in the 
cytosolic DNA-induced type 1 IFN response, yet MAVS-independent machinery has also 
been implicated in certain cell types such as MEF 
53
.  On the other hand, STING 
mediates cytosolic non-CpG DNA-induced type 1 IFN activation in MEF, BMDM 
(bone-marrow-derived macrophage), GM-DC and FL-DC 
72
.   
MAVS is firstly identified as a mitochondrial outer membrane protein, where it 
engages upstream PRRs and recruits TBK1 and IKK complexes to activate NF-κB and 
IRF3.  However, it becomes detergent-resistant when cells are infected with SeV, which 
indicates a possible protein translocation 
34
.  Indeed, a recent study finds MAVS is also 
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located within peroxisomes, which are single-membrane-bound structures known to be 
involved in metabolic pathways.  The different locations of MAVS confer distinct 
antiviral signaling kinetics: the peroxisomal MAVS is unable to induce type 1 IFN 
production, however, it launches a quick interferon-independent transcriptional program 
ISG (Interferon-Stimulated Genes) to establish the early antiviral state of the cells; the 
mitochondrial MAVS then assumes its function to activate type 1 IFN signaling, which in 
turn promotes the induction of ISGs 
73
.  NDV (Newcastle disease virus) triggers 
RIG-I-mediated type 1 IFN production, a recent report found it also induced the 
redistribution of MAVS to form speckle-like aggregates 
74
.  Mfn1 (Mitofusin 1), which 
regulates mitochondrial fission and fusion, associates with MAVS and is responsible for 
its virus-induced redistribution.  Indeed, disruption of mitochondrial fusion processes by 
knocking down Mfn1 abrogates both MAVS redistribution and type 1 IFN production in 
response to viral infections 
74
.  These findings support the notion that it is both the 
biochemical properties and localization of MAVS that determine its functional outcome. 
In fact, this is also true for the other adaptor STING.  The initial studies on STING 
showed discrepant findings regarding its subcellular localization: one group found this 
protein predominantly resided in the endoplasmic reticulum (ER) and interacted with a 
member of translocon-associated protein complex TRAPβ 69; while another group 
demonstrated STING was an exclusive mitochondrial outer membrane protein and 
associated with MAVS 
70
.  Microsomes comprised of ER, Golgi and vesicles are 
membrane structure artifacts when eukaryotic cells are homogenized.  In two 
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subsequent studies, STING was consistently identified in the microsomes fraction 
72, 75
.  
Interestingly, ER and mitochondria are not completely physically distinct organelles but 
are connected by the mitochondria-associated ER membrane (MAM).  STING was also 
found in these structures, which may explain why it was also present in the mitochondrial 
fraction.  However, upon HSV-1 (Herpes Simplex Virus-1) infection, STING was only 
associated with microsomes 
72
.  Furthermore STING could be degraded by a E3 ligase 
ring finger protein 5 (RNF5, also known as RMA1) 
75
.  Such functional interaction and 
regulation predominantly occur in mitochondria.  Although STING is barely detectable 
in the ER fraction at the resting state, it becomes more abundant when cells were infected 
with SeV (Sendai Virus) for 6h and diminished from the ER again by 24h post-infection 
75
.  The function of STING in response to RNA virus infection was questioned by 
another recent report that showed STING-deficient BMDM were fully capable of 
producing IFN-β in response to SeV infection 61.  The significance of viral specific 
functions and subcellular compartmentalization of these adaptors in modulating host 
antiviral innate immunity require further investigations. 
1.5 An overview of the NLR protein family  
NLR (nucleotide-binding domain, leucine-rich repeats-containing) proteins (also 
known as CATERPILLERs, NODs, NALPs or NACHT-LRRs) in mammals share great 
sequence homology with the plants NBS-LRR proteins which are pivotal in delivering 
disease resistance 
76, 77
.  Albeit there is scarce evidence showing the direct binding of 
NLRs to various cytosolic PAMPs and other DAMPs (damage-associated molecular 
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patterns), these proteins are generally thought to be critically involved in the sensing, 
regulation and translation of hazardous stimuli to host proinflammatory responses 
including caspase-1-dependent IL-1β and IL-18 processing as well as NF-κB-dependent 
defensins and cytokines induction 
67, 78
.  However, as evidences begin to accumulate, 
NLRs are also found pivotal in modulating cell death and RLR responses. 
NLRs are characterized by a central NBD (nucleotide-binding domain), a C-terminal 
LRR domain and an N-terminal effector domain, which could be CARD, Pyrin, BIR 
(baculovirus inhibitor of apoptosis repeat), AD (transactivation domain) or an X domain 
that cannot be categorized as any known motifs 
78
. 
One of the best characterized functions of NLRs is mediating the formation and 
activation of a dynamic multimeric protein complex named inflammasome 
79, 80
.  The 
identification of this complex is similar to that of the apoptosome, which is comprised of 
Apaf-1, deoxyribonucleic ATP, cytochrome c and pro-caspase-9 
6, 81
.  In the presence of 
cytochrome c, a wheel-shaped protein complex apoptosome is formed by Apaf-1 
oligomerization, which activates caspase-9 via a proximity-induced molecular model 
81
.  
Instead of activating caspase-9, inflammasome activation triggers the processing of 
pro-caspase-1 into caspase-1, which then generates the mature form of pro-IL-1β and 
pro-IL-18 
78
.   
The composition of inflammasome depends on the nature of proinflammatory insults, 
the first identification of such complex was based on the notion that an intracellular 
adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD, also 
15 
 
known as PYCARD, CARD5 or TMS1), pro-caspase-1 and an NLR protein NLRP1 were 
eluted from at the same fraction in a HPLC (high-performance liquid chromatography) 
experiment 
82
.  As the body of knowledge in the field grows, several functionally 
distinct and relevant inflammasomes have been discovered.  The proteins other than 
ASC and pro-caspase-1 found in the complex, including NLRP1, NLRP3, NLRC4, 
NLRB1, NLRP12 or AIM2, largely determine the specific agonists that activate a 
particular inflammasome. 
NLRP1 (also referred to as CLR17.1, CARD7, NALP1, NAC or DEFCAP) 
inflammasome is the first discovered inflammasome, which can be activated by MDP 
(muramyl dipeptide) 
83
.  Despite of the high evolutionary conservation of NLR proteins 
among species, the structures of human and mouse NLRP1 are different.  There are 
three Nlrp1 orthologs (Nlrp1a, 1b, 1c) in mouse, and the variations in the Nlrp1b locus 
are critical for mice susceptibility to Bacillus anthracis lethal toxin (LT) treatment 
84
.  
However, human macrophages are resistant to LT challenge 
85
, which renders the study of 
human NLRP1 function in response to LT difficult.  Human NLRP1 has a C-terminal 
CARD domain, which makes it capable of directly interacting with pro-caspase-1 without 
ASC although the latter augments pro-caspase-1 processing 
83
.  Mouse Nlrp1b 
inflammasome activation is independent of ASC, in contrast to human NLRP1, this 
mouse counterpart does not contain the Pyrin domain and is not able to associate with 
ASC . 
NLRP3 (also referred to as CLR1.1, Cryopyrin, NALP3, CIAS1 or PYPAF1) 
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inflammasome responds to a group of chemically and structurally diverse stimuli such as 
extracellular ATP 
86, 87
, MDP 
88
, hyaluronan 
89
, bacterial potassium ionophore nigericin, 
the marine toxin maitotoxin, listeriolysin O from Listeria monocytogenes, aerolysin from 
Aeromonas hydrophila 
86, 90
, α-hemolysin from Staphylococcus aureus 91, amyloid-β 92, 
uric acid crystals, calcium pyrophosphate dehydrate 
93
, silica, asbestos 
94, 95
, alum 
(aluminum hydroxide) 
96-98
 and cholesterol crystals 
99-101
.  However, little evidence has 
shown NLRP3 is directly engaged with any of the aforementioned stimuli.  A typical 
feature of many stimuli is the initiation of potassium efflux and decrease in cytosolic 
potassium concentration 
102, 103
.  One proposed mechanism underlying NLRP3 
inflammasome activation is based on the findings that numerous stimuli induced 
intracellular oxidative stress by generating ROS (reactive oxygen species) and broad 
spectrum NADPH (nicotinamide adenine dinucleotide phosphate) oxidase inhibitors 
ablated caspase-1 activation 
104, 105
.  In fact, potassium efflux is closely associated with 
ROS production at the membranes in plants 
106
.  A recent study suggests oxidative stress 
leads to the dissociation of TXNIP (thioredoxin-interacting protein) from oxidized TRX 
(thioredoxin) to allow the otherwise impossible assembly of inflammasome; consistently 
TXNIP deficiency leads to compromised inflammasome activation in response to uric 
acid crystals 
107
.  Inhibition of autophagy leads to accumulation of damaged 
mitochondria and enhanced ROS generation.  A recent study found NLRP3 and ASC 
co-locaolized with ER and mitochondria when activated; and mitochondrial dysfunction 
could repress both ROS and inflammasome activation 
108
.  Another proposed theory is 
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based on the crystal-mediated lysosomal membranes damage model, in which silica, 
alum and amyloid-β challenges would lead to lysosomal membrane rupture and release 
Cathepsin B to activate inflammasome 
92, 95
.  It is unclear whether these two models are 
parallel to each other or have causal relationships, more studies are required to address 
how these biochemically diverse stimuli initiate the same NLRP3 inflammasome  
assembly and activation. 
NLRC4 (also referred to as CLR2.1, IPAF, CARD12 or CLAN) inflammasome 
responds to Gram-negative bacteria, which encode either type III or type IV secretion 
system (T3SS or T4SS), such as Salmonella typhimurium 
109-111
, Shigella flexineri 
112
, 
Legionella pneumophila 
113
 and Pseudomonas aeruginosa 
114
.  In contrast to the NLRP1 
inflammasome, NLRC4 inflammasome is dependent on ASC for activating caspase-1.  
NLRC4 associates with pro-caspase-1 via the CARD:CARD homotypic interaction, 
however, whether NLRC4 interacts with ASC remains unclear 
79
.  Notably, although 
ASC is critical for NLRC4 inflammasome-dependent IL-1β production, it seems 
dispensable for NLRC4 inflammasome-dependent yet caspase-1-independent cell death.  
There are both flagellin-dependent and flagellin-independent mechanisms underlying the 
activation of NLRC4.  Salmonella typhimurium and Legionella pneumophila strains that 
lack the genes encoding flagellin are unable to activate inflammasome 
109, 111, 115, 116
.  In 
fact, transfection of flagellin into the cytosol induces caspase-1 activation in a 
NLRC4-dependent fashion 
109, 111
.  The T3SS or T4SS has been proposed to be 
responsible for injecting flagellin directly into the cytosol 
114, 117
.  Some studies have 
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demonstrated that flagellin-deficient Shigella flexneri and Pseudomonas aeruginosa can 
still activate NLRC4 inflammasome 
112, 114
, while some other studies found Pseudomonas 
aeruginosa lacking flagellin failed to induce pro-caspase-1 cleavage 
118, 119
. 
In addition to mediating the assembly of inflammasome and activating caspase-1, 
many NLRs assume inflammasome-independent functions, such as the modulation of 
canonical or non-canonical NF-κB pathways, transcription of MHC Class I and Class II 
genes, defensins and chemokine production, type 1 IFN induction as well as ribonuclease 
L activity 
67
.  NOD1 and NOD2 are two of the first studied NLR proteins.  These two 
proteins activate both the NF-κB signaling pathway and the MAPK (mitogen-activated 
protein kinase) p38, ERK pathway in response to the bacterial products during the 
synthesis and/or degradation of peptidoglycan 
120
.  NOD1 detects the dipeptide 
γ-D-glutamyl-meso-diaminopimelic acid (iE-DAP), which is generated by most 
Gram-negative and some Gram-positive bacteria.  NOD2 detects MDP, which is a 
common component of peptidoglycans.  Neither NOD1 or NOD2 has been shown to 
bind to iE-DAP or MDP directly, however, the LRR domain is essential to confer the 
responsiveness, suggesting this domain either binds to their respective peptidoglycan 
ligands or a bona fide sensor of the bacterial products 
67
.  Similar to the adaptors of RLR 
signaling, the subcellular translocation and their relationships with membranes structures 
predict the functional outcomes 
121
.  NOD2 relies on its C-terminus, which is critical for 
its association with plasma membranes, to activate NF-κB signaling in response to MDP; 
in fact, a Crohn’s disease-associated NOD2 variant NOD2 3020insC lacking the 
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C-terminus of the protein has been found unable to mount proinflammatory response to 
MDP 
122
.  In addition, NOD1 has also been found enriched at plasma membranes 
structure at the bacterial entry sites, and disruption of such localization pattern 
compromises its downstream signaling 
123
.  Despite of the structural homology among 
the 22 human NLRs, their significance in disease pathogenesis are diverse, and even one 
protein could assume different functions depending on the stimuli (Fig. 1.1). 
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1.6 Functions of NLR proteins in the modulation of MAVS-RLR signaling 
NLRX1 is a unique NLR not only because of its mitochondrial localization but also 
its modes of functioning 
2, 124
.  Instead of direct participation in response to microbial 
invasion, NLRX1 modulates the functions of a MAVS-dependent multimeric protein 
complex which could be ≥ 600kDa in its quiescent state 125.  This complex is pivotal in 
Figure 1.1  NLR proteins signal through different multimeric protein complexes. 
NLR signaling modules include the NLRC5/CIITA transcriptosome regulating the 
transcription of MHC Class I and II genes, the caspase-1-activating inflammasomes, the 
IFN/cytokine–inducing RLR signaling complex, the NF-κB/MAPK-activating NOD1/2 
complex, and the non-canonical modulation of NF-κB via NIK. This figure depicts the 
concept that one NLR can serve multiple functions, whereas multiple NLRs can also 
serve similar functions. 
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activating type 1 IFNs upon engagement with either RNA or DNA, which then leads to 
the mitochondrial recruitment of TRAF3 and TRAF6 to induce type 1 IFNs production.  
NLRX1 is a non-canonical NLR member in that its N-terminal effector domain does not 
share homology to any well-conserved motifs yet it contains a mitochondrial targeting 
sequence, and that its central nucleotide binding domain does not have a Walker A motif 
found in other NLRs.  Overexpression of NLRX1 inhibits RIG-I- or MDA5-mediated 
activation of NF-κB-, IRF3-dependent and IFNB1 promoter activity in a dose-dependent 
fashion.  In addition, NLRX1 also inhibits IFNB1 mRNA transcription upon RLR 
activation.  Knockdown of NLRX1 by siRNA results in an enhanced type 1 IFN 
signaling and thus confers resistance to Sindbis virus infection 
124
.  NLRX1 is located 
on the outer membrane of mitochondria and interacts with the adaptor MAVS. Exogenous 
NLRX1 expression potently represses SeV-induced homotypic CARD:CARD interaction 
between RIG-I and MAVS 
124
.  Interestingly, the inhibitory function of NLRX1 is 
specific to mitochondrial MAVS rather than peroxisome-localized MAVS 
73
 (Fig. 1.2).  
The role of NLRX1 in impeding MAVS-RIG-I interaction and the subsequent type 1 IFN 
induction has been further confirmed in gene deletion mice (manuscript under review).  
However, a recent study suggests that NLRX1 can be localized to the mitochondrial 
matrix and interacts with a matrix protein UQCRC2, although the physiological 
significance of such interaction is now known 
126
.  NLRX1 has been shown to be 
involved in the ROS production during Shigella flexneri and Chlamydia trachomatis 
infection 
127, 128
.  The discrepancy in localization may be due to the multi-faceted nature 
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of NLRX1 function in response to different stimuli.  As the RLR signaling adaptors and 
some NLRs rely on the membrane structure to modulate host responses, the trafficking 
and localization of NLRX1 in the presence of virus needs further investigation. 
In a recent screening of five NLR proteins including NOD1, NOD2, NLRC4, NAIP 
and NLRC3, Sabbah et al. 
129
 found that overexpression of NOD2 but not other NLRs 
endowed HEK293 cells with the capability to activate IRF3 in response to ssRNA.  
Interestingly, the endogenous level of NOD2 in A549 cells was shown to be inducible by 
viral infection.  The authors also showed that depletion of NOD2 resulted in ablated 
IFN-β production upon viral challenge.  Furthermore immunoprecipitation of 
over-expressed NOD2 led to the recovery of RSV nucleocapsid protein specific RNA, 
which was substantiated in a cell-free system using HA-NOD2 bound-agarose beads as 
the bait (Fig. 1.3).  Although it has been shown NLRP3 is involved in the recognition of 
influenza A virus 
130, 131
, this finding represents the first piece of evidence that NLR can 
associate with viral ssRNA and activate the RLR signaling.  However, it’s still 
premature to define NOD2 as a bona fide PRR.  Immunoprecipitation of NOD2 would 
be very likely to pull down NOD2-interacting proteins.  Since the adaptor MAVS 
(mitochondrial antiviral signaling protein) associates with NOD2 and MAVS interacts 
with RIG-I, it is also possible that the recovery of RSV-specific RNA was the results of 
co-immunoprecipitation of RIG-I.  In addition, the exact molecular features that activate 
NOD2 are still unknown.    
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Figure 1.2  NLR proteins and regulation of the RLR signaling. In the quiescent state 
(complex A), the CARD-CARD homotypic interaction between MAVS and RIG-I is 
prevented by MAVS association with NLRX1 and/or Atg5-Atg12 conjugate, perhaps by 
steric hindrance. Mfn2 interacts with the C terminus and the transmembrane region of 
MAVS to abolish its immune-activating function. The three regulatory proteins target 
different regions of MAVS to execute the “molecular brake.” In the presence of 
cytosolic 5′-triphosphate, ssRNA, or dsRNA, these brakes are released, which renders 
the assembly of the active form of mito-signalosome (complex B), in which MAVS 
interacts with NOD2 and RLRs, such as RIG-I, which directly interact with viral nucleic 
acid to trigger type 1 IFN production. 
 
For example, is the 5’-triphosphate moiety a necessity in this recognition?  Does dsRNA 
interact with NOD2?  Does NOD2 require ATP or GTP to associate with RNA? To 
demonstrate the direct binding of NOD2 to cytosolic RNA species and map the domain 
for such recognition, recombinant protein of full length NOD2 and its domain truncation 
mutants should be used in a cell-free binding assay.  Unfortunately many of the NLRs 
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become aggregated and thus insoluble in a mammalian or insect cells expression system, 
which renders the evaluation of direct binding technically challenging.  More sensitive 
assays such as protein-induced fluorescence enhancement (PIFE) or fluorescence 
resonance energy transfer (FRET) might shed light in resolving the conundrum.  
Evidences of direct binding would be compelling to establish the structural basis to group 
NOD2 into PRR. 
The fact that certain NLR protein expression is inducible by viral infection also 
raises the possibility that NLRs are actively involved in the antiviral signaling modulation.  
A novel cytoplasmic NLR member NLRC5 has been recently characterized by several 
independent groups 
132-136
.  NLRC5 is highly expressed in the hematopoietic cells and 
lowly expressed in epithelial cells.  Two groups noticed NLRC5 expression was 
upregulated by poly (I:C) treatment, SeV or Cytomegalovirus (CMV) infection 
134, 136
.  
In fact, NLRC5 contains the IFN-γ-responsive elements in its promoter region; and 
among a variety of treatments, including LPS, EGF (epidermal growth factor), TNF-α 
(tumor necrosis factor-α), Flagellin, TGF-β (transforming growth factor-β), MDP, 
Listeria monocytogenes and IFN-γ, only IFN-γ induces the expression of NLRC5 137.  
Overexpression of NLRC5 leads to the activation of the IFN-responsive regulatory 
promoter elements and the upregulation of antiviral target genes, such as IFN-α, OAS1 
and PRKRIR 
137
.  However, one group showed that overexpression of NLRC5 alone was 
not sufficient to activate type 1 IFN signaling, yet knockdown of NLRC5 reduced SeV- 
and poly (I:C)-mediated type 1 IFN induction in both THP-1 cells and human primary 
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dermal fibroblasts 
136
.  NLRC5 was also found to be critically involved in 
inflammasome activities 
138, 139
.  In contrast to these reported immune-activation effects, 
two other groups found that NLRC5 was a negative regulator of NF-κB and type 1 IFN 
signaling pathways 
132, 133
.  NLRC5 associated with RIG-I and MDA5 via the CARD 
domain to preclude their interaction with MAVS.  Reduction of NLRC5 level by RNA 
interference significantly increased type 1 IFN production.  In addition, NLRC5 also 
sequestered the IKKα/IKKβ complex to abolish their phosphorylation upon LPS 
challenges 
133
.  In agreement with the fact that NLRC5 overexpression inhibits NF-κB 
activity, reduction of NLRC5 leads to enhanced proinflammatory responses 
132, 133
.  
However, all these experiments relied on overexpression and RNA interference 
approaches.  A gene-deletion model has not been able to verify these findings 
139
, yet 
instead suggests a role for NLRC5 in inflammasome activation.  Our own study in 
human cell lines and primary monocytes also agrees with this finding 
138
. 
Inflammasome and RLR signaling complexes are two independent molecular 
machineries mediating caspase-1 and type 1 IFN activation.  Some nucleic acids sensors 
can only specifically activate one pathway but not the other 
62-65
.  However, RIG-I is 
also shown to associate with the inflammasome adaptor ASC to induce pro-caspase-1 
cleavage in a MAVS-, CARD9- and NLRP3-independent fashion.  In addition the 
activation of inflammasome by EMCV infection depends on MDA5, CARD9 and 
NLRP3 
140
.  The interaction between these pathways suggests that the assembly of either 
macromolecular complex depends on the characteristics of insults. 
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Figure 1.3  NOD2 signaling bifurcates into antibacterial and antiviral effector 
arms. A model of NOD2 signaling is presented in which NOD2 is bound to the 
chaperonin–ubiquitin ligase pair, HSP90 (heat shock protein 90) and SGT1 (suppressor 
of G2 allele of skp1), in the basal state (complex A). This is thought to hold the inactive 
NOD2 in a signaling-competent form. Upon stimulation with MDP, NOD2 binds to 
RIP2 and activates NF-κB and MAPK (p38 and JNK) through recruitment of several 
intracellular proteins, including cIAP1 and cIAP2 (complex B). This leads to the 
induction of chemokines, cytokines, and defensins, which mediate the antimicrobial 
responses. Similarly, viral infection can activate NOD2, leading to its translocation to 
the mitochondria, association with mitochondrial antiviral signaling protein (MAVS), 
and induction of the antiviral cytokine type I IFN (complex C). NOD2 also interacts 
with the dsRNA-binding protein OAS2. Overexpression of NOD2 can activate the 
RNase L pathway, providing a positive feedbaechanism for the mito-signalosome in 
response to RNA viruses. (complex C). RIG-I is depicted because it is the PRR that 
binds to viral nucleic acids, whereas TANK-binding kinase 1 (TBK1) and IκB kinase–ε 
(IKK-ε) lie downstream of MAVS to activate IRF-3. 
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1.7 The regulatory components of the RLR signaling pathways 
Given the great potential of MAVS and/or STING-mediated RLR signaling 
activation, this pathway is subjected to meticulous check mechanisms.  Thirteen host 
proteins have been identified up to date in the negative regulatory module of this complex 
including NLRX1, NLRC5, Atg5-Atg12 conjugate, gC1qR, Mfn2, RNF5, LGP2, CYLD, 
PCBP2, AIP4, A20, Triad3A and PSMA7 
75, 124, 125, 133, 141-149
 (Table 1.1).  RNAi-based 
reduction of these proteins levels results in enhanced type 1 IFN production in response 
to certain RNA viruses.  The complexity of this regulatory module safeguards against 
overzealous immune activation.  Although these proteins are functionally redundant, 
they primarily target RLR signaling via distinct mechanisms including molecular steric 
hindrance, autophagy as well as poly-ubiquitin (PUb) -mediated destabilization of 
adaptors and signaling modifications.  To be noted, one regulatory protein could employ 
different mechanisms to function and structurally diverse proteins could fall into the same 
regulatory mechanism category. 
The molecular steric hindrance hypothesis is based on the notion that some 
regulatory proteins could associate with the key molecules in the RLR signaling 
pathways, such as the PRRs, adaptors or downstream kinases; and such interaction 
competes them against their immune-activating engagement possibly by steric hindrance.  
This model has been supported by insights into the inhibitory mechanisms of NLRX1, 
NLRC5, LGP2, Atg5-Atg12 conjugate and Mfn2, all of which inhibit MAVS-mediated 
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induction of type 1 IFN.  In agreement with this, MAVS resides in a supramolecular 
complex in the quiescent state, but the majority of this protein migrates into a lower 
molecular weight complex when activated 
125
.  One possible explanation for the 
difference in signaling complex assembly could be attributed to the release of these 
molecular brakes.  In fact, overexpression of NLRX1 abolishes the interaction between 
RIG-I and MAVS, and knockdown of NLRX1 results in higher resistance to Sindbis virus, 
 
Regulatory 
Mechanisms Regulators 
Molecular 
Steric 
Hindrance 
Targeting 
MAVS CARD  NLRX1 NLRC5 
Atg5-Atg12 
conjugate NOD2     
Targeting 
MAVS 
C-terminus Mfn2 LGP2         
Autophagy 
Distrubance 
Deficiency in 
autophagy Mfn2 Atg5 
Atg5-Atg12 
conjugate       
Ub-mediated 
modulation 
Proteosomal 
degradation A20 PCBP2 AIP4 PSMA7 RNF5 Triad3A 
Signaling 
modification CYLD DUBA 
Unanchored 
PUb chain TRIM23 TRIM25   
Unknown 
mechanism   gC1qR           
 
Table 1.1  The modulators of RLR signaling.  The regulators of RLR signaling 
could be classified into three categories based on their functioning mechanisms.  The 
molecular steric hindrance hypothesis is based on the notion that some regulatory 
proteins could associate with the key molecules in RLR signaling to compete against 
their immune-activating engagement.  Autophagy disturbance has been implicated in 
aberrant ROS production and damaged mitochondria accumulation, which cultivates in 
RLR signaling modification.  PUb-mediated modulation is a set of delicate regulatory 
mechanisms composed of both PUb-mediated destabilization of the adaptors and 
PUb-mediated non-proteolytic signaling modification.  Red color denotes negative 
RLR signaling regulators; dark blue color denotes positive regulators. 
29 
 
which induces type 1 IFN production in a RIG-I-dependent manner 
124
.  Similarly, 
NLRC5 preferentially binds to the CARD domain of RIG-I and strongly competes with 
MAVS for engagement.  NLRC5 does not interact with MAVS, IKKi, TBK1, TRIF, 
TRAF3 or IRF3, which underlies the fact that NLRC5 potently inhibits RIG-I- and 
MDA5-induced IFNB1 promoter activation yet only shows weak effect on MAVS- and 
TBK1-induced RLR signaling induction 
133
.  The accessibility to the CARD domain of 
PRR by either regulatory proteins or adaptor proteins determines the functional outcome 
RLR signaling.  It is not surprising to see another regulatory component that employs 
the same mechanism to keep this pathway in-check.  The Atg5-Atg12 conjugate intrudes 
between RIG-I and MAVS to abolish the homotypic CARD interactions and inhibits type 
1 IFN production 
141
.  The proper functioning of MAVS depends on the integrity of both 
CARD and its C-terminus, in fact, the truncation of the transmembrane domain 
completely ablates its capacity to mount type 1 IFN production.  Another “molecular 
break” Mfn2, targets the C terminal region of MAVS instead of the N-terminal CARD for 
modulation; and reduction of Mfn2 by siRNA leads to a decrease in the MAVS apparent 
molecular mass 
125
.  This strategy is also shared by a unique RLR member LGP2, which 
has a DExD/H domain as RIG-I and MDA5 do, yet lacks the CARD domain.  LGP2 
also interacts with the C-terminus of MAVS and precludes its interaction with 
downstream IKKi 
145, 150
.  However, in the gene-deletion mouse model, Lgp2
-/-
 cells 
demonstrate impaired ability to mount type 1 IFN production in response to picornavirus 
infection; in addition the ATPase activity of LGP2 is essential for its facilitation of host 
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antiviral responses against encephalomyocarditis virus 
151
.  In the current model, these 
regulatory proteins target different regions of MAVS for steric preclusion of its 
engagement with immune-activating molecules.  Interestingly, the molecular steric 
hindrance mechanism can also be presented by the splice variants of the adaptor itself.  
A recent report identified two MAVS splice variants: MAVS1a lacking exon 2 and 
MAVS1b lacking exon 3 
152
.  During the excision of exons, a frame shift occurs.  Both 
splice variants possess the CARD domain, which is essential to engage with upstream 
RLRs.  However, MAVS1a does not have the essential signaling domains to transduce 
RLR interaction to downstream effector activation.  Meanwhile MAVS1b could interact 
with FADD and RIP1 to selectively induce type 1 IFN production 
152
.  Hence, MAVS1a 
functions as a steric blockade for full length MAVS to recruit downstream signaling 
complexes.  
Macroautophagy (referred to as autophagy)-related mechanisms represent a 
group of novel host strategies in keeping RLR signaling from over-reacting.  Besides 
mitochondria, ER, MAM and peroxisomes, another membrane bound structure that has 
been emerging to be a platform for antiviral signaling modulation is autophagosome.  
Autophagy is an evolutionarily conserved cellular function to recycle nutrients and 
maintain homeostasis.  This process together with the proteosome-dependent 
mechanisms constitutes the major intracellular degradation system.  It not only recycles 
damaged or aged organelles, misfolded proteins but also sequesters invading 
microorganisms as a primary host defense strategy.  Autophagy disturbance has been 
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implicated in cellular components turnover, development, differentiation, tissue 
remodeling and numerous diseases such as cancer, muscular disorders, neurodegeneration 
and infectious diseases 
153, 154
. 
Autophagy has been artificially categorized into four phases: (1) vesicle nucleation, 
in this phase the double-membrane structure begins to form and sequesters part of the 
cytoplasm and damaged organelles; (2) vesicle elongation, in this phase, the membranes 
continue to grow until they reach the next phase; (3) docking and fusion, autophagosome 
formation is complete at this stage where the ends of isolated vesicles finally meet; (4) 
vesicle fusion and content breakdown, the autophagosome fuses with lysosome to deliver 
cargo into the newly formed autolysosome for content and inner membrane degradation 
154
.   
Inhibition of the TOR kinase is a major stimulus that activates autophagy 
155, 156
, 
which involves Atgs (Autophagy-related Genes encoded proteins).  Among about 30 
Atgs identified to date, there are two essential conjugation systems centering on Atg12 
and Atg8 (also referred to as LC3 in mammals) for autophagosome formation.  Similar 
to ubiquitin, Atg12 and Atg8 have conserved ubiquitin-fold regions despite their lack of 
amino acids sequence homology to ubiquitin 
157, 158
.  Once activated, Atg12 will be 
transferred to Atg5 with the assistance of E1-like enzyme Atg7 and E2 enzyme Atg10.  
The Atg5-Atg12 conjugate also interacts with Atg16 to form a protein complex.  Atg8 is 
conjugated to phosphatidylethanolamine (PE) (Atg8-PE or LC3-II) during 
autophagosome membrane expansion 
159
.  Hence biochemical detection of LC3-II is 
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widely accepted as a measurement for autophagy 
160
. 
Besides being actively involved in autophagosome biogenesis, Atg5-Atg12 conjugate 
has been recently found to associate with RIG-I and MAVS via the CARD domain and 
inhibit downstream type 1 IFN signaling activation.  Overexpression of Atg5-Atg12 
results in dampened NF-κB and IRF3 activation; and Atg5-/- MEFs are more resistant to 
VSV infection due to enhanced type 1 IFN production 
141
.  The deficiency of autophagy 
itself could lead to the accumulation of damaged mitochondria, which results in the 
buildup of MAVS and enhanced levels of intracellular ROS.  Either of such effect leads 
to the induction of type 1 IFN 
142
. 
The functions of autophagy in antiviral innate immune response are cell type specific.  
Plasmacytoid dendritic cells (pDCs) primarily rely on TLRs to recognize viral PAMPs in 
a MAVS-independent fashion.  Autophagy is essential for the transport of cytosolic viral 
replication intermediates into the endosomal/lysosomal compartment for TLR7 
engagement 
161
.  In pDCs, absence of autophagy results in compromised antiviral innate 
immune response in contrast to the hyperactive type 1 IFN production in MEFs, which 
utilize the RLR axis to respond to the viral infections. 
Mitochondria are closely associated with autophagosomes, and many proteins in both 
organelles have been linked to functional regulation of the other.  For example, 
autophagic proteins Atg5 and Atg9 can be transiently localized onto mitochondria 
162, 163
; 
similarly mitochondrial proteins Bif-1 and Sirt1 are essential for autophagy 
164, 165
.  A 
recent study shows that both Atg5 and LC3 can be temporarily localized to punctae on 
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mitochondria.  Importantly, mitochondria provide membranes for the biogenesis of 
autophagosomes 
4
.  Mfn2 is responsible for tethering mitochondria to ER, and 
deficiency in Mfn2 leads to the disruption of the transfer of lipids from ER, which is 
necessary for proper mitochondrial functioning.  Indeed Mfn2
-/-
 cells have severely 
impaired autophagosome formation 
4
.  Given the fact that reduction of Mfn2 also leads 
to enhanced RLR signaling, it is plausible that Mfn2 not only contributes to the molecular 
steric hindrance in blocking MAVS association with downstream IKK complexes, but 
also inhibit this pathway via autophagy-mediated mechanism.  However, further study is 
needed to understand how Mfn2 deficiency-mediated autophagy defects contribute to the 
RLR signaling modulation. 
Although the molecular explanations of fasting or calories restriction favor its 
beneficial role in lowering the risks of obesity and reasonably prolonging human life 
expectancy 
154
, it might not be salutary for the innate defense system.  As the caspases 
system is generally considered to be the initiators and executioners of programmed cell 
death, Atgs are pivotal in the biogenesis of autophagosomes as well; to be noted, there are 
a plethora of non-caspase proteins that have been identified up to date to have 
pro-apoptotic functions in a caspase-dependent fashion, intensive search for additional 
factors that are critical in mediating virus-induced autophagy needs to be performed to 
gain deeper insight into the mechanisms by which host cells use to modify 
autophagy-related innate immune responses. 
Polyubiquitin (PUb)-mediated modulation has emerged as an important regulatory 
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mechanisms of RLR signaling, which involves both polyubiquitination- mediated 
destabilization of the adaptors and PUb chain-mediated non-proteolytic signaling 
modification.  Ubiquitin conjugation system is composed of a three-step program, in 
which an ubiquitin-activating enzyme (E1) activates the globular ubiquitin protein by 
forming an E1~Ub thioester bond in an ATP-dependent fashion.  Activated Ub is then 
transferred to an Ub-conjugating enzyme (E2), which directs the reaction intermediates to 
the Ub ligase (E3).  E3 associates with both E2 and the target protein to deliver Ub to 
the corresponding lysine residues.  E3 alone or sometimes E2 and E3 together dictates 
the substrate specificity of PUb modification 
166
.  There are 2 E1 enzymes, over 40 E2 
enzymes and 600 E3 enzymes in human cells.  There are two classes of E3 enzymes 
which contain a HECT (homology to E6AP C-terminus) or a RING (really interesting 
new gene) domain respectively 
167
.  It is the diversity of E3 that expands the repertoire 
of Ub substrates.  Ub can be delivered to a protein as a monomer or a PUb chain.  The 
difference in the Ub linkage also activates distinct regulatory pathways.  Ub contains 7 
lysine residues including K6, K11, K27, K29, K33, K48 and K63.  The protein 
modification via the K48 residue of Ub is frequently transported to the 26S proteosome, 
leading to protein degradation and Ub recycling.  However, a modification of K63 
residue-linked PUb chain is associated with alteration of signaling activity 
166
. 
RIG-I is heavily polyubquitinated when transfected into HEK293T cells, however, 
the mutant lacking the CARD domain has no PUb modifications.  A recent study 
identified K63 linkage of RIG-I, which raised the possibility that RIG-I function is 
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modulated by polyubiquitination 
168
.  In fact, a further mass-spectrometry analysis 
revealed an E3 ligase TRIM25 as a RIG-I-binding partner.  TRIM25 contains a RING 
domain in addition to its B box/coiled-coil domain (B Box/CCD) and C-terminal SPRY 
domain, which is responsible for RIG-I-binding.  Deficiency in TRIM25 not only results 
in diminished polyubiquitination of RIG-I, but also compromises type 1 IFN signaling 
168
.    
Such polyubiquitination modification is also tightly regulated by phosphorylation at 
RIG-I Thr-170 site, which is in close vicinity to a primary site of K63 polyubiquitination 
Lys-172.  A mutation of Thr-170 to Glu-170 abolishes both polyubiquitination 
modification of RIG-I and downstream type 1 IFN signaling 
169
.  Consistently, 
RIG-I-mediated RLR signaling activation is negatively regulated by a deubiquitinating 
enzyme tumor suppressor CYLD (cylindromatosis), which removes K63-linked PUb 
chains.  CYLD expression level is reduced in the presence of viral infections and RNA 
interference targeting its mRNA leads to augmented type 1 IFN production 
147
.  
Deubiquitinase also targets TRAF3, which is recruited to the MAVS upon activation.  
DUBA (deubiquitinating enzyme A20) is known to cleave the K63-linked PUb chains on 
TRAF3 to abolish its association with downstream TBK1 and subsequent type 1 IFN 
production.  Overexpression of DUBA quenches RLR activation and reduction of 
DUBA augments such responses 
170
.  Similarly proper RLR signaling also depends on 
the polyubiquitination of NEMO (also known as IKKγ) at the K27 residue by an E3 
enzyme TRIM23.  Deficiency in TRIM23 expression impaires RLR signaling 
171
. 
The essential role of K63 polyubiquitination in activating RLR signaling is further 
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corroborated in an in vitro reconstitution experiment.  RIG-I isolated from virus-infected 
cells can potentiate the dimerization of IRF3, which is a hallmark of RLR activation, in 
the presence of mitochondria and cytosolic extracts.  When RIG-I and TRIM25 are 
incubated with E1 and a panel of E2s, Ubc5 and Ubc13 have been shown to be essential 
for RLR activation 
172
.  Interestingly, in addition to the K63-linked PUb chains 
conjugation, a recent study demonstrated an unusual function of unanchored PUb chains 
in the modulation of RLR signaling 
172
.  Incubation of the helicase domain truncation 
mutant of RIG-I (ΔRIG-I) with a PUb chain comprised of 4 ubiquitin molecules linked 
via K63 potently induces IRF3 dimerization.  However, the PUb chains linked via K48 
or shorter PUb chains comprised of 2 ubiquitin molecules are inert in activating RLR 
signaling.  When full length RIG-I is incubated with 5’ppp-dsRNA and K63 PUb chains, 
IRF3 dimerization is also potently induced as observed in experiment with the 
constitutively activated ΔRIG-I.  Notably endogenous K63 PUb chains concentration is 
approximately 300 folder higher than the EC50 for RLR activation, which explains why 
overexpression of ΔRIG-I is sufficient to induce type 1 IFN production.  These findings 
identify the ubiquitin system has profound effects on the outcome of RLR activation 
172
. 
PUb-mediated destabilization represents another distinct set of mechanisms by which 
RLR signaling is regulated.  The target proteins are either the adaptor proteins, MAVS 
and STING, or essential downstream signaling molecule such as TRAF3.  In two 
independent yeast two hybrid screenings for MAVS-interacting proteins, PCBP2 and 
PSMA7 were identified as interacting partners.  PCBP2 recruits an E3 ligase AIP4 to 
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mediate the proteosomal degradation of MAVS.  Interestingly, the expression level of 
PCBP2 is induced by viral infections 
148
, suggesting this molecule might be harnessed by 
certain viruses to subvert host defense system.  Another protein PSMA7, which is a 
subunit of the 20S proteosome, also mediates the proteosomal degradation of MAVS.  
Reduction of PSMA7 results in enhanced type 1 IFN signaling although the precise 
mechanism of its function remains unclear 
144
.  STING is targeted by an E3 ligase RNF5, 
which adds the PUb chain to the Lys150.  Despite the multiple localizations of RNF5 at 
ER, endosome and mitochondria, SeV infection induces local condensation of RNF5 at 
mitochondria accompanied by the downregulation of STING 
75
.  Another 
virus-inducible E3 enzyme is Triad3A, which includes TRAF-interacting motifs (TIMs).  
Triad3A binds to TRAF3 via TIM; and the TRAF3 Y440 and Q442 mutations disrupt 
such association.  Triad3A negatively regulates RLR signaling by targeting TRAF3 for  
proteosomal degradation 
149
.  A20 is an ubiquitin-editing enzyme composed of both an 
N-terminal deubiquitination domain and a C-terminal ubiquitin ligase domain.  
Overexpression of A20 potently inhibits RLR signaling and only the ligase domain but 
not the deubiquitination domain is responsible for its inhibitory function.  However, 
RIG-I is not degraded by A20, further studies are necessary to delineate the molecular 
mechanism of its function 
146
. 
The Mitochondrial Immune Signaling Complex is a dynamic protein complex 
localized in the mitochondria, whose composition is responsive to cytosolic 5’-ppp RNA, 
dsRNA and DNA.  NLR proteins actively participate in the activation and regulation of 
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this complex to induce type 1 IFN production.  In addition to immune modulation, the 
complex also contains proteins that are pivotal in autophagy 
141, 142
 and apoptosis 
173, 174
.  
Further characterization of its composition and function would certainly shed light on our 
understanding of mitochondria as a critical platform for host-virus interaction and future 
strategic design of antiviral therapeutics to elicit host antiviral response to full potential. 
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CHAPTER TWO 
 
MAVS-MEDIATED APOPTOSIS AND ITS INHIBITION BY VIRAL PROTEINS 
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2.1 Abstract 
Host responses to viral infection include both immune activation and programmed cell 
death.  The mitochondrial antiviral signaling adaptor, MAVS (IPS-1, VISA or Cardif) is 
critical for host defenses to viral infection by inducing type-1 interferons (IFN-I), 
however its role in virus-induced apoptotic responses has not been fully elucidated.  We 
show that MAVS is a pro-apoptotic protein independent of its function in initiating IFN-I 
production.  MAVS-induced cell death requires mitochondrial localization, is caspase 
dependent, and displays all of the hallmarks of apoptosis.  Consistent with these data, 
fibroblasts from Mavs
-/-
 animals are resistant to Sendai virus-induced apoptosis.  A 
functional screen of the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) 
genome identified the nonstructural protein (NSP15) that inhibited MAVS-induced 
apoptosis, possibly as a method of immune evasion.  This study describes a novel role 
for MAVS in controlling viral infections through the induction of apoptosis, and 
identifies viral proteins, which inhibit this host response. 
41 
 
2.2 Introduction 
In recent years, knowledge of host cell-signaling responses to viral infection has 
progressed rapidly.  It is known that cells of the immune system contain toll-like 
receptors (TLRs) capable of detecting extracellular or endosomal viral nucleic acid and 
activating appropriate signal transduction pathways leading to the up-regulation of 
immune and inflammatory cytokines.   Besides detecting extracellular viral products, 
somatic cells can also respond to intracellular viral RNA by activating the recently 
identified mitochondrial antiviral signaling pathway.  Following cytoplasmic detection 
of viral nucleic acid by the RIG-I-like helicases (RLH) family of receptors, these and 
other signaling proteins are recruited to the mitochondria where they interact with the 
mitochondrial antiviral signaling adaptor protein MAVS (IPS-1, VISA and Cardif) 
34-37
.  
In vitro and In vivo experiments have revealed a critical role for MAVS and its 
mitochondrial localization in the activation of host antiviral responses 
34, 175
.  Although 
the role of MAVS in type-1 interferon (IFN-I) responses is known, the localization of 
MAVS to the mitochondria suggests other putative mitochondrial functions for MAVS, 
prominent among these is apoptosis.  However, to date, there are no comprehensive 
studies focused on testing this hypothesis.  Notably, host cell apoptosis is a successful 
strategy to impede viral replication and restrict virus spreading during a productive 
infection 
176
. 
Multicellular organisms are equipped with at least two evolutionarily conserved 
defensive arms to eradicate viral infections: programmed cell death and innate immune 
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responses.  Many proteins which function in both apoptotic and inflammatory signaling 
cascades contain a caspase recruitment domain (CARD), which functions as a homotypic 
interaction motif.  In fact, the biological function of the CARD domain was initially 
described in a subset of caspases which activate mitochondrial dependent apoptotic 
signaling 
177
.  For example, the CARD containing Apaf-1 (apoptosis protease-activating 
factor-1) protein binds to cytochrome c and forms a ternary multimeric protein structure 
called the apoptosome which functions to activate caspase-9 via a proximity-induced 
mechanism 
178
.  Other CARD-containing proteins including some members of the NLR 
(nucleotide-binding domain and leucine-rich repeat containing) protein family have been 
linked with both apoptotic and inflammatory signaling 
179
.  For example, the 
CARD-containing NLR, Nod1, has been shown to activate a caspase-9 dependent 
apoptosis and play a positive regulatory role in pathogen-induced NF-κB activation 180.  
Similarly, Nod2, a protein linked with the etiology of the autoinflammatory Crohn’s 
disease, has been reported to augment caspase-9-induced apoptosis when overexpressed 
181
. A third CARD-containing NLR, IPAF (NLRC4), mediates cell death through a 
caspase-1 dependent fashion 
110, 182, 183
. 
Similar to the aforementioned proteins, MAVS contains an N-terminal CARD-like 
domain, in addition to a central proline-rich region and a C-terminal transmembrane (TM) 
domain, which targets MAVS to the mitochondrial outer membrane 
34
.  Recent crystal 
structure analysis reveals that the CARD-like domain of MAVS is indeed a classical 
CARD fold with surface charge profiles of a typical CARD domain involved in 
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homotypic associations 
184
.  Consequently, the presence of a CARD-like domain 
coupled with its mitochondrial localization suggests a putative role for MAVS in both 
immune and cell death responses.  In fact, both the N-terminal CARD-like and TM 
domains are indispensable for MAVS-mediated activation of interferon regulatory 
factor-3 (IRF-3) and subsequent transcription of the antiviral IFN-I, suggesting that these 
domains are critical to MAVS function 
34
.  As a survival mechanism, it is known that 
some viruses have evolved strategies to inhibit MAVS function through selective 
targeting of these functional domains.  For example, the genome of hepatitis C virus 
(HCV) has evolved to include a serine protease, NS3/4A, which cleaves the MAVS TM 
domain and dislodges MAVS from the mitochondria, thereby abrogating MAVS mediated 
IFN-I production 
37, 185
.  Similar to HCV, hepatitis A virus (HAV) encodes for the 3ABC 
protein, which localizes to the mitochondria and inhibits MAVS signaling via proteolytic 
cleavage 
2, 186
.  Currently, there are no reports of viral proteins targeting MAVS for 
inhibition of virus-induced cell death responses. 
Host cell apoptosis has been reported to suppress viral replication and the 
subsequent production of infectious progeny viruses 
187
.  For example, adenoviruses and 
baculoviruses which are defective in anti-apoptotic genes are compromised in producing 
progeny viruses 
187
.  In addition, several viruses infectious to humans, including the 
coronaviruses, are known to modulate host cell apoptotic responses 
188, 189
.  In 2003, 
researchers from several labs identified a unique coronavirus linked with the 
pathogenesis of severe acute respiratory syndrome (SARS) in humans 
190-192
.  The 
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spread of SARS-CoV, reaching near pandemic levels, resulted in the death of over 900 
individuals with a case fatality rate of 11% 
193
.  Since that time, the sequencing of the 
complete SARS-CoV genome has allowed scientists to study the function of each 
SARS-CoV encoded protein in greater details.  Phylogenetic analyses revealed that 
SARS-CoV was not closely related to any other characterized coronaviruses 
194, 195
.  The 
distinct nature of the SARS-CoV genome suggests possible unique strategies employed 
by this virus to subvert host defense mechanisms.  Notably, unlike other common 
human respiratory viral infections, such as influenza A virus, the viral loads in the upper 
airway of SARS patients progressively increase, reaching a peak around 10 days after the 
initial onset of symptoms 
196
.  This indicates that at least during the initial stages of 
SARS-CoV infection, this virus might suppress host defensive responses.  In fact, 
several SARS-CoV proteins have been shown to inhibit host IFN-I responses 
188, 189, 197
.  
Although the fact that certain clinical manifestations of SARS such as lymphopenia and 
cell death in the lung or liver are thought to be related to the ability of SARS-CoV to 
induce apoptosis in specific cell types and that several pro-apoptotic proteins have been 
found in SARS-CoV genome 
198-200
, the early pathogenesis of SARS is poorly understood 
and how apoptosis contributes to the initial pathological changes is largely unknown.  In 
addition, the replication of SARS-CoV seems to be restrained to the first two weeks upon 
symptom onset with little evidence of continued replication after this time window 
201
.  
Clearly, the temporal and cell-type specific expression of SARS-CoV proteins could 
account for the dynamics of SARS-CoV infection and given that host cell fate decisions 
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are a part of overall host responses to any pathogen, it is conceivable that like SARS-CoV 
inhibitory effects on IFN-I responses, this virus could employ proteins which function as 
inhibitors of host cell death.  In this report, we describe a novel function of MAVS in 
mediating virus-induced apoptosis, and identify a SARS-CoV protein which inhibits this 
response.  
2.3 Results 
MAVS induces caspase-dependent apoptosis. 
 Transient expression of MAVS protein causes HEK293T cells to crenate and lose 
adherence, suggesting that MAVS is cytotoxic (Fig. 2.1A).  Although some cell death 
was observed at 24 hours post-transfection, it was most evident at 48 hours 
post-transfection, which was quantitated by the Trypan blue exclusion test of cell viability.  
In this assay, we observed a dose-dependent increase in the percentage of Trypan blue 
positive cells at 48 hours post-transfection with MAVS plasmid (Fig. 2.1B).  This result 
was confirmed by measurements of cell viability via XTT assay.  MAVS-induced cell 
death is potent as 10ng of MAVS plasmid was sufficient to decrease cell viability by 40% 
(Fig. 2.1C). 
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Figure 2.1 MAVS induces cell death.  (A) MAVS overexpression in HEK293T cells 
results in cell death. (B) MAVS-induced cell death displays dose dependency 
determined by Trypan blue exclusion cell counting. Cells were harvested for Trypan 
Blue counting 48 h post-transfection. (C) In the XTT cell viability assay, 
1.0×10
4
 HEK293T were plated in 96-well plate, and increasing doses of MAVS from 0 
ng/well to 200 ng/well were transfected and total amount of plasmids for each well was 
maintained at 400 ng by mixing pcDNA3 and MAVS plasmids together. XTT assays 
were performed 48 hours post-transfection. Error bar represents standard deviation of 
triplicates of biological samples and each graph represents three individual 
experiments. 
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MAVS contains a N-terminal CARD-like domain, which is well conserved from 
human to pufferfish 
34
; and the CARD domain of other proteins has been shown to 
mediate the activation of caspases, facilitating apoptosis 
202
.  Therefore, we next sought 
to test the hypothesis that MAVS induces apoptosis through a caspase-dependent 
mechanism.  It is well known that blockade of caspase activity will inhibit the intrinsic 
apoptotic pathway
203
.  Thus, we treated HEK293T cells with a pan-caspase inhibitor 
(Z-VAD-FMK) followed by transfection of increasing amounts of MAVS plasmid.  As 
expected, transient MAVS expression in untreated cells resulted in a significant loss of 
cell viability as measured by XTT assay (Fig. 2.2A, black bars); and application of the 
pan-caspase inhibitor resulted in a complete reversal of MAVS-induced cell death (Fig. 
2.2A, grey bars).  It is known that caspase-dependent apoptosis can cause Poly 
(ADP-ribose) Polymerase (PARP) cleavage, thus we investigated the effect of MAVS 
expression on the triggering of PARP cleavage.  HEK293T cells were transfected with 
two different doses of MAVS plasmid and both adherent and floating cells were harvested  
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Figure 2.2  MAVS expression leads to apoptosis.  (A) MAVS-induced cell 
death is caspase-dependent. HEK293T cells were treated with a pan-caspase 
inhibitor z-VAD-FMK before transfection with a titration doses of MAVS, and 
cell viability was measured by XTT assay. (B) MAVS triggers PARP cleavage as 
well as the activation of caspase-3 and caspase-9. One million HEK293T cells 
were transfected with 1 µg or 3 µg of MAVS-expressing plasmids and harvested 
24 h or 48 h post-transfection. Cell extracts were immunoblotted for PARP, 
caspase-3 and caspase-9. (C) Densitometry analysis on the Western blot shown 
in (B). (D) Apoptotic morphological features of MAVS-induced cell death. 
Three micrograms of MAVS plasmids were transfected into 5×105 HEK-293T 
cells. Transmission electron microscopy (TEM) analysis was carried out 48 
hours post-transfection. Arrows: (I) intact plasma membrane; (II) marginated 
and condensed chromatin; (III) large vacuole; (IV) swollen mitochondria. Each 
graph represents two individual experiments. 
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and lysed 24 and 48 hours post-transfection.  Immunoblotting followed by densitometry 
measurements revealed a dose-dependent increase in PARP cleavage (Fig. 2.2B-C).  In 
congruence with the PARP cleavage pattern, caspases-3 and caspase-9 protein levels also 
showed a dose-dependent increases following MAVS expression (Fig. 2.2B-C). 
Transmission electron microscopy examination of HEK293T cells transfected with 
MAVS or empty vector was performed at 48 hours post-transfection (Fig. 2.2D).  Unlike 
the otherwise healthy cells transfected with empty vector (Fig. 2.2D, top panel), 
MAVS-expressing cells exhibit all of the morphological hallmarks of apoptosis including 
an intact plasma membrane (Fig. 2.2D, bottom panel arrow I), crenation, condensed and 
marginated chromatin (arrow II), large vacuoles (arrow III), cytoplasm shrinkage, 
membrane blebbing, an intact nuclear envelope, and swollen mitochondria (arrow IV)  
204
.  Interestingly, even though the expression of MAVS reached peak at 24h 
post-transfection (Fig. 2.3A), the apoptosis became apparent at later time point (Fig. 
2.3B). 
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Figure 2.3  The kinetics of MAVS expression and MAVS-induced apoptosis. (A) 
5×10
5
 HEK293T cells were plated in 6 well plate, 3µg MAVS plasmids were 
transfected at 3h, 12h, 24h and 48h prior to cell harvesting. Half of the cells were lysed 
in RIPA buffer and blotted with anti-FLAG to determine the protein expression 
kinetics. (B) The other half of the cells from each well were stained with Annexin V 
and analyzed by flow cytometry. 
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Virus-induced apoptosis in primary mouse fibroblasts requires MAVS.  
The aforementioned studies analyzed the effect of transient expression of MAVS on 
cell death.  To explore the physiological role of endogenous MAVS in mediating 
virus-induced apoptosis, we extended these 
findings to investigations of recombinant Sendai 
virus expressing GFP (rSeV-GFP) infected mouse 
embryonic fibroblasts (MEFs) isolated from 
MAVS knockout or wild type littermate control 
mice.  MAVS deficiency was confirmed by 
Western Blot (Fig. 2.4).  Mavs
-/-
 and wildtype 
littermate control MEFs were infected with 
rSeV-GFP, a known inducer of apoptosis 
205
,  48 
hours post-infection, infection efficiency in both 
cell lines was measured by the percentage of rSeV-GFP. No difference in infection 
percentage was found between wildtype and Mavs
-/-
 MEFs (Fig. 2.5A, top graph).  In 
contrast, the percentage of Annexin V positive cells was >30% among infected wildtype 
MEFs compared to <8% for the Mavs
-/-
 MEFs (Fig. 2.5A, bottom graph).  Similarly, 
MAVS-deficient MEFs maintained a spindle-like fibroblastic morphology (Fig. 2.5B, 
GFP bottom panel), while wildtype MEFs crenated and became detached from the plate.  
In addition, rSeV-GFP infected wildtype MEFs have higher propidium iodide/Hoechst 
staining ratio as compared to MAVS
-/-
, further indicating an increase in cell death (Fig.  
 
Figure 2.4  Confirmation of 
MAVS knockout by Western 
Blot. One million Mavs
+/+
 and 
Mavs
−/−
 MEFs were lysed in 
RIPA buffer containing proteinase 
inhibitor cocktail. Cell extracts 
were subjected to SDS-PAGE and 
Western blotting for rodent- 
specific MAVS. 
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Figure 2.5  MAVS is essential for virus-induced apoptosis in primary mouse 
embryonic fibroblasts.  (A) MAVS is critical for SeV-induced apoptosis. MAVS wild 
type and knockout MEFs were infected with recombinant Sendai virus expressing GFP 
at a MOI of 0.5. Forty-eight hours post-infection, GFP-positive cells were gated (top 
graph) and then subjected to Annexin V binding analysis (bottom graph) by flow 
cytometry. (B) MAVS wild type and knockout MEFs were infected with rSeV-GFP at 
the MOI of 0.5. Forty-eight hours post-infection, cells were stained with Hoechst blue 
and Propidium Iodide (PI). (C) Morphological features of MAVS wild type and knock 
out MEFs infected by SeV. TEM pictures were taken 48 h post-infection. While SeV 
infected wildtype cells displayed morphology typical of apoptotic cells, SeV infected 
Mavs
−/−
 cells did not exhibit such morphology. Each graph represents two separate 
experiments. 
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2.5B, Hoechst and PI panels).  Transmission electron micrographs taken for both cell 
types, with or without SeV, demonstrated that SeV infection resulted in the presence of 
typical apoptotic features in the wildtype MEFs (Fig. 2.5C, left panels).  However, SeV 
infected Mavs
-/-
 showed little signs of apoptosis and are indistinguishable from the 
uninfected controls (Fig. 2.5C, right panels).   
Mitochondrial localization is required for MAVS-induced apoptosis. 
Previous reports have shown that the MAVS C-terminal transmembrane domain (TM) 
is essential to MAVS function as an adaptor in IFN-I signaling 
34
.  Therefore we sought 
to determine the essential domain that mediates MAVS-induced apoptosis.  We 
expressed full length MAVS protein or three truncation mutants (Fig. 2.6A) in HEK293T 
cells and measured Annexin V and 7-AAD staining.  The MAVSΔTM mutant, which 
lacks the mitochondrial transmembrane sequence, was completely incapable of inducing 
apoptosis, suggesting that similar to the role of MAVS in interferon signaling, 
mitochondrial localization is essential to MAVS activation of apoptosis (Fig. 2.6B, top 
right panel).  Truncation of the MAVS CARD domain (MAVSΔCARD) significantly 
inhibited MAVS-induced apoptosis, but to a lesser extent than the aforementioned 
MAVSΔTM mutant (Fig. 2.6B, bottom left panel).  Truncation of the MAVS proline rich 
region (MAVSΔProl) had little effect on MAVS-induced apoptosis (Fig. 2.6B, bottom 
middle panel).  All the MAVS truncation mutants were expressed well (Fig. 2.7A, 2.7B), 
thus the differences in the potency of inducing apoptosis are not due to the protein 
expression but the intrinsic ability to activate downstream pro-apoptotic signaling.  To 
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solidify the  
  
 
Figure 2.6  Distinct MAVS domains are required for apoptosis.  (A) The domain 
structure of MAVS. MAVS contains a N-terminal CARD-like domain, a C-terminal 
transmembrane domain (TM) and a central proline-rich region. The cartoon shows the 
structure of the three truncation mutants we used in the study. (B) The TM and 
CARD-like domains are not dispensable for the pro-apoptotic function of MAVS. 1 µg 
of wildtype MAVS and its three mutants depicted in (A) were introduced in HEK293T 
cells; and apoptosis was assessed by flow cytometry 48 h post-transfection using 
7-AAD and Annexin V as markers of dead and apoptotic cells respectively. (C) The 
mitochondrial localization of MAVS is critical for its pro-apoptotic function. Cell 
viability was determined by XTT assay. (D) MAVS induces mitochondrial membrane 
potential collapse in HEK293T cells as quantified by TMRE staining. Each graph 
represents two separate experiments. 
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Figure 2.7  Expression test of MAVS truncation mutants. 3 µg FLAG-MAVS wild 
type, FLAG-MAVSΔCARD, FLAG-MAVSΔpro and HA-MAVSΔTM plasmids were 
transfected to 5×105 HEK-293T cells seeded in 6 well plate. Cell were harvested 24 h 
post-transfection and blotted with anti-FLAG or anti-HA antibody to confirm protein 
expression efficiency. 
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mitochondrial dependency of MAVS-induced cell death, we co-expressed MAVS with the 
hepatitis C virus (HCV) protein NS3/4A.  NS3/4A is a serine protease which has been 
shown to target the MAVS TM domain for cleavage and subsequent inhibition of MAVS 
antiviral signaling 
37, 186
.  Consistent with its role in inhibiting MAVS mediated IFN-I 
signaling, NS3/4A inhibited MAVS induced apoptosis (Fig. 2.6B, bottom right panel).  
The inhibitory effects of MAVSΔTM mutant and NS3/4A were also verified by a 
measurement of cell viability via XTT assay (Fig. 2.6C).  Mitochondrial membrane 
potential collapse marks a point-of-no-return during apoptosis and occurs earlier than 
DNA fragmentation 
206, 207
.  Only wildtype MAVS resulted in compromised 
mitochondrial membrane potential as measured by TMRE staining while the addition of 
NS3/4A abrogated this effect (Fig. 2.6D).   
MAVS-induced apoptosis is independent of type-1 interferon production or NF-κB 
activity. 
It has been shown that exogenous MAVS expression triggers IFN-I production 
34, 
175
.  Type-1 IFNs mediate their effects by binding to cell surface receptors, activating 
downstream interferon-stimulated genes or ISGs, among which more than 15 genes have 
pro-apoptotic functions 
208
.  We sought to determine if MAVS-induced apoptosis was 
the result of activation of a distinctive signaling pathway or as a consequence of IFN 
production.  First, we induced IFN-I production in HEK293T cells by ectopic 
expression of upstream signaling molecules that activate MAVS-mediated IFN 
production.  As previously reported, a helicase domain truncation mutant of RIG-I 
33
,  
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Figure 2.8  MAVS, ΔRIG-I and MDA5 plus Poly (I:C) induce increased 
transcription of IFNB1 and IFNA4.  5×10
5
 HEK293T cells were seeded in 6-well 
plates and grown overnight. 1 µg of MAVS and ΔRIG-I plasmids were transfected into 
the cells the next day, similarly 1 µg MDA5 and 100 ng poly (I:C) were co-transfected 
into the cells as well. RNA samples were extracted from each group of cells 24 h 
post-transfection and subjected to real time RT-PCR analyses on the transcripts of 
IFNB1 and IFNA4. 
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full-length MAVS 
34
, or MDA-5 in conjunction with its ligand poly(I:C) 
209
 are all potent 
IFN-I inducers (Fig. 2.8A, 2.8B).  Neither ΔRIG-I nor MDA-5 plus poly(I:C) induced 
any observable cell death or Annexin V-positive cells (Fig. 2.9A, bottom panels).  Only 
full-length MAVS triggered apoptosis as quantified by Annexin V and 7-AAD staining 
(Fig. 2.9A, top right panel).  To explore the role of IFN- in MAVS-induced apoptosis, 
HEK293T cells were treated with 200 neutralization IU/ml IFN-β antibody prior to 
transient expression of MAVS followed by XTT measurements.  We found that blocking 
IFN-β from binding to its cell surface receptor had no effect on MAVS-induced apoptosis 
(Fig. 2.9B) even though the antibody efficiently blocked the function of secreted IFN-β 
(Fig. 2.10).  In congruence with these findings, GFP-Sendai virus infections of the 
interferon-α/β receptor (IFNAR) knockout and wildtype MEFs demonstrated that this 
receptor is not required for SeV-induced cell death as visualized by PI staining (Fig. 
2.9C).  Although to a lesser extent than IFN-I responses, MAVS is also capable of 
inducing the transcription factor NF-κB, which is known to activate a wide array of genes 
linked to immune, inflammatory, and cell-fate processes 
210
.  To test the involvement of 
NF-κB in MAVS-induced apoptosis, we co-expressed MAVS with the non-degradable 
super-repressor form of IκBα.  This super-repressor is a known potent inhibitor of 
NF-κB activation and as expected inhibited MAVS-induced NF-κB activation (Figure S6) 
211
.  However, transient expression of MAVS in HEK293T cells induced apoptosis even 
in the presence of the NF-κB super-repressor (Fig. 2.9D).  There are 14 subtypes of 
type-1 interferons, and a plethora of other secreted soluble factors induced by MAVS  
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Figure 2.9  MAVS-induced apoptosis is independent of type I IFNs production.  
(A) Three molecules (ΔRIG-I, MDA5 and MAVS) that activate the production of type I 
IFNs were introduced into HEK293T cells; only MAVS is able to induce apoptosis. (B) 
Anti-IFN-β antibody was added to the medium at the final concentration of 200 
neutralization units/ml to prevent secreted IFN-β binding to IFNAR, this neutralization 
process did not inhibit MAVS-induced apoptosis. (C) SeV-induced apoptosis is 
IFN-I-independent. MEFs from both C57BL/6 wild type and Ifnar
−/−
 mice were infected 
with rSeV-GFP. Cells were stained with Hoechst and PI 48 h post-infection. (D) The 
non-degradable form of IκB was co-expressed with different doses of MAVS, yet cell 
viability loss was not restored. (E) HEK293T cells were plated at both the lower 
chamber and upper chamber of the transwell plate separated by an insert filter membrane 
with 0.4 µm pore size. 1 µg of MAVS-containing plasmid was transfected into the cells 
in the lower chamber and all cells were harvested 48 h post-transfection for flow 
cytometry analysis. 
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expression.  Therefore, we performed a transwell assay designed to definitively answer 
if MAVS-induced cell death was intrinsic to the host cell or caused by some unknown 
secretory factor.  HEK293T cells were plated in two different chambers (top and bottom) 
separated by an insert filter membrane, permissive to all secretory cytokines but 
impermeable to FuGENE6:DNA complexes.  In this experiment, only the lower 
chamber was transfected with MAVS.   Cells in the upper chamber were not transfected 
with MAVS, but were exposed to the same cytokine milieu.  As expected, MAVS 
induced cell death in the lower chamber (transfected cells); however the upper well 
(untransfected cells) remained healthy and unchanged from controls (Fig. 2.9E).  This 
 
Figure 2.10  IFN-β neutralizing antibody is able to block the function of secreted 
IFN-β.  A549 cells were seeded in 96-well plate at the density of 2×104 per well, 1 µl 
of media or anti-IFN-β antibody was added to reach the final concentration of 200 
neutralization IU/ml the next day. One hour after incubation with the antibody, 
recombinant IFN-β was added to culture at a series of doses from 31.25 to 500 IU/ml. 
Cells were infected with Encephalomyocarditis virus (EMCV) at 4×10
6
 pfu/ml 16 h 
after IFN treatment. The plates were blind scored 24 h post-infection using “1” as 
maximal protection (most cells are protected by IFN), “0.5” as about 50% of the cells 
were not protected by IFN, and “0” as no IFN protection (most cells are dead). 
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indicates that the MAVS-induced death is not caused by an undefined secretory product(s) 
which includes the interferon family members.  IRF3 is a critical transcription factor for 
IFN-I production and can be activated by MAVS.  Therefore we intended to determine 
whether MAVS-induced apoptotic signaling depends on IRF3.  HEK293T cells were 
plated in 96-well plate and endogenous IRF3 was knocked down by transfecting a pool of 
four siRNA into the cells, MAVS was introduced 24 hours after siRNA transfection. Cell 
viability was measured by XTT assay 48 hours after MAVS or control empty vector 
plasmids transfection.  Depletion of IRF3, however, did not restore MAVS-induced cell 
viability loss (Fig. 2.11A, 2.11B).  In order to further strengthen these findings, we 
repeated our experiments in 6 well plates and harvested cells 48 hours after plasmids 
transfection. Half of the cells from each well were stained for Annexin V and analyzed by 
flow cytometry, and the other half of the cells were lysed in RIPA buffer for Western 
blotting analyses on IRF3. As expected we were able to deplete above 90% of the 
endogenous IRF3, yet MAVS-induced apoptosis was not abrogated (Fig. 2.11C, 2.11D). 
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Figure 2.11  MAVS-induced apoptosis does not depend on IRF3.  (A) 1.0×10
4
 
HEK293T cells were plated in 96-well plates, a pool of four siRNA targeting IRF3 or 
control siRNA were added to each well, 24 hours later 200 ng MAVS or empty vector 
plasmids were transfected into the cell. XTT assay was performed 48 hours thereafter. 
Error bars shown in the plot represents three biological replicates. (B) The same 
IRF3-targeting and non-targeting siRNA transfection reagents used in (A) were applied 
to 5.0×10
5
 cells, and all cells were lysed in RIPA buffer 48 hours post-transfection and 
subjected to Western blotting to confirm knockdown. (C) 5.0×10
5
 HEK293T cells were 
plated in 6-well plates and treated with IRF3 or control siRNAs, 24 hours later 3 µg of 
MAVS expression plasmid or empty vector plasmids were introduced into the cells. 
Half of the cells from each well were harvested 48 hours thereafter and stained with 
Annexin V. The plot represents two separate experiments and the percentages of 
Annexin V positive cells were averaged for quantification. (D) The other half of the 
cells described in (C) were lysed in RIPA buffer and subjected to western blot analyses 
to confirm IRF3 knockdown. 
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The SARS-CoV non-structural protein 15 inhibits MAVS-induced apoptosis. 
While host response that elicits apoptosis may function as an antiviral strategy, 
viruses have also evolved diverse mechanisms to evade these host antiviral responses.  
Therefore we performed a functional screen of 12 SARS-CoV-encoded proteins to 
identify any potential modulators of MAVS-induced apoptosis. Each of these SARS-CoV 
genes were cloned into an expression vector and co-expressed with MAVS plasmid 
followed by XTT cell viability measurements.  Protein expression was verified by an 
immunoblot (Fig. 2.12).   Of the 12 tested proteins, only one SARS-CoV protein, 
NSP15, significantly altered MAVS-induced apoptosis of HEK293T cells (Fig. 2.13A).  
Further examination shows that NSP15 significantly inhibited MAVS induced apoptosis 
in a dose-dependent manner (Fig. 2.13B).  The anti-apoptotic function of NSP15 shows 
specificity since it did not inhibit staurosporine-induced apoptosis (Fig. 2.13C).  We 
sought to investigate if the anti-apoptotic function of NSP15 was specific for SARS-CoV 
or shared by other coronaviruses.  When the NSP15 protein encoded by the SARS-CoV, 
 
Figure 2.12  SARS-CoV proteins 
were expressed in HEK293T 
cells. Twelve SARS-CoV protein- 
encoding sequences were cloned 
into expression vectors with an HA 
tag. HEK293T cells were seeded in 
6-well plate and transfected with 1 
µg plasmid of each protein when 
cells reached 60% confluence, all 
cells were harvested and lysed 24 h 
post-transfection for Western 
blotting analysis with anti-HA 
antibody. 
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HKU1 or NL63 genome was coexpressed with MAVS, only SARS-CoV NSP15 inhibited 
MAVS-mediated apoptosis as measured by Annexin V and 7-AAD staining, while the 
others showed little effect on cell viability (Fig. 2.13D).   
2.4 Conclusion 
Host cellular response to virus infection involves the concomitant activation of 
 
Figure 2.13  The SARS-CoV NSP15 protein abrogates MAVS-induced apoptosis.  
(A) Twelve of the SARS-CoV proteins were co-expressed with MAVS and NSP15 is 
the only one that exhibited a potent inhibitory effect on MAVS-induced apoptosis as 
assessed by XTT cell viability assay. (B) The inhibitory effect of NSP15 displays 
dose-dependency. Cell death was measured by an adenylate kinase activity assay. (C) 
The anti-apoptotic function of NSP15 does not extend to staurosporine-induced cell 
death. NSP15-expressing plasmid or empty vector were transfected in HEK293T cells 
seeded on 96-well plate, cells were treated with 500 nM staurosporin or PBS 24 h 
post-transfection, cell death fold change was evaluated by the adenylate kinase activity 
assay. (D) The inhibitory effects of NSP15 is unique to SARS-CoV. MAVS was 
co-expressed with NSP15 encoded by SARS-CoV, HKU1 and NL63. Flow cytometry 
analysis of 7-AAD/Annexin V stained cells was performed 48 h post-transfection. The 
results represent two separate experiments. 
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parallel signaling pathways leading to the transcription of a plethora of cytokine genes, 
prominent among these are the genes encoding type-1 interferons (IFN-I).  It is the 
autocrine and paracrine action of these and other cytokines which encompasses the 
comprehensive host immune response designed to defend against viral infection.  This is 
accompanied by a reciprocal activation of programmed cell death in infected host cells, 
which is also known to reduce viral load.  Apoptosis has been suggested to play a 
protective role at the organismal level in preventing the virus from completing its 
replication and producing infectious progeny viruses 
187
.  Consequently, the exact 
mechanisms underlying both virus-induced apoptotic signaling in addition to viral 
strategies to subvert these responses is currently a topic of intensive research.  While 
pathways that govern IFN-I have been extensively investigated, the molecular mediators 
that activate host cell apoptosis during viral infection are less known.  In this study we 
have identified a role for MAVS in the initiation of virus-induced apoptosis (Fig. 2.14).  
Furthermore, we have identified a viral gene encoded by the SARS-CoV which functions 
as an inhibitor of MAVS-mediated apoptosis.   
 It is known that MAVS is a potent inducer of IFN-I responses and that IFN-I can 
activate host apoptotic responses, therefore it was important to determine whether the cell 
death responses observed in the current study were a consequence of IFN-I secretion.  In 
fact, IFN-I consist of several species including IFN-α, IFN-β, IFN-ω and IFN-κ and these 
cytokines bind to surface receptors leading to the activation of the Jak-Stat signal 
transduction pathway resulting in the transcriptional activation of virtually hundreds of 
66 
 
IFN-stumulated genes (ISGs), whose protein products play pivotal roles in a plethora of 
biological events, including but not limited to immunomodulation, cell differentiation, 
anti-angiogenesis and programmed cell death.  For example, type-1 IFN induction of 
apoptotic responses can be mediated by a multitude of ISGs, illustrated by the finding 
that more than 15 ISGs pro-apoptotic functions 
208
.  In addition, the involvement of 
proteins on IFN axis in virus-induced host cell apoptosis has been implicated in another 
previous report, in which MAVS has been shown to be critical for reovirus-triggered 
caspase-3/7 activation in HEK293T cells 
212
, however, the study did not evaluate whether 
MAVS mediates virus-induced apoptosis and what roles type 1 IFNs play in 
MAVS-mediated apoptosis..  Using a multi-pronged approach we demonstrate that 
MAVS-mediated apoptosis is not a consequence of IFN-I induction by MAVS.  We 
show that (a) the over-expression of RNA helicases that induce IFN-I does not lead to 
apoptosis; (b) anti-IFN- antibodies does not ablate MAVS-induced apoptosis; (c) the 
targeted deletion of IFN receptor does not alter MAVS-induced apoptosis; (d) the 
co-culture of MAVS-transfected cells with nontransfected cells separated by a trans-well 
membrane does not induce apoptosis in the latter, indicating that a soluble secretory 
factor is likely not responsible for the apoptosis-inducing activity.    
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IRF3 is downstream of MAVS in inducing IFN-I transcription, and exogenous 
expression of MAVS could lead to its phosphorylation and nuclear translocation
34
.  In 
addition, it’s been shown that expression of the constitutively active form of IRF3 is toxic 
and wild type IRF3 expression can augment SeV-induced apoptosis
205, 213
.  We evaluated 
if MAVS-induced apoptosis depends on the presence of IRF3.  However we found that 
depletion of endogenous IRF3 by means of RNAi did not reverse MAVS-induced cell 
 
Figure 2.14  A proposed model for the dual functions of MAVS.  MAVS is 
engaged in two distinct host protective responses to viral infections. Upon activation by 
RNA viruses, MAVS initiates type 1 IFN signaling by activating the nuclear 
translocation of NF-κB and IRF3. In addition, host cells could mount apoptotic 
responses to viruses such as SeV via MAVS. Notably MAVS is targeted by viruses not 
only for abrogating IFN-I production but also inhibiting host apoptosis. For example, 
HCV NS3/4A and SARS-CoV NSP15 proteins abrogate MAVS-mediated apoptosis. 
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viability loss.  Together with our findings that MAVS-induced apoptosis is 
IFN-I-independent, we believe that the MAVS-induced apoptotic signaling pathway is 
different from the classical MAVS-mediated antiviral signaling and that the reported 
pro-apoptotic effects of the constitutively active form of IRF3 might be independent of its 
transcriptional activity in inducing IFN-I production.  In fact our data suggests other 
IFN-I signaling molecules such as the constitutively active form of RIG-I and MDA5 
does not result in apoptosis despite of their potency in inducing IFN-I.  However, the 
exact mechanisms of MAVS activation of caspases remain unclear.           
The dual function of MAVS in virus-induced IFN-I and apoptosis highlights this 
molecule as a putative target for viral evasion strategies designed to escape host immunity.  
For example, it is already known that Hepatitis C Virus (HCV) produces a serine protease, 
NS3/4A, which disrupts IFN-I production through the targeted cleavage of the MAVS 
transmembrane region and the subsequent dislodging of MAVS from the mitochondria 
37, 
185
.  In fact, we found that loss of MAVS mitochondrial localization through mutation of 
the transmembrane domain, also completely abolished its pro-apoptotic effects.  
Consistent with these results, when HCV NS3/4A protein was co-expressed with MAVS, 
this viral protein completely inhibited MAVS-induced cell death.  This result would 
suggest that the host immune evasion strategies of the HCV NS3/4A protein may be 
extended to inhibition of MAVS-mediated apoptosis.  Similarly hepatitis A virus (HAV), 
a picornavirus, employs a cysteine protease 3ABC to abrogate type-1 IFNs production by 
targeting MAVS 
186
.  Therefore, it is likely that other uncharacterized viral mechanisms 
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target MAVS for modulation of host cell death responses.   
One novel strategy described in this study is employed by the SARS-CoV.  Similar 
to SARS-CoV abilities to inhibit IFN-I responses, we have found that this virus is also 
capable of interfering with host cell death responses by targeting MAVS.  We showed 
that among the 12 SARS-CoV proteins tested, NSP15 alone can completely abrogate 
MAVS-induced apoptosis.  The underlying mechanism is currently unclear since the 
function of NSP15 is not yet fully defined.  However, an earlier report indicates that this 
protein is indeed important for SARS pathogenesis in that it is essential for viral 
replication 
214
.  However, until we understand the exact temporal expression patterns of 
each of the SARS-CoV proteins during the course of an infection, the relative 
contributions of each to the evasion of host immunity and apoptosis will not be fully 
understood.  Further studies are needed to determine the exact mechanism of action for 
NSP15 on inhibiting MAVS-induced cell death.   Since SARS-CoV replication is 
limited to the first two weeks after symptom onset and NSP15 is critical for its replication 
201, 214
, this would support the theory that NSP15 may function as an inhibitor of host cell 
death during this time, which would possibly benefit viral replication.  Further studies 
are ongoing to determine how NSP15 and other SARS-CoV proteins contribute to overall 
viral evasion strategies. 
The finding that MAVS mediates virus-induced apoptosis posits a new mechanism 
by which mitochondria serves as a bona fide intracellular sentinel for antiviral and 
apoptotic responses.  It is well established that the permeabilization of the mitochondria 
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outer membrane by the pro-apoptotic Bcl-2  family member BAK  results in the 
activation of caspase-9 in a classical Apaf-1-dependent or an alternative 
Apaf-1-independent pattern 
215
. Furthermore, it is known that proteins localized in the 
mitochondria are targeted by viruses to modulate host responses.  For example, the 
cytomegalovirus RNA can interact with the mitochondrial enzyme complex I (reduced 
nicotinamide adenine dinucleotide–ubiquinone oxido-reductase) to modulate the classical 
mitochondria-mediated apoptosis 
216
.  Recent discoveries also underscore the 
mitochondria as a platform orchestrating host antiviral type-1 IFNs through the 
mitochondrial-localized MAVS protein.  This study describes, for the first time, a 
duality of function for the MAVS protein in regulating both IFN-I and apoptotic antiviral 
responses from within the mitochondria and suggests that MAVS is a pivotal molecule in 
the bifurcation of host responses following viral challenge.  Furthermore, the 
identification of SARS-CoV NSP15 as an inhibitor of host apoptotic responses reveals 
both novel host defense mechanisms as well as viral immune-evasion mechanisms that 
might serve as useful templates for the development of anti-viral drug strategies.   
2.5 Materials and Methods 
Cells and Plasmids 
 HEK293T cells, MAVS
+/+
, MAVS
-/-
, IFNAR
-/-
 mouse embryonic fibroblasts were 
maintained in DMEM media supplemented with 10% FBS, 1% penicillin and 100µg/ml 
streptomycin. Cells were passed every three days and grown at 37°C in 5% CO2. 
The mammalian expression plasmids of NS3/4A, wild type MAVS and truncation 
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mutants were kindly provided by Dr. Zhijian Chen at the University of Texas 
southwestern medical center. HA-tagged SARS-CoV proteins expression plasmids, 
HKU1 NSP15 and NL63 NSP15 expression plasmids were gifts of Drs. Ralph Baric and 
Matthew Frieman at the University of North Carolina. 
Transfections and Viral Infections 
HEK293T cells were seeded in 96-well or 6-well plates, and the total DNA 
transfected into these cells was 400ng/well and 1µg/well, respectively. Standard 
transfection protocol was performed using FuGENE6 (Roche Applied Science)according 
to the commercial protocol. Cells were incubated for the indicated times prior to assay.  
rSeV-GFP is a recombinant Sendai virus expressing GFP and was originally made 
by Dr. Daniel Kolakofsky. For viral infections, 1.6 × 10
4
 MEFs were plated into 12-well 
plate one day prior to Sendai virus (SeV) infection. Viral infections were performed when 
cells reached 60% confluence. MEFs were incubated with SeV for 1h in serum-free 
DMEM supplemented with 0.5% trypLE Select at the MOI of 0.5.  Serum-free DMEM 
supplemented with 0.5% trypLE Select was used for mock infection.  Virus inoculum 
was removed and cells were replenished with complete media supplemented with 0.5% 
trypLE Select following incubation with virus. 
Cell Viability Assays  
XTT salt (Sigma, St. Louis, MO) (1mg/ml) was dissolved in serum-free media 
and phenazine methosulfate (PMS) (5mM) (Sigma, St. Louis, MO) solution was prepared 
fresh.  For activated XTT solution, PMS and XTT solutions were mixed at a ration of 
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5:1, respectively.  50µl of activated XTT solution was added to each 96 well (1× 10
4 
cells/well), incubated at 37°C for 4 hours and absorbance read at a wavelength of 450nm. 
An adenylate kinase non-destructive cytotoxicity assay was performed utilizing the 
ToxiLight bioassay kit (Lonza) following the manufacturers standard protocol for 
adherent cells in a 96 well plate. For Trypan blue exclusion test of cell viability, 10µl of 
cell suspension was mixed with 10µl of 0.4% Trypan blue solution (Sigma, St.Louis, 
MO), and both unstained (viable) and stained (dead) cells were counted on the 
hemacytometer. The percent of dead cells was calculated by dividing the number of 
stained cells by the total number of cells. 
Flow Cytometry 
Cells were harvested and washed in cold FACS buffer (5% FBS in 1× PBS) twice 
and once using 1× Annexin V binding buffer (BD Bioscience, San Diego, CA). Cells 
were transferred into 96-well plate and resuspended in 45µl Annexin V binding buffer.  
Cells were stained according to standard cell staining protocol 
217
using Annexin V 
conjugated to FITC or APC (BD Biosciences, San Diego, CA).  Cells were washed in 
FACS buffer and stained with 7-AAD (Invitrogen, Carlsbad, CA)for 10 min at room 
temperature.  Cells were washed twice and resuspended in FACS buffer containing 
1µg/ml Actinomycin D. After 5 min incubation, all samples were fixed in 500µl 1% EM 
grade formaldehyde (Polysciences, Warrington, PA) for immediate flow cytometry 
analyses.  For the rSeV-GFP infected samples, GFP positive cells were gated and 
Annexin V and 7-AAD quantitated.  
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Mitochondrial membrane potential Δψ was assessed by flow cytometry analysis 
on a Δψ- sensitive fluorophore tetramethylrhodamine ethylester (TMRE) (Molecular 
Probes, Eugene, OR). After treatment, HEK-293T cells were incubated with TMRE at the 
concentration of 10nM per 1×10
6
 cells for 40min at 37°C. Immediate flow cytometry 
analysis was performed after staining. 
All flow cytometry data were collected on either a FACSCalibur (BD Biosciences, 
San Jose, CA) or CyAn flow cytometer (Dako North America, Carpinteria, CA) and then 
analyzed by FlowJo software (Tree Star, Ashland, OR) 
Imaging 
Transmission electron microscopy examination was performed as described 
124
. 
MEFs or HEK293T cells were harvested and fixed in glutaraldehyde and all samples 
were post-fixed in 1% OsO4 for transmission electron microscopy examination. Cells 
were embedded in London Resin White and sections were analyzed using a LEO EM-910 
transmission electron microscope (LEO Electron Microscopy Inc., Thornwood, NY). 
Hoechst and Propidium Iodide (PI) dual staining was used to evaluate SeV-induced cell 
death. Samples were photographed using a Leica DMIRB inverted fluorescence 
microscope (Leica Microsystems Inc., Bannockburn, IL) with a digital camera 
(MicroPublisher, Q-Imaging, Burnaby, BC, Canada) - 
Immunoblotting 
Cells were lysed in RIPA lysis buffer (1% Triton X-100, 0.25% DOC, 0.05% SDS, 
50mM Tris pH8.0, 150mM NaCl and 50mM NaF) containing proteinase inhibitor 
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cocktails (Roche) for 30min at 4°C.  Whole cell lysates were suspended in Laemmli’s 
sample buffer and loaded onto NuPAGE Bis-Tris 4-12% gradient pre-cast gels 
(Invitrogen, Carlsbad, CA) for SDS-PAGE and subsequent immunoblotting for PARP, 
caspase-3 and caspase-9 (Abcam, Cambridge, MA), IRF3 (Santa Cruz Biotechnology, 
Santa Cruz, CA), rodent specific MAVS (Cell Signaling, Danvers, MA). Densitometry 
was performed using ImageJ analysis software. 
Caspase and Interferon inhibition treatments 
HEK293T cells were incubated with 50µM Z-VAD-FMK to inhibit caspase 
activity. HEK293T cells were treated with human IFN-β neutralizing antibody (GeneTex, 
San Antonio, TX) at the concentration of 200 neutralization units/ml.  
Depletion of endogenous IRF3 
HEK293T cells were transfected with a pool of four targeting siRNA according to 
the manufacturer’s protocol (Dharmacon, Chicago, IL). The sequences are: (1) sense 
5’-CGAGGCCACUGGUGCAUAUUU, antisense 5’-PAUAUGCACCAGUGGCCU 
CGUU; (2) sense 5’-CCAGACACCUCUCCGGACAUU, antisense 5’-PUGUC 
CGGAGAGGUGUCUGGUU; (3) sense 5’-GGAGUGAUGAGCUACGUGAUU, 
antisense 5’-PUCACGUAGCUCAUCACUCCUU; (4) sense 5’-AGACAUUCU 
GGAUGAGUUAUU, antisense 5’-PUAACUCAUCCAGAAUGUCUUU. A pool of 4 
non-targeting siRNA were used as control. Empty vector or MAVS expression plasmids 
were introduced into the cells 24 hours after the transfection of siRNA. 
Transwell Assay 
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HEK-293T cells were seeded on the bottom of both chambers in a HTS 24-well 
transwell plate with 0.4µm pore polycarbonate membrane (Corning Incorporated Life 
Sciences, Lowell, MA). MAVS expression plasmid DNA was transfected into the cells on 
the bottom of lower chamber and flow cytometry analysis on apoptosis was performed 
48h post-transfection on cells grown in each chamber.  
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CHAPTER THREE 
 
NLRX1 AND TUFM FORM A MITOCHONDRIAL COMPLEX  
THAT REGULATES TYPE 1 INTERFERON AND AUTOPHAGY 
  
77 
 
3.1 Abstract 
Mitochondria are crucial in the regulation of host innate antiviral responses.  A prime 
example is the intersection of the mitochondrial protein MAVS/IPS-1/VISA/CARDIF 
with RLR (RIG-I-like receptors) to induce type 1 interferon (IFN-I).  NLRX1 is a 
mitochondrial NLR (nucleotide-binding, leucine-rich repeats containing) protein that 
attenuates MAVS-RLR signaling.  More in-depth analysis utilizing cells from 
gene-deletion mice indicates that NLRX1 not only attenuates IFN-I production, it 
additionally promotes autophagy during viral infection.  This dual regulatory function of 
NLRX1 parallels the previously described functions of Atg5-Atg12, although NLRX1 
does not associate with Atg5-Atg12.  High throughput quantitative mass spectrometry 
and biochemical analysis revealed a novel NLRX1-interacting partner, mitochondrial Tu 
translation elongation factor (TUFM/P43/EF-Tu/COXPD4/EF-TuMT), which does 
interact with Atg-5-Atg12.  Similar to NLRX1, TUFM potently inhibits RLR signaling 
and promotes autophagy during a viral infection.  This study establishes the first link 
between an NLR protein and a viral-induced autophagic machinery via an intermediary 
partner, TUFM.   
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3.2 Introduction 
The mitochondrion is a coordinating site for several key host responses against viral 
infection including apoptosis and type 1 IFN (IFN-I) signaling 
5, 173, 218
.  Upon infection 
with a RNA virus, virus-related RNA species are recognized by RIG-I (retinoic-acid 
inducible gene I)-like receptors (RLRs), including RIG-I and MDA5 (melanoma 
differentiation associated gene 5) 
218.  The 5’-ppp moiety of cytosolic dsRNA is the 
molecular signature that activates RIG-I 
41, 43
, and RIG-I deficiency leads to compromised 
IFN-I in response to VSV (vesicular stomatitis virus), SeV (Sendai virus) and NDV 
(Newcastle disease virus) 
40
.  The helicase domain drives the unwinding of dsRNA with 
3’-terminal overhang via its ATPase activity 38.  Upon activation, RIG-I binds to its 
adaptor, the mitochondrial antiviral signaling protein (MAVS, also referred to as IPS-1, 
VISA or Cardif) via homotypic CARD interaction to activate IFN-I by facilitating the 
nuclear translocation of the transcription factors NF-κB and IRF3 34-37.  Similar to 
MAVS, another adaptor protein MITA (also referred to as STING, ERIS and MPYS) is 
ubiquitously expressed and is indispensable for inducing IFN-I upon RIG-I activation 
69-72, 75
.  Overexpression of MITA/STING is less potent than MAVS in the activation of 
IRF3 
70
, and it may employ a separate mechanism via its association with components of 
the endoplasmic reticulum translocon-associated protein (TRAP) complex to modulate 
RLR signaling 
69
. 
Due to the detrimental effects of IFN-I at high levels, several molecular machineries 
keep the RLR pathway in-check.  A unique member of the nucleotide-binding domain 
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(NBD) and leucine-rich-repeats (LRR)-containing proteins (NLRs), NLRX1, resides in 
the mitochondria and attenuates the activation of MAVS by binding to its CARD domain, 
possibly precluding its engagement with RIG-I 
124
.  The NLR family was first 
discovered by bioinformatic data mining based on the sequence of CIITA 
219
.  NLRs 
have diverse biological functions including formation of the caspase-1 activating 
inflammasome protein complex, modulation of host anti-pathogen response, regulation of 
gene transcription and cytokine, chemokine and defensin production 
67, 220
.  Emerging 
evidence suggests that NLRs actively participate in antiviral signaling pathways.  For 
example, NLRP3 inflammasome has been shown to respond to influenza A virus, VSV 
and EMCV (Encephalomyocarditis virus) infection 
130, 131, 221, 222
.  NOD2 is shown to 
associate with MAVS to induce IFN-I 
129
.  On the other hand, NLRX1 is the first NLR 
found to negatively impact IFN-I production 
124
, although the evidence was largely 
obtained in cell lines with transfected protein or shRNA-mediated gene reduction.  
Overexpression of NLRX1 inhibits ΔRIG-I-induced NF-κB- and IRF3-dependent 
promoter activity, and a reduction of NLRX1 results in enhanced transcription of IFNB1 
124
.  Recent studies linked NLRC5 to IFN-I production, however conflicting evidence 
exists where the protein is found to be either a negative 
133
 or positive regulator 
134, 136
 of 
IFN-I, while a gene-deletion study shows that it has no effect on IFN-I response 
139
.  
Thus the link between NLRs and IFN-I requires more in-depth analysis. 
In addition to NLR-based complexes, the autophagy-related protein conjugate, 
Atg5-Atg12, has also been shown to regulate the RLR signaling pathway.  The absence 
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of autophagy, which causes the degradation of misfolded proteins and cytoplasmic 
organelles to recycle nutrients 
223, 224
, results in significantly higher RLR signaling, 
leading to more IFN-I production in mouse embryonic fibroblasts 
141, 142
.  One study 
showed that Atg5 deficient cells and Atg7-deficient cells, in which the Atg5-Atg12 
conjugation is impeded, exhibit enhanced IFN-I response to virus 
141
.  The role of 
autophagy in RLR signaling appears to be cell type specific since such inhibitory effects 
were not seen in plasmacytoid dendritic cells 
161
.  Nonetheless, the relationship between 
the two regulatory functions of RLR in IFN-I and autophagic signaling remains to be 
studied and how NLRs might integrate these two pathways has not been addressed in the 
literature.   
This study employs quantitative proteomics approaches and uncovered a novel 
regulatory mitochondrial protein platform comprised of NLRX1 and mitochondrial Tu 
translation elongation factor (TUFM/P43/EFTu/COXPD4/EF-TuMT).  This complex 
regulates virus induced IFN-I activation and autophagy by engaging RIG-I and the 
autophagy-related proteins, Atg5-Atg12 conjugate.  This shows that a novel complex 
comprised of NLRX1, TUFM, RIG-I and Atg5/Atg12 controls two crucial anti-viral 
functions: IFN-I induction and autophagy. 
3.3 Results 
NLRX1 inhibits type 1 IFN signaling in MEFs 
To assess the role of NLRX1 in modulating IFN-I signaling, we generated 
C57BL/6 mice deficient in the Nlrx1 gene (Nlrx1
-/-
).  A more thorough in vivo analysis 
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of this strain is described in a report that is currently being reviewed.  Nlrx1
-/-
 mouse 
embryonic fibroblasts (MEFs) were cultured from 13.5 day embryos; and the lack of 
Nlrx1 transcripts was confirmed by RT-PCR (Fig. 3.1).  In agreement with a previous  
 
 
 
 
 
 
study where overexpressed NLRX1 in transformed cell lines was shown to inhibit IFN-I 
promoter activation by ΔRIG-I 124, Nlrx1-/- MEFs showed enhanced Ifnb1 mRNA 
transcription in response to the RIG-I ligand, cytoplasmic 5’-ppp-dsRNA (Fig. 3.2A).  
Control dsRNA without the 5’-ppp moiety failed to induce IFN-I.  When MEFs from 
both genotypes were challenged with VSV, a deficiency in NLRX1 resulted in enhanced 
IFN-I production (Fig. 3.2B).  We previously found that NLRX1 interacts with MAVS 
to impede the latter’s interaction with RIG-I at a basal state, thus suggesting that NLRX1 
might form an active inhibitory complex at the unstimulated state 
124
.  To further explore 
this possibility, we employed size exclusion chromatography and found that NLRX1 is 
most abundant in a higher molecular mass during the resting state, while it resides in 
smaller molecular complexes upon RLR activation by its known ligand, 5’ppp-dsRNA 
(Fig. 3.2C, upper panels).  As an internal control, the mitochondrial protein COX IV- 
 
 
Figure 3.1 Confirmation of gene deletion.  
Nlrx1
+/+
 and Nlrx1
-/-
MEFs were harvested for 
RNA extraction.  Nlrx1 mRNA level was 
evaluated by RT-PCR.  18s mRNA level was 
assessed as internal control. 
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Figure 3.2 NLRX1 inhibits VSV-induced IFN-I response.  (A) Nlrx1
+/+
 and 
Nlrx1
-/-
 MEFs were transfected with control dsRNA or 5’ppp-dsRNA, and IFNB1 
mRNA levels were assessed by real time PCR. Nlrx1
-/-
cells produced approximately 
9× more IFNB1 mRNA than controls.  (B) Nlrx1
+/+
 and Nlrx1
-/-
 MEFs were mock 
treated or infected with VSV (MOI of 0.1), and IFNB1 mRNA levels were assessed by 
real time PCR.  Nlrx1
-/-
cells produced approximately 30× more IFNB1 mRNA than 
WT controls.  (C)  Five million HEK293T cells were transfected with 5’ppp-dsRNA 
or control dsRNA, cells were harvested and homogenized in hypotonic lysis buffer 
16h post-transfection.  Protein extractions were then separated by size exclusion 
chromatography, and collected fractions were subjected to western blotting against 
NLRX1 and COX IV. 
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containing complex did not display an altered size profile in response to 5’-ppp dsRNA 
challenge (Fig. 3.2C, lower panels).   
TUFM associates with NLRX1 
Fig. 3.2 indicates that NLRX1 is a component of a larger molecular complex.  To 
identify additional molecules which might be a component of the NLRX1 complex, we 
employed the amino acid-coded mass tagging (AACT, also known as SILAC)-assisted 
quantitative mass spectrometry to identify NLRX1-interacting proteins 
225, 226
 (Fig. 3.3A).  
The N-terminal domains of NLRs are considered to mediate protein-protein interaction 
while LRRs are considered inhibitory 
124, 227
.  Hence, we constructed vectors encoding 
full-length NLRX1 and a mutant lacking the LRR domain, and used these as baits to 
identify interacting partners.  Eluted proteins from both groups (Eluates I and II) (Fig. 
3.3A) were separately fractionated by SDS-PAGE (Fig. 3.3B) followed by 
high-performance liquid chromatography and mass spectrometry.  A subcellular 
compartment localization analysis of the NLRX1 interactome revealed that a high 
percentage of interacting partners are mitochondrial proteins (Fig. 3.4).  Among these, 
peptide profiles that matched the mitochondrial Tu translation elongation factor (TUFM) 
with ion scores of >39 were identified in both eluates (Fig. 3.5A-D).  This indicates 
with >95% certainty that these peptides represent TUFM (Table 3.1).  Similar to 
NLRX1 
124
, TUFM is ubiquitously expressed in multiple tissue and cell types (Fig. 3.6). 
To further validate these findings, reciprocal co-immunoprecipitation experiments 
were performed to show interaction between ectopically expressed NLRX1 and TUFM  
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Figure 3.3 TUFM interacts with NLRX1.   (A) Scheme of AACT/SILAC mass 
spectrometry identification of NLRX1-interacting partners.  (B) Immunoprecipitated 
proteins were eluted by HA-peptide and separated by SDS-PAGE, the gel was 
continuously sliced as indicated  for further high performance liquid chromatography 
and mass spectrometry analyses.  (C) HA-tagged NLRX1 was co-transfected with 
either empty vector or FLAG-tagged TUFM.  Cells were lysed and 
immunoprecipitated proteins were blotted for FLAG-TUFM.  (D) HA-tagged NLRX1 
was co-transfected with empty vector or FLAG-tagged TUFM and immunoprecipitated 
with anti-FLAG-agarose beads, and immuno-blotted for HA-NLRX1.  (E) HEK293T 
cells were lysed and immunoprecipitated with either isotype control antibody or 
anti-TUFM antibody and immuno-blotted for NLRX1, TUFM and Bcl-xL.  (F) 
Full-length NLRX1 or its truncation mutants were expressed in HEK293T cells, and 
protein samples were immunoblotted for endogenous TUFM and eEF1α1.  (G) 
Over-expressed NLRX1, NLRP12 and CIITA were immunoprecipitated from 
HEK293T cells, and immuno-blotted for endogenous TUFM.  Results represent 2-3 
independent repeats. 
86 
 
  
 
Figure 3.4 NLRX1 interactome subcellular localization.  NLRX1-interacting 
proteins were annotated on their subcellular localization based on the Gene Ontology 
database.  The number of proteins that reside in the same compartment was divided 
by the total number of proteins to calculate the percentage. 
87 
 
  
 
Figure 3.5  Mass Spectrometry identification of the TUFM peptides.  (A, B) 
MS/MS spectrum of the peptides AEAGDNLGALVR and LLDAVDTYIPVPAR were 
captured from those derived from the interacting partners with NLRX1 full-length 
protein.  (C, D) MS/MS spectrum of the peptides ELLTEFGYK and 
AEAGDNLGALVR were captured from those derived from the interacting partners with 
NLRX1ΔLRR protein. These peptides are further shown in Table S1. 
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Table 3.1 The peptides sequences matching TUFM were identified in both 
NLRX1 full-length group and NLRX1ΔLRR mutant group. Peptides were eluted 
from NLRX1 or NLRX1LRR.  Two unique peptides with at least five consecutive 
amino acids sequences which matched sequences in IPI database were found in each 
eluate.  The ion scores for all peptides shown are equal or greater than 39, which 
indicates a greater than 95% possibility that the peptides detected represent TUFM 
protein ID in the International Protein Index database. 
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Figure 3.6 TUFM is ubiquitously expressed in multiple cell and tissue types.  The 
mRNA expression data of human TUFM is made available by the BioGPS project 
(http://biogps.gnf.org/), which is funded by the Genomics Institute of the Novartis 
Research Foundation.  TUFM was used as the key identification word. 
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(Fig. 3.3C-D).  More importantly, endogenous TUFM co-immunoprecipitated with 
endogenous NLRX1 (Fig. 3.3E).  As a negative control, TUFM did not 
co-immunoprecipitate with another mitochondrial protein Bcl-xL.  NLRX1-TUFM 
interaction requires the N-terminus of NLRX1 as its deletion (NLRX1-X) abolished this 
interaction (Fig. 3.3F).  Deletion of the LRR domain (NLRX1-LRR) slightly increased 
this interaction while constructs expressing NBD or LRR alone (NLRX1-NBD, 
NLRX1-LRR) did not interact with TUFM.  As negative controls, NLRX1 did not bind 
to the cytoplasmic homolog of TUFM, eEF1α1 (Fig. 3.3F).  Furthermore, TUFM did not 
co-precipitate with other NLRs such as NLRP12 and CIITA (Fig. 3.3G). 
Both NLRX1 and TUFM are mitochondrial proteins 
        NLRX1 is a highly conserved protein, thus we also evaluated the evolutionary 
conservation of TUFM.  TUFM is conserved from humans to its bacterial counterpart. 
The bacterial elongation factor Tu (EF-Tu) serves as a PAMP (pathogen-associated 
molecular pattern) in plant cells to elicit immune activation 
228, 229
.  However, despite 
this general sequence homology, the key activating sequence of bacterial EF-Tu KxKFxR 
no longer exists in the human counterpart; instead the N-terminus of TUFM has 
undergone drastic changes (Fig. 3.7).  Previously, we investigated the localization of 
NLRX1 using sucrose gradients similar to the ones used to localize MAVS 
34
.  However, 
a separate study reported NLRX1 as a matrix protein 
126
.  To clarify this issue, we used 
an additional approach to study mitochondrial proteins.  We isolated crude mitochondria 
from cell homogenates and treated the preparation with increasing doses of digitonin  
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Figure 3.7 TUFM is evolutionarily conserved.  The protein sequences of human 
TUFM (Accession: AAH01633), mitochondrial EF-Tu in A. thaliana (Accession: 
AAH01633) and EF-Tu in L. monocytogenes (Accession: YP_002759310) were aligned 
using ClustalW2 software.  The essential N-terminal immune-activating sequence 
KXKFXR of the L. monocytogenes EF-Tu is highlighted and missing in the plant and 
human sequences.   
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Figure 3.8 Both NLRX1 and TUFM are mitochondrial proteins.  Isolated 
mitochondria were treated with increasing doses of digitonin (0-1.0%) and then 
subjected to SDS-PAGE and immunoblotted with the indicated antibodies.  
Results represent 2 independent repeats. 
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which gradually extracted mitochondrial proteins from the less detergent-resistant outer 
membrane fraction to the more detergent-resistant inner membrane/matrix fraction 
75
 (Fig. 
3.8).  MAVS (upper band) displayed a profile similar to Bcl-xL, a well-accepted 
mitochondrial outer membrane protein.  Consistent with the initial identification of 
MAVS 
34
, the anti-MAVS antibody also recognized a smaller, detergent-resistant portion 
(lower band) (Fig. 3.8).  The extraction profile of NLRX1 more closely resembled that 
of Bcl-xL and the higher molecular weight MAVS protein, but not the mitochondrial 
matrix protein HSP60.  On the other hand, a portion of TUFM appeared to be in the 
inner membrane/matrix compartment, however it can not be ruled out that TUFM also 
resides in the outer-membrane. 
TUFM potently inhibits RIG-I signaling 
        Given the interaction of NLRX1 with TUFM and previous findings that 
NLRX1 attenuates MAVS and RIG-I induced IFN-I production and NF-B signaling 124, 
we analyzed the role of TUFM in these same pathways.  Similar to NLRX1, TUFM 
inhibited ISRE-, NF-κB-dependent and IFNB1 promoter activation by ΔRIG-I in a 
dose-dependent fashion (Fig. 3.9A-C).  IFN-I signaling in response to cytosolic viral 
PAMPs is also regulated by the adaptor MITA/STING 
69, 70, 72
.  However, neither TUFM 
nor NLRX1 affected ISRE activation by MITA/STING (Fig. 3.9D, E).  In addition to 
reporter assays, TUFM squelched ΔRIG-I-induced IFNB1 mRNA production, similar to 
NLRX1 (Fig. 3.9F).  RNA interference targeting of TUFM (si-TUFM) partially reduced 
TUFM expression and increased IFN-β mRNA induction by ΔRIG-I (Fig. 3.9G, 3.10A).   
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Figure 3.9 TUFM inhibits RIG-I mediated type I IFN production.  (A-E) 
HEK293T cells were transfected with ΔRIG-I or MITA/STING expression plasmid plus 
luciferase reporter plasmids for ISRE, NF-κB or IFNB1 activation.  FLAG-TUFM 
plasmid was titrated into the system and cells were lysed 24h post-transfection for 
luciferase assays.  (F) ΔRIG-I was co-transfected with either TUFM or NLRX1 into 
HEK293T cells; and cells from all groups were harvested for real time PCR analysis 
24h post-transfection.  (G) Endogenous TUFM was partially reduced by transfecting a 
pool of 4 targeting siRNA into the cells; ΔRIG-I was transfected to induce IFNB1 
mRNA as measured by real time PCR.  (H)  HEK293T cells with reduced TUFM 
expression and control cells were challenged with VSV, and plaque assay was 
performed to assess the viral titers.  (I) HEK293T cells were transduced with control 
lentiviruses and infected with VSV-GFP (MOI of 0.1) for 16h and analyzed by flow 
cytometry for GFP as a marker for VSV.  (J) HEK293T cells transduced with 
sh-TUFM were treated and analyzed as described in (I).  (K) HEK293T cells 
transduced with scrambled control shRNA or sh-NLRX1 were treated with control or 
siRNA pool targeting TUFM.  Cells were then harvested 16h post transfection of either 
empty vector control or ΔRIG-I plamid.  IFNB1 mRNA abundance was analyzed by 
real time PCR.  Results of all panels are representative of three independent 
experiments. 
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Figure 3.10 Confirmation of TUFM knockdown by shRNA.  HEK293T cells 
were transduced with lentiviruses containing either tetracycline-inducible TRIPZ™ 
control vector or shRNA targeting TUFM. One µg/ml doxycycline was added to cell 
culture and incubated for 48h before cells were harvested for protein extraction.  
Samples were subjected to SDS-PAGE and immunoblotting for TUFM. 
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Reduction of TUFM expression level also resulted in lower viral plaque forming units 
(PFU) compared to control cells (Fig. 3.9H).  As an additional approach to assess the 
IFN-I-regulatory function of TUFM, GFP-expressing VSV was used to infect HEK293T 
cells stably transduced with a doxycycline-inducible shRNA lentivirus (Fig. 3.10B).  In 
the control group, doxycycline did not affect the percentage of infected cells and viral 
infection as assayed by the GFP-positive population and mean fluorescence intensity 
(MFI) (Fig. 3.9I).  By contrast, induction of TUFM shRNA reduced both signals (Fig. 
3.9J).  These results indicate that TUFM is similar to NLRX1 in attenuating RLR 
signaling.  In fact, by reducing the expression of both NLRX1 and TUFM, the 
transcription of IFNB1 was further enhanced, suggesting a complementary effect of these 
two proteins in attenuating RIG-I induced IFN-I activation (Fig. 3.9K). 
NLRX1 is essential for VSV-mediated autophagy 
Another key host response that is elicited by virus is autophagy.  In addition to 
IFN-I induction, VSV is known to induce autophagy 
141, 230
 during which the light chain 3 
(LC3) protein is converted from a cytosolic form (LC3B-I) to a LC3B-lipidated, 
membrane-associated form (LC3B-II) and displays a punctate appearance 
231, 232
.  We 
next explored the role of NLRX1 in autophagy.  VSV-infected wild type (WT) MEFs 
displayed punctate LC3B staining while Nlrx1
-/-
 cells exhibited a diffuse cytoplasmic 
staining pattern, implicating for the first time a role for NLRX1 in autophagy (Fig. 
3.11A).  VSV-infected WT and Nlrx1
-/-
 MEFs were further assayed for LC3B-II level by 
immunoblot, and LC3B-II level relative to β-actin was greatly reduced in the Nlrx1-/- cells 
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(Fig. 3.11B).  Rapamycin, an inhibitor of the mTOR signaling, is a common inducer of 
autophagy.  Rapamycin-treated Nlrx1
-/- 
MEFs showed a modest reduction in LC3B-II 
compared to WT cells (Fig. 3.11B), while a more dramatic reduction was observed in 
VSV-treated samples.  Transmission electron microscopy 
160
 confirmed that VSV 
infection resulted in more autophagosomes in WT than Nlrx1
-/-
 cells (Fig. 3.11C).  To 
extend these findings to human cells, lentiviral vector harboring shRNA targeting human 
NLRX1 and its controls were produced.  HEK293T cells with sh-NLRX1 construct 
showed reduced endogenous NLRX1 expression and reduced LC3B-II level relative to 
β-actin compared to controls (Fig. 3.11D). The association of the Atg5-Atg12 conjugate 
with MAVS has been shown to inhibit MAVS-mediated IFN-I production 
141
.  Thus we 
explored the interaction of Atg5-Atg12 with NLRX1, but we failed to detect any 
association of NLRX1 and Atg5-Atg12 under stringent lysis and wash conditions (Fig. 
3.11E).  Given the fact that Nlrx1
-/-
 MEF resembles Atg5
-/-
 MEF in increasing type 1 
IFN production and both proteins associate with MAVS, we hypothesized that an 
additional member exists to engage with both proteins and stabilizes a regulator protein 
complex.  Thus we explored if TUFM might constitute such a protein. 
TUFM associates with Atg5-Atg12 conjugate 
        To test our original hypothesis that TUFM engages with both NLRX1 and 
Atg5-Atg12 conjugate, we performed co-immunoprecipitation analysis and revealed 
strong interaction between TUFM and Atg5-Atg12 (Fig. 3.12A), in contrast with the 
earlier failure to detect NLRX1:Atg5-Atg12 interaction.  MAVS also displayed  
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Figure 3.11 NLRX1 is essential for VSV-mediated autophagy.  (A) WT and 
Nlrx1
-/-
MEFs were infected with VSV (MOI of 0.1), fixed and stained for LC3B 4h 
post-infection and examined by confocal imaging.  Quantitation is shown below.  (B) 
WT and Nlrx1
-/-
 MEFs were infected with VSV and harvested 16h post-infection, or 
treated with rapamycin and harvested 2h post-stimulation.  Protein samples were 
immuno-blotted for LC3B.  Densitometry analysis (below) of the bands representing 
LC3B-II was performed using ImageJ.  (C) WT and Nlrx1
-/-
 MEFs were infected with 
VSV (MOI of 1.0) for 16h and examined by electron microscopy for autophagosomes.  
Quantitation is based on counting the number of autophagosomes present in 2-3 fields 
per treatment.  (D) HEK293T cells were transduced with control lentiviral sh-EV, 
sh-scrambled or sh-NLRX1 (left).  The cells were then challenged with VSV and 
harvested 16h post-infection for LC3B immunoblot (right).  (E) FLAG-tagged NLRX1 
or MAVS and HA-tagged Atg5, Atg12 expression plasmids were transfected into 
HEK293T cells. Cell extracts were harvested 24h post-transfection and subjected to 
co-immunoprecipitation as indicated.  Results of all experiments are representative of 
at least 2-3 repeats. 
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interaction with Atg5-Atg12 as reported 
141
, while MITA/STING did not (Fig. 3.12A).  
        A previous study has shown that Atg5-Atg12 can be transiently localized to the 
mitochondria 
4
.  If so, a model can be evoked where MAVS, NLRX1, TUFM and 
Atg5-Atg12 association takes place within the mitochondria.  To assess this, we 
prepared mitochondria-enriched fractions using the protocol shown in Fig 3.13.  We 
detected Atg5-Atg12, NLRX1, TUFM and MAVS but not the endoplasmic reticulum 
proteins KDEL and calreticulin in the mitochondrial fraction, which is also enriched for 
mitochondrial COX IV and Bcl-xL (Fig. 3.12B).  To map the essential domains for the 
Atg5-Atg12 conjugate recruitment, TUFM truncation mutants were generated (Fig. 
3.12C).  The N-terminal domain I of TUFM was required for optimal interaction with 
Atg5-Atg12, while domains II and III were not as critical (Fig. 3.12D).  To explore the 
physiological significance of such interaction, we utilized the TUFM stable knockdown 
cells described above to investigate if TUFM also affects autophagy.  Lentiviral vector 
transduced HEK293T cells were challenged with VSV, which induced LC3B-II formation.  
However, cells with sh-TUFM displayed significantly reduced LC3B-II (Fig. 3.12E).  
This indicates that TUFM, similar to NLRX1, also regulates viral-induced autophagy. 
3.4 Conclusion 
The NLR family is comprised of twenty-two proteins, and a prominent subgroup contains 
those that mediate inflammasome function.  Our previous analysis identified a new 
function for NLRs and demonstrated that NLRX1 is a negative regulator of the 
MAVS-RIG-I induced IFN-I response.  Since then, accumulative evidence has shown  
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Figure 3.12 TUFM associates with the Atg5-Atg12 conjugate.  (A) FLAG-tagged 
NLRX1, TUFM, MAVS, MITA or CIITA was co-transfected with HA-Atg5 and 
HA-Atg12; cell lysates were immunoprecipitated with anti-FLAG M2 affinity gel and 
then immuno-blotted for the HA-Atg5-Atg12 conjugate. (B) Crude mitochondria were 
isolated from cells mock treated or infected with VSV using protocol described in 
Figure S6.  All samples were subjected to SDS-PAGE and immunoblot.  (C) Domain 
structures of TUFM and truncation mutants.  (D) FLAG-tagged TUFM wildtype and 
domain truncation mutants were co-transfected with HA-Atg5 and HA-Atg12 into 
HEK293T cells, cell extracts were immunoprecipitated with anti-FLAG and 
immuno-blotted for HA-Atg5-Atg12 conjugate. (E) HEK293T cells transduced with 
tetracycline-inducible shRNA for TUFM and or control shRNA were infected with 
VSV-GFP (MOI of 0.1) and harvested for LC3B immunoblot. 
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Figure 3.13 Protocol for subcellular fractionation.  For each cell fractionation 
experiments, 5×10
7
 cells were lysed in hypotonic lysis buffer with a dounce 
homogenizer.  Then serial centrifugation was carried out to separate each 
compartment according to the scheme. 
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additional NLR proteins which can control IFN-I in both negative and positive ways.  In 
the current study, we show an additional role for NLRX1 and demonstrated that it dually 
regulates IFN-I and autophagy.  This involves the engagement of a new mitochondrial 
protein, TUFM.  TUFM binds to NLRX1 and the Atg5-Atg12 conjugate in both 
over-expression system and via endogenous protein-protein interaction, thus it is likely to 
serve as an intermediary between NLRX1 and Atg5-Atg12.  Similar to NLRX1, TUFM 
inhibits NF-κB-, ISRE-dependent and IFNB1 promoter activities in a dose-dependent 
manner and the over-expression of TUFM squelched IFNB1 mRNA transcription.  
Reduction of both NLRX1 and TUFM resulted in enhanced IFN-I activation, indicating 
that their effects are additive.  These experiments demonstrate a partnership between 
NLRX1 and TUFM to control host anti-viral responses. 
We have previously found that endogenous NLRX1 interacts with endogenous 
MAVS, and that this interaction interferes with MAVS interaction with RIG-I.  Domain 
mapping showed that the CARD domain of MAVS can interact with both NLRX1 and 
RIG-I 
124
.  This has led to the hypothesis that NLRX1 impedes MAVS-RLR association 
by steric hindrance 
67
.  The molecular steric hindrance hypothesis postulates that 
negative regulatory proteins can associate with molecules in the RLR signaling pathways, 
such as the RLRs, adaptors or downstream kinases, and this association prevents their 
engagement with other essential regulator such as MAVS.  This model has been 
supported by the analysis of other inhibitory proteins including Atg5-Atg12 conjugate, 
Mfn2 and NLRC5 
124, 125, 133, 141
.  Among these other modulators, only Mfn2 is a 
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mitochondrial protein, and the rest are likely recruited to the mitochondria via association 
with MAVS.  The association of multiple checkpoint proteins with MAVS is supported 
by the finding that MAVS is found to be in a supramolecular complex in the quiescent 
state, but a majority of MAVS migrates into a lower molecular weight complex when 
cells are activated 
125
.  This suggests that during viral activation, MAVS is released from 
these molecular brake, presumably so that it can engage the RLR protein that are 
themselves activated by the binding of viral RNAs.   
The data in this report show that NLRX1 also resides in a larger molecular complex 
in the quiescent state but migrates to smaller molecular mass in response to cytosolic 
5’ppp-dsRNA treatment. This led us to postulate the existence of a larger NLRX1 
complex, and to identify TUFM as an NLRX1-interacting partner.  To date, functional 
analysis of these two proteins indicates that they phenocopy each other.  Thus TUFM 
also serves to attenuate RIG-I dependent IFN-I production.   Further study would be 
necessary to better understand the relationship among NLRX1, TUFM and the other 
regulators of RLR such as Mfn2, NOD2 and NLRC5. 
This report also shows that similar to NLRX1, TUFM can promote viral-induced 
autophagy.  Autophagy has been increasingly appreciated as a central mechanism for 
modulating host innate antiviral responses.  Several proteins are found to dually control 
IFN-I and autophagy, and the intersection of IFN-I and autophagy pathway has been 
noted in the literature.  For example, Atg5 and formation of the Atg5-Atg12 conjugate 
are found to regulate the RLR signaling pathway and negatively impact IFN-I activation 
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141, 142
.  In MEFs, the absence of Atg5 results in enhanced IFN-I partially because of the 
accumulation of intracellular ROS due to a deficiency of autophagy 
142
.  Additionally, 
the Atg5-Atg12 conjugate has been shown to intercalate between RIG-I and MAVS, 
abolishing RLR-induced IFN-I gene activation 
141
.  Another protein that has been found 
to dually regulate autophagy and IFN-I is Mfn2.  Mfn2 is a mitochondrial outer 
membrane GTPase and regulates mitochondrial fusion together with its close homologue 
Mfn1 
233
.  Recent evidence suggests that Mfn2 is needed for autophagosome formation 
4
, 
while Mfn2
-/-
 cells exhibited enhanced IFN-I production 
125
.  Interestingly Mfn2 also 
interacts with MAVS to preclude its association with RLR, providing a plausible 
mechanism for how it interferes with the RLR-MAVS signaling complex 
125
.  
Mechanistically, NLRX1 and TUFM resemble both Mfn2 and Atg5 in that they are all 
essential for virus-induced autophagy and function as molecular brakes of IFN-I.  Thus 
the downregulation of IFN-I and induction of autophagy appear to be mediated by a 
group of proteins with dual functions, including NLRX1 and TUFM described here. 
Although the immune function of TUFM has not demonstrated before, its bacterial 
homologue EF-Tu is known to function as an immune-activating PAMP in the plant 
system 
228, 229
.  EF-Tu homologs are found across the bacterial kingdom, thus its 
recognition by host cells might represent a shared pathway by which bacteria modulate 
host responses.  The immune-eliciting activity of EF-Tu depends on its N-terminus.  In 
fact, a short polypeptide that is comprised of the N-terminal 12 amino acids of EF-Tu 
plus an N-terminal acetylation is sufficient to activate immune system to its full potential.  
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The sequence acetyl-xKxKFxRxxxxxxxxx has been found to be the minimal sequence 
required to elicit an immune reaction in Arabidopsis thaliana 
228
.  A reverse-genetic 
approach identified the transmembrane protein EFR (Elongation Factor Tu Receptor) as 
the receptor of EF-Tu 
229
.  The endosymbiosis theory hypothesized that mitochondrion 
originated from the integration of alphaproteobacteria into the host cells, which then 
interacts with host factors 
1
.  It is possible that bacterial EF-Tu is incorporated into host 
cells and gradually evolves to become TUFM, while its function evolved from 
immune-activation to immune-suppression.  In our sequence homology comparison 
analysis of EF-Tu and TUFM, it appears that the N-terminus of EF-Tu has undergone 
drastic changes, which generates a mitochondrial-targeting sequence in the mammalian 
homologue.  Additionally, the sequence essential for immune-activation is lacking in 
TUFM, in agreement with the possible evolution of immune activating EF-Tu to an 
immunosuppressive form.  In addition to immune modulation, TUFM has also been 
implicated in protein translation elongation, oncogenesis, oxidative phosphorylation and 
protein quality control 
234-236
.  More investigations are necessary to elucidate the 
molecular complexes involved in these distinct functions, and whether the diverse 
functions of TUFM are inter-related. 
In summary, previous studies have shown a central role for Atg5-Atg12 in autophagy 
induction and IFN-I inhibition.  This work identifies a novel mitochondrial protein 
platform which is comprised of NLRX1 and TUFM that coordinately controls these two 
functional outcomes through association of the latter with Atg5-Atg12.  By recruiting 
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Atg5-Atg12 and NLRX1, TUFM serves as a nodal check point of the RIG-I-MAVS axis.  
These studies significantly expand our understanding of the players involved in 
controlling diverse mitochondria-based anti-viral responses.  While NLRX1 is the first 
NLR linked to mitochondrial function 
124
, there is increasing evidence of NLR proteins 
that regulate MAVS function as well as mitochondrial functions that regulate NLRs 
129, 237
.  
Future studies are likely to reveal multiple intersections of NLRs and the mitochondria. 
3.5 Materials and Methods 
Cell culture.  HEK293T cells were maintained in complete DMEM medium 
supplemented with 10% fetal bovine serum, 4.5g/L glucose, 110mg/L sodium pyruvate, 
2mM L-glutamine, 1% penicillin and 100µg/ml streptomycin.  Nlrx1
+/+
 and Nlrx1
-/-
 
MEFs were made from 13.5-day embryos and maintained in the complete DMEM 
medium described above.  Cells transduced with tetracycline-inducible shRNA delivery 
lentiviruses were cultured in DMEM complete medium containing 10% tet system 
approved FBS (Cat. 631105, Clontech, Mountain View, CA). All cells were grown in 
37°C incubator supplied with 5% CO2.   
Experimental animals.  The Nlrx1
-/-
 C57BL/6 mice were generated in conjunction with 
the InGenious Targeting Laboratory, Inc (Stony Brook, NY).  The conventional 
NLRX1-targeting construct was made by replacing the genomic region including exons 4 
and 5 with the Neo cassette.  The genotyping primers used to confirm gene deletion are: 
AT1 forward, 5’-GGTTTGATGGCCGTACATTCACAG-3’; WT1 reverse, 
5’-AGCCGGAAGTCAAGGTTGAGG-3’; UNI reverse, 
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5’-AGCGCATCGCCTTCTATCGCCTTC-3’.  All experimental mice were bred in a 
pathogen-free facility at the University of North Carolina at Chapel Hill in accordance 
with the National Institutes of Health Guide for the Care and Use of Laboratory Animals 
and the Institutional Animal Care. 
Plasmids and molecular cloning.  FLAG-tagged TUFM expression plasmid was a kind 
gift from Dr. Nono Takeuchi at the University of Tokyo, Japan.  FLAG-tagged MITA 
expression plasmid and ISRE reporter plasmid were generously provided by Dr. 
Hongbing Shu at Wuhan University, China.  The domain truncation mutants of TUFM 
were generated according to standard molecular cloning protocols with the following 
primers: a) for TUFMΔDI, 
5’-GTCGAATTCACCACAATGGCGGCCGCCACCCTGCTG-3’, 
5’-CTCCAGGTCCCGGGCGGGGTCGCGCACGTAAGTCTT-3’, 
5’-AAGACTTACGTGCGCGACCCCGCCCGGGACCTGGAG-3’, 
5’-GTCCTCGAGTCAACCCCATTTGATATTCTTCTCCTC-3’; b) for TUFMΔDII, 5’- 
GTCGAATTCACCACAATGGCGGCCGCCACCCTGCTG-3’, 
5’-CTTGATGGAACCTGGCTTACGGCCAGGGACGGAGTA-3’, 
5’-TACTCCGTCCCTGGCCGTAAGCCAGGTTCCATCAAG-3’, 5’- 
GTCCTCGAGTCAACCCCATTTGATATTCTTCTCCTC-3’; c) for TUFMΔDIII, 5’- 
GTCGAATTCACCACAATGGCGGCCGCCACCCTGCTG-3’, 
5’-CTCCTCCTCAGTCATGGCGGAACCTGGCTTGACCAT-3’, 
5’-ATGGTCAAGCCAGGTTCCGCCATGACTGAGGAGGAG-3’, 5’- 
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GTCCTCGAGTCAACCCCATTTGATATTCTTCTCCTC-3’; d) for TUFMΔDIΔDII, 
5’-GTCGAATTCGGCACCGTGGTGACAGGTACACTAGAG-3’, 5’- 
GTCCTCGAGTCAACCCCATTTGATATTCTTCTCCTC-3’. The TUFMR339Q point 
mutation was generated using the QuickChange site-directed mutagenesis kit (Stratagene, 
La Jolla, CA).  The primer pair used was: 
5’-GGGAGGACTTGCGGCAGGGCCTGGTCATGGT-3’, 
5’-ACCATGACCAGGCCCTGCCGCAAGTCCTCCC-3’. 
Real time RT-PCR and gene tissue expression.  Total RNA was extracted from cells 
using the RNeasy plus mini kit (Cat. 74134, Qiagen, Valentia, CA).  cDNA was reversed 
transcribed using random primers and MMLV reverse transcriptase (Invitrogen, Carlsbad, 
CA).  Real time RT-PCR was performed using SYBR green master mix (Applied 
Biosystems, Foster City, CA) and data was acquired by an AB Prism 7700 analyser 
(Applied Biosystems, Foster City, CA).  All samples were run in triplicate and data were 
analyzed by SDS2.2.2 software (Applied Biosystems, Foster City, CA).  The primer pair 
used for IFN-β mRNA evaluation was: 5’-CATTACCTGAAGGCCAAGGA-3’, 
5’-CAATTGTCCAGTCCCAGAGG-3’; the primer pair for 18s was: 
5’-GCTGCTGGCACCAGACTT-3’, 5’- CGGCTACCACATCCAAGG-3’.  The 
expression data of TUFM in multiple cell and tissue types was made available by the 
BioGPS project (http://biogps.gnf.org/), which is funded by the Genomics Institute of the 
Novartis Research Foundation. 
RNAi-based protein expression knockdown.  NLRX1 mRNA was targeted using a 
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lentiviral delivery system to stably introduce shRNA expressed from a pol III promoter.  
The promoter, targeting shRNA or scrambled shRNA hairpin sequence, and polyT 
termination signal were amplified by PCR from a U6 promoter template and cloned into 
the lentiviral vector FG12.  A universal forward PCR primer 
(5’-TGGCGGCCGCTCTAGAACTAGTGGA-3’) was used together with the following 
specific reverse PCR primers (hairpin sequences are highlighted): A) sh-NLRX1: forward 
5’-CTCCGCTCGAGAAAAAGCACATCTTCCGTCGGGATTCTCTTGAAATCCCGA
CGGAAGATGTGCGGTGTTTCGTCCTTTCCACAAGATATATAAAGCC-3’. B) sh- 
scrambled: 5’-CTCCGCTCGAGAAAAAGCACATCGCTTCTCGGGATTCTCTTGA- 
AATCCCGAGAAGCGATGTGCGGTGTTTCGTCCTTTCCACAAGATATATAAAGCC
-3’. To generate the tetracycline-inducible lentiviral shRNA delivery system targeting 
TUFM, we obtained Expression Arrest™ non-silencing TripZ control bacteria stock (Cat. 
RHS4743, Thermo Scientific Open Biosystems, Huntsville, AL) and TUFM-targeting 
shRNA-containing construct bacteria stock (Oligo ID V2THS_222080, Cat. 
RHS4696-99362407, Thermo Scientific Open Biosystems, Huntsville, AL).  The 
ON-TARGETplus SMARTpool of 4 siRNA targeting TUFM (Cat. L-016741-01-0005, 
Thermo Scientific, Huntsville, AL) and the control pool of 4 siRNA (Cat. 
D-001810-10-05, Thermo Scientific, Huntsville, AL) were transfected into the cells 
according to the manual.  The TUFM-targeting siRNA sequences are as following: 
5’-AGACUUACGUGCGCGACAA-3’, 5’-GAACAAGGCUGACGCUGUC-3’, 
5’-CGAGAUGGCAACCGGACUA-3’, 5’-CAGCUUCCCUUGCGUUUAA-3’. 
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AACT-based mass spectrometry.  HA-tagged NLRX1 full-length and NLRX1ΔLRR 
truncation sequences were cloned into a retroviral pHSPG vector containing a GFP 
selection marker according to standard molecular cloning procedure.  The primers pairs 
are as following: for NLRX1 full length construct, 
5’-GTGGAATTCATGTACCCATACGATGTTCCTGACTATG-3’, 
5’-CCGCTCGAGTCAGCTTCCAGAGCTTCCCAGC-3’; for NLRX1ΔLRR construct, 
5’-GTGGAATTCATGTACCCATACGATGTTCCTGACTATG-3’, 
5’-CCGCTCGAGTCAGGTCTGCCCAGCAGGCGTG-3’.  The retroviruses were made 
by transfecting the empty vector or expression construct together with gag-pol and VSVg 
plasmids into the packaging cells.  HEK293T cells were transduced with these three 
retroviruses respectively and sorted by FACS based on GFP-positivity.  Cells with 
empty vector were grown in DMEM L-Leucine-deficient medium (Cat. D9816, US 
Biological, Swampscott, MA) supplemented with L-Leucine-5,5,5-d3 (Cat. 486825, 
Sigma-Aldrich, St.Louis, MO), 10% FBS, 110mg/L sodium pyruvate, 2mM L-glutamine, 
1% penicillin and 100µg/ml streptomycin.  NLRX1-expressing or 
NLRX1ΔLRR-expressing cells were cultured in regular medium.  One billion cells 
expressing either NLRX1 or NLRX1ΔLRR and equal number of control group cells were 
lysed and immunoprecipitated with anti-HA affinity matrix (Cat. 11815016001, Roche, 
Indianapolis, IN).  Equal amount of beads from both control group and protein 
expression group were mixed together and eluted with HA peptide (Protein Chemistry 
core facility, UNC-CH).  The elutes were subjected to SDS-PAGE and Coomassie 
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staining.   
The Coomassie-stained gel lanes were continuously excised, and each slice was cut into 
ca. 1mm cubes and subsequently subjected to in-gel digestion.  The gel pieces and 
trypsin solution (10ng/µL in 25mM ammonium bicarbonate) were pre-chilled at 4°C for 
2h to ensure complete absorbance of enzyme into the gel, and then incubated overnight at 
37°C with gentle shaking.  Following extraction of the peptides with the extraction 
buffer (50% acetonitrile, 50% water, 0.1% formic acid), the peptides were lyophilized 
and then resuspended in buffer A (2% acetonitrile, 98% water and 0.1% formic acid).  
LC-MS/MS analysis was performed on a nanoAcquity UPLC - QTOF API US system 
(Waters, UK).  A 5µL sample was loaded onto a reversed phase C18 column 
(75µm×25cm, 1.7µm particle, Waters Company). Linear gradient was run from 100% 
buffer A to 40% buffer B (98% acetonitrile, 2% water and 0.1% formic acid) in 150min, 
and then to 80% B in another 30min.  Eluted peptides were acquired in the 
data-dependent mode using MassLynx software (version 4.0, Waters). Top five parent 
ions of each cycle were selected for further MS/MS analysis.  
All the raw files acquired on QTOF were processed using Mascot Distiller software 
(version 2.3, Matrix Science, UK) and then searched against human International Protein 
Index (IPI) protein database (version 3.26, 67665 sequences).  SILAC quantification 
was automatically done using Quantitation Toolbox in Distiller.  Decoy database search 
function was also enabled, which ensured the false discovery rate was less than 0.01. 
Only proteins that had at least two unique peptides achieving an ion score above 39 and 
113 
 
contained at least five consecutive amino acids matching the data base peptides 
sequences were considered to be positive identifications.  All the raw spectrum and 
SILAC ratios were manually evaluated.  Gene Ontology annotation analysis was 
performed using DAVID Bioinformatics Resources (http://david.abcc.ncifcrf.gov/). 
Transfections and viral infections.  HEK293T cells were plated so that they could 
reach about 80% confluence the next day for transfections.  FuGENE
®
 6 (Cat. 
11814443001, Roche, Indianapolis, IN) was diluted in serum-free DMEM medium, and 
corresponding amount of plasmids DNA was added to the transfection reagent so that the 
DNA:FuGENE
®
 6 ratio was 1:3.  The mixture was incubated at room temperature for 
20min and then added to the cell culture medium.  VSV-GFP virus was generously 
provided by Dr. John Hiscott at McGill University, Canada.  The virus was propagated 
in VERO cells (ATCC, Manassas, VA).  VSV was propagated in Vero cells (ATCC, 
Manassas, VA). For VSV titering by plaque assays, ten-fold dilutions of virus-infected 
cell supernatants were made in serum-free DMEM medium in duplicates or triplicates, 
and added to each well of a 6-well dish plated with confluent VERO cells in monolayer. 
VERO cells were incubated at 37°C for 1 h, after which the inoculum was removed and 
an overlay of 1% methyl cellulose in DMEM supplemented with 10% FBS was added to 
each well. Three days later, the methyl cellulose overlay was aspirated and cells were 
fixed in 4% formaldehyde and stained with 0.2% crystal violet for plaque counting.  
Cell lines or primary cells were plated 24h prior to infection so that HEK293T cells and 
MEFs could reach about 80% confluence the next day.  Virus inoculum was prepared in 
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pre-warmed serum free DMEM and incubated with cells for 1h at 37°C.  Then the virus 
inoculum was removed and cells were replenished with complete media. 
Co-immunoprecipitation and Western blots.  Cells were lysed in RIPA buffer (1% 
Triton X-100, 0.25% DOC, 0.05% SDS, 50mM Tris-HCl pH8.0, 150mM NaCl and 
50mM NaF) or NP-40-based lysis buffer (1% NP-40, 50mM Tris-HCl pH8.0, 150mM 
NaCl) containing complete protease inhibitor cocktail (Cat. 11873580001, Roche, 
Indianapolis, IN).  For the endogenous co-immunoprecipitation experiments, whole cell 
lysates were pre-cleared with protein A resin (Cat. L00210, GenScript, Piscataway, NJ) 
and protein G resin (Cat. L00209, GenScript, Piscataway, NJ) for 1h at 4°C, and then 
incubated with primary antibody overnight.  The protein A/G UltraLink
®
 resin (Cat. 
53132, Thermo Scientific, Huntsville, AL) was added the next day and incubated for 2h 
at 4°C.  Beads were washed 5 times before resuspension and boiling in the Laemmli’s 
sample buffer.  Protein samples were separated by NuPAGE Bis-Tris 4-12% precast gels 
(Cat. NP0322BOX, Invitrogen, Carlsbad, CA) or Tris-Glycine 16% precast gels (Cat. 
EC64952BOX, Invitrogen, Carlsbad, CA).  The antibodies used in this study are as 
following: High-affinity anti-HA-peroxidase (Cat. 12013819001, Roche, Indianapolis, 
IN), Anti-FLAG
®
 M2 affinity gel (Cat. A2220, Sigma-Aldrich, St.Louis, MO), 
anti-LC3B (Cat. 2775, Cell Signaling, Danvers, MA), anti-TUFM (Cat. ab67991, abcam, 
Cambridge, MA), anti-TUFM (Cat. HPA018991, Sigma-Aldrich, St. Louis, MO), 
anti-eEF1α1 (Cat. sc-28578, Santa Cruz, Santa Cruz, CA), anti-Bcl-xL (Cat. 2762, Cell 
Signaling, Danvers, MA), anti-Atg5 (Cat. 2630, Cell Signaling, Danvers, MA), anti- 
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calreticulin (Cat. 2891S, Cell Signaling, Danvers, MA), anti-Actin-HRP (Cat. 
sc-1615HRP, Santa Cruz, Santa Cruz, CA). 
Luciferase assays.  HEK293T cells were plated in 96-well plate at the density of 
1.0×10
4
 per well 24h prior to transfection. The firefly luciferase reporter plasmids for 
NF-κB, ISRE and IFNB were transfected together with ΔRIG-I/MITA and increasing 
doses of TUFM according to the experimental templates.  Empty vector plasmid was 
added so that each well contained 250ng DNA.  Cells were lysed with passive lysis 
buffer (Cat. E194A, Promega, Madison, WI) compatible with luciferase assays.  
Readings were recorded by a luminometer (Molecular Devices, Sunnyvale, CA) that is 
capable of injecting luciferase assay buffer (25mM Gly-Gly, 15mM potassium phosphate 
buffer, 15mM MgSO4, 4mM EGTA, 2mM ATP, 1mM DTT) and substrate (0.2mM 
luciferin, 20mM Gly-Gly, 1mM DTT). 
Laser confocal imaging analysis.  Nlrx1
+/+
 or Nlrx1
-/- 
MEFs were seeded on 8-well 
glass slide (Cat. 154534, Thermo Fisher Scientific, Rochester, NY) 24h prior to 
treatments. The next day cells were incubated with VSV-GFP at the MOI of 0.1 for 1h in 
serum-free DMEM, and then the virus inoculum was removed. Cells were replenished 
with complete medium and incubated for 4h.  Cells were fixed and permeabilized with 4% 
paraformaldehyde containing 0.1% Triton-X 100 for 20min at room temperature.  The 
cells were washed 3 times with 1× PBS.  Samples were incubated with blocking buffer 
(7% BSA, 1% FBS, 2% goat serum, 1% Fc block) for 1h at room temperature. LC3B 
antibody was diluted at 1:400 in the blocking buffer.  The samples were incubated with 
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primary antibody overnight at 4
o
C followed by the 2h incubation with Alexa Fluor
®
 647 
goat anti-rabbit antibody (Cat. A-21244, Invitrogen, Carlsbad, CA) diluted at 1:2000 ratio 
in the blocking buffer.   Images were acquired with an Olympus FV500 confocal 
microscope. 
Size Exclusion Chromatography.  2×10
7
 HEK293T cells were transfected with either 
control dsRNA or 5’-ppp dsRNA (Invivogen, San Diego, CA).  Cells where harvested 
16h post-transfection and lysed in hypotonic lysis buffer with a Dounce homogenizer.  
The homogenate was centrifuged at 500g for 15min to separate nuclei.  The 
supernatants were filtered and loaded onto Superose 6 HR-10/30 columns (GE 
Healthcare).  500µl of each fraction was collected and separated by SDS-PAGE. 
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CHAPTER FOUR 
 
DISCUSSION AND FUTURE DIRECTION  
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4.1 Viruses can subvert MAVS-dependent type 1 IFN production 
Given the broad consequences of type 1 IFN production in the viral life cycles, 
MAVS pathway has been heavily targeted by different viruses to abrogate such response.  
Three simplified models have been proposed to explain how viruses subvert 
MAVS-mediated antiviral responses: 1) abrogating MAVS function by cleaving the 
protein off the mitochondria; 2) imposing steric hindrance by interfering with the 
association between MAVS and upstream RLRs; 3) destablizing MAVS by 
polyubiquitination-based mechanisms.   
Several viral proteins have been identified to cleave MAVS.  HCV encodes a serine 
protease NS3/4A to cleave MAVS at the residue Cys508, dislodging MAVS from 
mitochondria 
37, 185
.  Similarly a closely related virus GB virus B (GBV-B) employs 
NS3/4A to cleave MAVS 
238
.  A picornavirus HAV uses the 3ABC precursor of its 
3C(pro) cysteine protease to cleave MAVS at the Gln428 site 
186
.   
In addition to cleaving MAVS, association with MAVS or upstream RLR to compete 
with their signaling-activating engagement is another widely used strategy by different 
classes of viruses.  The non-structural protein NS1 encoded by influenza A virus inhibits 
host type 1 IFN response by not only binding to dsRNA to sequester activating RNA 
species from RLR but also directly associating with RIG-I to prevent IRF3 nuclear 
translocation 
239-241
.  The PB2 subunit of influenza RNA polymerase can associate with 
MAVS and inhibits type 1 IFN production.  Although the mitochondrial localization of 
PB2 is not essential for viral growth in vitro, non-mitochondrial PB2-encoding virus 
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induces higher level of type 1 IFN 
242, 243
.  The non-structural protein NS2 encoded by 
human Respiratory Syncytial Virus interacts with the CARD domain of RIG-I and blocks 
its association with MAVS to inhibit IFN promoter activation 
244
.  The Z proteins 
encoded by four New World arenaviruses including Guanarito virus (GTOV), Junin virus 
(JUNV), Machupo virus (MAVC), and Sabia virus (SABV) have been found to interact 
with RIG-I and interferes with RIG-I:MAVS association 
245
.  The LCMV nucleoprotein 
interacts with both RIG-I and MDA5 to inhibit type 1 IFN signaling triggered by LCMV 
RNA or other RLR ligands 
246
.  V proteins encoded by paramyxoviruses associate with 
MDA5 and abrogate downstream type 1 IFN activation 
247
.  A recent report 
demonstrated that V proteins target a region within the MDA5 helicase domain to 
interrupt dsRNA binding and its homotypic dimerization 
248
. 
Destablizing MAVS is not only a host strategy to keep immune activation in-check, 
but also hijacked by viruses to evade immune surveillance.  In a clinical samples 
analysis, MAVS was downregulated in hepatocellular carcinomas of Hepatitis B Virus 
(HBV) origin 
249
.  In fact the protein HBX encoded by HBV has been found to associate 
with MAVS and facilitate its proteosomal degradation through PUb at the Lys136 site.  
Consistently, the HBX knock-in transgenic mice display enhanced susceptibility to VSV 
infection 
249
.  MAVS can also be disrupted by non-proteosomal pathway.  For example, 
Human Rhinovirus 1a (HRV1a) infection can result in degradation of MAVS 7h 
post-infection.  Ectopic expression of HRV1a and polioviral 2A(pro) and 3C(pro) results 
in the destabilization of MAVS 
250
. 
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4.2 Viruses target apoptotic signaling 
In addition to being a critical adaptor for type 1 IFN signaling induced by RLR 
engagement, we demonstrate that MAVS mediates virus-induced apoptosis in an 
IFN-independent fashion.  After our findings were published, two other groups reported 
similar results regarding the pro-apoptotic function of MAVS 
251, 252
.  Overexpression of 
MAVS is similarly found to induce apoptosis in a caspase-3, -8, and -9 dependent manner.  
Anoikis is a type of apoptosis induced by the detachment of epithelial cells from the 
extracellular matrix.  Not only can anoikis induce the upregulation of MAVS but also 
recruit caspase-8.  Furthermore, MAVS binds to death-associated protein 3 (DAP3); and 
reduction of MAVS protein level inhibits DAP3-mediated anoikis 
251
.  We demonstrate 
MAVS is essential for SeV-induced apoptosis.  Another group reported MAVS is 
similarly critical for Dengue Virus (DENV)-induced apoptosis.  RNAi-based reduction 
of MAVS results in delayed caspases activation and attenuated cell death 
252
.  Dislocated 
MAVS not only loses its function in activating type 1 IFN, but becomes inert in activating 
the apoptotic pathway.   
The MAVS-mediated apoptotic signaling is targeted by different classes of viruses.  
By either truncating the transmembrane domain  of MAVS or cleaving it by 
co-transfecting NS3/4A completely abolishes its pro-apoptotic capacity.  In addition, we 
identified the NSP15 protein encoded by SARS-CoV as an inhibitor of this pathway.  
NSP15 does not affect staurosporin-induced apoptosis.  However, the detailed molecular 
mechanism of its inhibitory function remains unclear; and further investigation is needed 
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to understand how MAVS-centered apoptosis is regulated by viral proteins. 
Viruses utilize a wide variety of strategies to target host apoptotic signaling.  
Depending on the stages of viral infection, apoptosis induction or inhibition will benefit 
the viruses in their spreading and intracellular replication.  Thus viruses of diverse 
families encode pro-survival inhibitors to induce apoptosis, or on the other hand, express 
viral Bcl-2 homologues to antagonize cell death.   
Based on the origins of stimuli, distinct molecular complex that is involved, 
apoptosis is generally categorized into extrinsic and intrinsic apoptotic signaling.  The 
extrinsic apoptotic pathway, also known as death-receptor pathway is induced by the 
engagement of death receptors such as TNF receptor-1 (TNFR1) or Fas with their 
corresponding ligands 
253
.  This pathway is Bcl-2 protein-independent and functions by 
recruiting caspase-8 through the death domain of the death receptors.  Fas deficiency 
has been implicated in many autoimmune lymphoproliferative syndrome cases, in which 
double-negative T cells accumulate in the peripheral 
254
.  Upon activation, Fas binds to 
FADD to form a molecular platform DISC (death-inducing signaling complex) for 
caspase-8 and -10 activation.  The activation of caspase-8 will eventually activate 
downstream effector caspases such as caspase-3, -6 or -7.  FLICE is a critical adaptor 
protein that shares homology to both FADD and caspases.  It can bind to the death 
domain of FADD and induce apoptosis, treatment of caspases inhibitors can block its 
function 
255
.  The intrinsic apoptotic pathway, also known as mitochondrial apoptotic 
pathway, involves the proper function of Bcl-2 family members.  Diverse insults, such 
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as UV irradiation, chemotherapeutic drugs, unfolded protein response and microbial 
infections etc, could result in the release of cytochrome c, SMAC/Diablo and HtrA2/Omi 
into the cytosol, which facilitates the assembly of apoptosome and activation of caspase-9 
256
. 
The extrinsic pathway is targeted by different classes of viruses that employ similar 
strategies such as DISC formation interference, TNF receptor mimicry and caspase 
inhibition 
253, 257
.  Some γ-herpesviruses including  Kaposi's-sarcoma- associated 
human herpesvirus-8 (KSHV) and Molluscum Contagiosum Virus (MCV) express 
vFLIPs, which contain two DED domains and interacts with FADD.  Such interaction 
blocks the recruitment and activation of FLICE 
258
.  In addition, TNFR receptors have 
been identified in both Leporipoxviruses and Orthopoxviruses 
259
.  Cowpox virus 
encodes several cytokine response modifier CrmB, -C, -D and –E to bind to TNF and 
attenuate host TNF signaling 
260-263
. 
The mitochondrial apoptosis pathway has also been harnessed by viruses belonging 
to various families in favor of their replication at the early stage of infection or 
dissemination at later stages.  Inhibition of apoptosis facilitates the establishment of 
viral replication niche within the host, many viruses have evolved homologs of 
mammalian Bcl-2 proteins to antagonize host apoptotic signaling.  Some viral Bcl-2 
proteins (vBcl-2s) do not share sequence homology with mammalian Bcl-2, however, 
their protein structures demonstrate remarkable similarity to their host counterparts.  
One of the earliest vBcl-2s identified is the E1B-19K protein encoded by adenovirus 
264
.  
123 
 
A significant portion of this protein is located on the mitochondria and sequesters 
pro-apoptotic proteins Bax and Bak from facilitating MOMP 
264
.  Similar mechanisms 
are also shared by many other viral proteins such as vaccinia virus F1L protein, Myxoma 
virus M11L protein, Fowlpox virus FPV039, parapoxvirus ORF virus ORFV125, 
Epstein-Barr virus (EBV) BALF1 and BHRF1 proteins etc 
265
. 
Viruses also have evolved proteins activating the mitochondrial apoptotic signaling 
pathway, possibly facilitating their dissemination to adjacent cells.  These proteins 
function by directly forming a channel on mitochondrial membranes or interacting with 
host factors to promote MOMP.  For example, the Vpr protein encoded by Human 
Immunodeficiency Virus 1 (HIV-1) directly binds to ANT and VDAC via its C-terminus, 
promoting MOMP 
266
.  Such effects could be efficiently blocked by Bcl-2 and 
ANT/VDAC inhibitors 
266
. 
4.3 Tu translation elongation factors are versatile proteins 
In the current study, we identified TUFM as an interacting partner of NLRX1.  
TUFM recruits Atg5-Atg12 conjugate to the NLRX1-containing mitochondrial complex 
to negatively regulate type 1 IFN.  TUFM is an evolutionarily conserved protein with 
sequence homologous to EF-Tu in bacteria.  In mammalian cells, there are two forms of 
EF-Tu: one is eEF1A which is primarily located within the cytosol; and the other one is 
TUFM, which resides within mitochondria.  Besides its well known function in 
translation elongation, this protein has been implicated in carcinogenesis, oxidative 
phosphorylation and immune elicitation. 
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One of the best characterized functions of EF-Tu is its role in peptide elongation.  
EF-Tu delivers aminoacyl-tRNA to the A-site of the ribosome when a match between 
codon and anticodon is detected.  Then the peptidyl-tRNA·mRNA complex moves from 
the A site to the P site, allowing A site to accept deposit of next amino acid.  This amino 
acid delivery process is GTP-dependent, which explains the high degree of conservation 
of the GTPase domain of mammalian EF-Tu and that of its bacterial counterpart.  
Crystal structure analysis of EF-Tu revealed three well defined domains.  The 
N-terminal domain I is responsible for GTP hydrolysis, domain II is responsible for 
aminoacyl-tRNA binding, the function of the C-terminal domain III is less clear 
267
. 
Among one of the initial identifications of TUFM, one report demonstrated 
upregulation of TUFM in a variety of tumors of human or animal origin 
234
.  Similarly, 
in a more recent two-dimensional electrophoresis proteomics on the 
mitochondria-enriched fraction indicated TUFM was highly expressed in human gastric 
carcinoma cell line AGS 
268
.  In fact, this protein is also found to be accountable for 
tumor cell resistance to chemotherapeutic drug Artesunate (ART) 
269
.  However, the 
molecular mechanisms of its function underlying carcinogenesis remain unclear.  It is 
possible that more proteins need to be synthesized due to the active life cycle of cancer 
cells, thus the proteins involved in protein synthesis are upregulated.  Interestingly, not 
all translation elongation factors are upregulated during carcinogenesis, which indicates 
alternative explanations of the overexpression of TUFM in tumor cells.  We found 
reduction of TUFM resulted in compromised autophagy.  Recent evidence highlights the 
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significance of autophagy in cancer development.  Cancer cells could exploit this 
conserved host cellular function to sustain their viability in the nutrient-poor tumor 
environment 
154, 270
.  Further investigation will be essential to elucidate whether the 
functions of TUFM in autophagy underlie its roles in carcinogenesis. 
A point mutation in the domain II of TUFM R339Q has been reported to be 
associated with the clinical presentation of neonatal lactic acidosis, rapidly progressive 
encephalopathy and severely compromised mitochondrial protein synthesis as well as 
deficiency in the mitochondrial respiratory chain 
235
.  Although this point mutation is 
unlikely to cause a drastic structural change since its interaction with adjacent amino acid 
residues is minimal, it is speculated that the mutation may interfere with the proper 
formation of the TUFM:aminoacyl-tRNA:GTP complex 
235
.  Notably the oxidative 
phosphorylation process is defective in the mutant-carrying cells.  Galactose is used in 
lieu of glucose to selectively eliminate oxidative phosphorylation deficient cells.  The 
R339Q-carrying cells were eradicated in this medium, suggesting a possible role of 
TUFM in oxidative phosphorylation 
235
. 
In addition, TUFM has also been shown to possess chaperone properties in vitro in a 
GTP-dependent fashion.  Protein thermal aggregation is inhibited by recombinant 
TUFM, and refolding of denatured protein is consistently promoted by TUFM 
236
.  
TUFM is highly similar to its cytoplasmic homologue eEF1α1, which displayed very 
diverse biological functions in addition to peptide elongation as well 
267
.  Similar to 
TUFM, eEF1α1 also possesses chaperone properties for protein quality control.  In fact, 
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eEF1α1 has been shown to be essential for ubiquitin-dependent degradation of 
N
α
-acetylated proteins 
271, 272
.  eEF1α1 was firstly identified as an actin-associating 
protein 
273
.  Its ability to bind and bundle actin filaments has also been confirmed in 
vitro 
274
.  With an in vivo assay in the yeast Saccharomyces cerevisiae, eEF1α1 
displayed significance in cytoskeleton organization, which is independent of its function 
in protein translation 
275
.  Given the significance and abundance of eEF1α1 within the 
cells, it has been hijacked by various viruses for their replication and propagation 
267
.  
The conserved 3'-terminal stem-loop (3' SL) of the WNV genomic RNA has been found 
to associate with eEF1α1, dephosphorylation of which abolished such interaction 276.  
Mutations that disturb its association with eEF1A1 negatively impacted viral growth.  
However, viral polyprotein translation efficiency was not altered upon these mutation.  
Instead, the minus-strand RNA synthesis was closely correlated with the binding 
efficiency to eEF1A1.  Such association between viral RNA was also observed in other 
flaviviruses 
277
. 
The function of TUFM in antiviral signaling remains largely unknown, in the current 
study, we identified TUFM as a potent inhibitor of host type 1 IFN signaling, which is 
mediated by its interaction with the Atg5-Atg12 conjugate.  We found TUFM inhibited 
NF-κB-, ISRE-dependent and IFNB1 promoter activities in a dose-dependent manner.  
Overexpression of TUFM squelched IFNB1 mRNA transcription.  Consistently, 
reduction of TUFM resulted in enhanced immune activation, which depends on the 
integrity of its N-terminus.  Interestingly, although the function of TUFM in the immune 
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system has not been demonstrated before, its bacterial homologue EF-Tu has been shown 
to be a potent immune-activating PAMP in the plant immune system 
228, 229
.  EF-Tu is 
conserved across bacterial kingdom, thus its recognition by host cells warrants rapid and 
accurate detection of invading microorganisms.  The immune-eliciting activity depends 
on its N-terminus, as a matter of fact, a short polypeptide comprising of the N-terminal 
12 amino acids of EF-Tu plus an N-terminal acetylation is sufficient to activate immune 
system to its full potential.  The sequence acetyl-xKxKFxRxxxxxxxxx has been found 
to be the minimally required elicitor in Arabidopsis thaliana immune system 
228
.  A later 
reverse-genetic approach identified the transmembrane protein EFR (Elongation Factor 
Tu Receptor) as the receptor of EF-Tu.  EFR contains a LRR-rich extracellular domain, 
a single transmembrane domain and an intracellular domain, which displays typical 
features of a serine-threonine protein kinase.  In the Nicotiana benthamiana plants that 
are resistant to EF-Tu signaling, transformation of cells with EFR delivered the capacity 
of specific binding to the N-terminus of EF-Tu; in addition, transformed cells gained 
responsiveness to EF-Tu challenge 
229
.  The endosymbiosis theory hypothesized that 
mitochondrion originated from the integration of alphaproteobacteria into the host cells, 
in which host factors constantly interact with the endosymbiont.  When bacterial EF-Tu 
gradually evolves to host TUFM, its function has been transformed from being 
immune-activating to immune-suppressive.  In our sequence homology comparison 
analysis, the N-terminus of EF-Tu is the only region that undergoes drastic changes, 
which generates a mitochondrial-targeting sequence in the mammalian homologue.  
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Notably the sequence essential for immune-activation no longer exists in TUFM.  The 
biological functions of TUFM have been implicated in protein translation elongation, 
oncogenesis, oxidative phosphorylation, protein quality control as well as host antiviral 
immunity.  More investigations are necessary to elucidate the molecular complexes 
involved in these distinct functions. 
4.4  Future directions 
The adaptor proteins could form different macromolecular complexes in response to 
insults of distinct nature.  Our group and others have shown that MAVS activate 
caspase-3 and -9, the activity of which depends on the formation of apoptosome.  
However, it’s not yet clear whether MAVS-mediated apoptosis induce the 
oligomerization of Apaf-1.  It would be necessary to perform SEC (size exclusion 
chromatography) to analyze apoptosome in wildtype and MAVS-deficient cells.  In 
addition to caspases cleavage induction, activated caspases can also cleave MAVS, 
however, a pan-caspase inhibitor zVAD does not inhibit the cleavage 
250, 278
.  The 
physiological role of cleaved MAVS is still unclear, it might be possible that cleavage of 
MAVS could activate the cell death pathway.  Further research is needed to elucidate the 
mechanism underlying the pro-apoptotic function of MAVS.  For example, MAVS 
activation could result in the dissipation of mitochondrial membrane potential Δψm, what 
molecular complex is involved in the MAVS-induced MOMP remains unkown.  A 
proteomics approach to identify MAVS-interacting protein in response to apoptotic 
stimuli will generate more clues.  We have identified SARS-CoV NSP15 as a potent 
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inhibitor of MAVS-mediated apoptosis, the exact inhibitory mechanism is still elusive.  
Notably the inhibitory function is specific to SARS-CoV yet not shared by other CoV.  
SARS-CoV replication is mostly restricted to the first two weeks of disease onset, the 
temporal regulation of NSP15 is critical in abrogating host apoptotic responses and thus 
benefiting the viruses.  As an important strategy to evade host surveillance, it is possible 
that SARS-CoV designates multiple proteins to interfere with host apoptotic signaling.  
In fact, we have found another protein encoded by SARS-CoV that strongly inhibits 
MAVS-mediated apoptosis as well.  The Papain-like Protease (PLP) can process the 
SARS-CoV replicase polyprotein.  We found when co-transfected with MAVS, PLP 
abrogated MAVS-mediated apoptosis (Fig. 4.1).  PLP contains an ubiquitin-like domain 
(UBL), which was essential to its inhibitory function.  It has previously been shown that 
PLP possesses deubiquitinating enzyme activity 
279-282
, it is possible that this enzymatic 
activity underlies its inhibitory effect on apoptotic signaling.  Ectopic expression of 
MAVS activates both type 1 IFN and apoptotic signaling, we found that MAVS was 
heavily ubiquitinated when activated (Fig. 4.2A).  PLP potently inhibited MAVS 
polyubiquitination, while the truncation of its UBL completely abolished such inhibition 
(Fig. 4.2A).  Polyubiquitination is generally categorized into K63-linked and 
K48-linked modification, with the former being more involed in signaling alteration and 
the latter being related to proteosomal-mediated protein degradation.  We found when 
we coexpressed MAVS with K63-only ubiquitin, which adds polyubiquitin chain 
exclusively in a K63-linked manner, PLP also completely deubiquitinated the modified 
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MAVS and UBL domain was essential for such function (Fig. 4.2B).  However, it is 
unclear how polyubiquitination of MAVS modulates its pro-apoptotic function and which 
lysine residue is primarily responsible for such modification.   
 
Figure 4.1    Papain-like protease inhibits MAVS-mediated apoptosis.  
1.0×10
6
 HEK293T cells were transfected with 1.5µg MAVS with either 1.5µg 
control empty vector or PLpro, PLproΔUBL, NS3/4A expression plasmids.  Cells 
were harvested 48h post-transfection for 7-AAD and Annexin V staining.  All 
samples were then subjected to flow cytometry analysis. 
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Figure 4.2  PLP inhibits polyubiquitination of MAVS.  (A) HEK293T cells 
were transfected with HA-ubiquitin, FLAG-MAVS together with PLP or its 
truncation mutant.  Cells were harvested 24h post-transfection and MAVS was 
immuno- precipitated with anti-FLAG agarose beads, all samples were then 
subjected to SDS-PAGE.  (B) HEK293T cells were transfected with K63-only 
HA-ubiquitin, FLAG-MAVS together with PLP or its truncation mutant.  Cells 
were harvested 24h post-transfection and analyzed as described in (A). 
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MAVS protein contains 14 lysine residues (Fig. 4.3), future studies are needed to identify 
the ones that are primarily responsible for polyubiquitination and delineate the functional 
significance. 
 In the current study, we found NLRX1 associated with TUFM to form a molecular 
platform for RLR signaling modulation.  In our proteomics study, we have identified 
multiple interacting proteins (Table 4.1), many of which might suggest the biological 
significance of NLRX1 in both antiviral immune signaling and other pathways.  For 
example, NLRX1 could interact with translocon-associated protein; and translocon 
components have been suggested in the STING-mediated antiviral responses 
69
, although 
we did not find any regulatory effects of NLRX1 on STING-induced ISRE activation, it 
is possible that NLRX1 might affect other STING-related functions such as intracellular 
DNA recognition pathways.  We have also noticed that NLRX1 is associating with 
HSP70, the peptide sequence coverage of which is approximately 30%.  HSP70 has 
been documented in regulating immune responses, protein quality control and ER-stress 
 1 mpfaedktyk yicrnfsnfc nvdvveilpy lpcltardqd rlratctlsg nrdtlwhlfn 
       61 tlqrrpgwve yfiaalrgce lvdladevas vyqsyqprts drppdplepp slpaerpgpp 
      121 tpaaahsipy nscrekepsy pmpvqetqap espgenseqa lqtlspraip rnpdggples 
      181 ssdlaalspl tssghqeqdt elgsthtaga tssltpsrgp vspsvsfqpl arstprasrl 
      241 pgptgsvvst gtsfsssspg lasagaaegk qgaesdqaep iicssgaeap anslpskvpt 
      301 tlmpvntval kvpanpasvs tvpsklptss kppgavpsna ltnpapsklp instragmvp 
      361 skvptsmvlt kvsastvptd gssrneetpa aptpagatgg ssawldssse nrglgselsk 
      421 pgvlasqvds pfsgcfedla isastslgmg pchgpeeney ksegtfgihv aenpsiqlle 
      481 gnpgppadpd ggprpqadrk fqerevpchr pspgalwlqv avtgvlvvtl lvvlyrrrlh 
 
Figure 4.3  MAVS contains 14 lysine residues.  MAVS protein sequence 
contains 14 lysine residues, which are highlighted. 
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regulation 
283-285
.  It suggests NLRX1 might be involved in other signaling pathways 
other than innate immune responses.  Interestingly some proteins involved in the 
oxidative phosphorylation, such as Peroxiredoxin and Thioredoxin, have also been found 
in the interacting partners list.  To further our understanding in the functions of NLRX1 
in disease pathogenesis, it is necessary to develop in vivo animal models as well.  It is 
possible that NLRX1 may have very diverse functions in different tissues and disease 
models.  The TUFM genetic deletion animal model is not yet available, generation and a 
full characterization of this strain would provide deeper insight into this multimeric 
regulatory complex. 
As a novel nodular check-point of RLR signaling, the studies of post-translational 
modifications of NLRX1 and TUFM are not currently available.  A protemoics approach 
to identify potential modification sites on these proteins will provide valuable tools to 
further analyze the RLR regulatory network.  
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Accession NLRX1-interacting Proteins 
IPI00000643   BAG family molecular chaperone regulator 2   
IPI00000690   Isoform 1 of Apoptosis-inducing factor 1, mitochondrial precursor   
IPI00000816   14-3-3 protein epsilon   
IPI00000874   Peroxiredoxin-1   
IPI00003362   HSPA5 protein   
IPI00003865   Isoform 1 of Heat shock cognate 71 kDa protein   
IPI00007188   ADP/ATP translocase 2   
IPI00007702   Heat shock-related 70 kDa protein 2   
IPI00007765   Stress-70 protein, mitochondrial precursor   
IPI00009104   RuvB-like 2   
IPI00011134   Heat shock 70 kDa protein 7 (Fragment)   
IPI00019385   Translocon-associated protein, delta subunit precursor   
IPI00024145   Isoform 1 of Voltage-dependent anion-selective channel protein 2   
IPI00025156   Isoform 1 of STIP1 homology and U box-containing protein 1   
IPI00025874  
 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa 
subunit precursor  
IPI00027107   Tu translation elongation factor, mitochondrial   
IPI00030275   Heat shock protein 75 kDa, mitochondrial precursor   
IPI00216298   Thioredoxin   
IPI00220644   Isoform M1 of Pyruvate kinase isozymes M1/M2   
IPI00291467   ADP/ATP translocase 3   
IPI00293276   Macrophage migration inhibitory factor   
IPI00299904   Isoform 1 of DNA replication licensing factor MCM7   
IPI00302927   T-complex protein 1 subunit delta  
IPI00303476   ATP synthase subunit beta, mitochondrial precursor   
IPI00304925   Heat shock 70 kDa protein 1   
IPI00306301  
 Pyruvate dehydrogenase E1 component alpha subunit, somatic form,   
mitochondrial precursor   
IPI00329629   DnaJ homolog subfamily C member 7   
IPI00339269   Heat shock 70 kDa protein 6   
IPI00376005   Isoform 2 of Eukaryotic translation initiation factor 5A-1   
IPI00382470   Heat shock protein HSP 90-alpha 2   
IPI00419585   Peptidyl-prolyl cis-trans isomerase A   
IPI00456762   Protein TMEM142B  
IPI00465248   Isoform alpha-enolase of Alpha-enolase   
IPI00465260   GARS protein   
IPI00646779   TUBB6 protein   
  
Table 4.1  NLRX1 interactome.  NLRX1 interacts with multiple proteins 
involved in antiviral signaling, oxidative phosphorylation and protein quality 
control etc. 
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4.5 Concluding remarks 
The mitochondrial immune signaling protein complex plays pivotal roles in the host 
antiviral innate immune responses.  The adaptor MAVS associates with upstream PRRs, 
such as RIG-I and MDA5 when they are engaged in their respective ligands, and 
activates NF-κB and IRF3 to mount type 1 IFN production34-37, which together with 
apoptosis constitutes the first line of host defense against viruses.  Here we identified a 
novel mitochondrial complex that potently modulates host innate antiviral responses.  
MAVS has dual roles in mounting type 1 IFN production and initiating virus-induced 
apoptosis.  Both functions have been targeted by a variety of viral proteins for 
modulation.  A closely associated inhibitory complex, which is composed of NLRX1, 
TUFM and the Atg5-Atg12 conjugate, potently modulates MAVS-mediated type 1 IFN 
activation and virus-induced autophagy.  We have established the first physical link 
between an NLR protein and the virus-induced autophagic machinery via an intermediary 
protein TUFM.  Although to decipher how a single protein can be involved in different 
molecular complexes and their exquisite structural basis remains to be a major challenge, 
the results in this study shed light on the future identification of critical antiviral 
therapeutic targets to activate innate immune system to its full potential. 
  
136 
 
REFERENCES 
 
1. Gray, M.W., Burger, G. & Lang, B.F. Mitochondrial evolution. Science (New York, 
N.Y 283, 1476-1481 (1999). 
 
2. Moore, C.B. & Ting, J.P. Regulation of mitochondrial antiviral signaling 
pathways. Immunity 28, 735-739 (2008). 
 
3. Starkov, A.A. The role of mitochondria in reactive oxygen species metabolism 
and signaling. Annals of the New York Academy of Sciences 1147, 37-52 (2008). 
 
4. Hailey, D.W. et al. Mitochondria supply membranes for autophagosome 
biogenesis during starvation. Cell 141, 656-667 (2010). 
 
5. Brenner, D. & Mak, T.W. Mitochondrial cell death effectors. Curr Opin Cell Biol 
21, 871-877 (2009). 
 
6. Oberst, A., Bender, C. & Green, D.R. Living with death: the evolution of the 
mitochondrial pathway of apoptosis in animals. Cell death and differentiation 15, 
1139-1146 (2008). 
 
7. Kleine, T., Maier, U.G. & Leister, D. DNA transfer from organelles to the nucleus: 
the idiosyncratic genetics of endosymbiosis. Annual review of plant biology 60, 
115-138 (2009). 
 
8. Dolezal, P., Likic, V., Tachezy, J. & Lithgow, T. Evolution of the molecular 
machines for protein import into mitochondria. Science (New York, N.Y 313, 
314-318 (2006). 
 
9. Hayashi, T., Rizzuto, R., Hajnoczky, G. & Su, T.P. MAM: more than just a 
housekeeper. Trends in cell biology 19, 81-88 (2009). 
 
10. Hettema, E.H. & Motley, A.M. How peroxisomes multiply. Journal of cell science 
122, 2331-2336 (2009). 
 
11. Kroemer, G. & Reed, J.C. Mitochondrial control of cell death. Nature medicine 6, 
513-519 (2000). 
 
12. Green, D.R. & Kroemer, G. The pathophysiology of mitochondrial cell death. 
Science (New York, N.Y 305, 626-629 (2004). 
137 
 
13. Liu, X., Kim, C.N., Yang, J., Jemmerson, R. & Wang, X. Induction of apoptotic 
program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 
147-157 (1996). 
 
14. Li, K. et al. Cytochrome c deficiency causes embryonic lethality and attenuates 
stress-induced apoptosis. Cell 101, 389-399 (2000). 
 
15. Li, P. et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 
complex initiates an apoptotic protease cascade. Cell 91, 479-489 (1997). 
 
16. Bernardi, P., Scorrano, L., Colonna, R., Petronilli, V. & Di Lisa, F. Mitochondria 
and cell death. Mechanistic aspects and methodological issues. European journal 
of biochemistry / FEBS 264, 687-701 (1999). 
 
17. Kokoszka, J.E. et al. The ADP/ATP translocator is not essential for the 
mitochondrial permeability transition pore. Nature 427, 461-465 (2004). 
 
18. Galluzzi, L. & Kroemer, G. Mitochondrial apoptosis without VDAC. Nature cell 
biology 9, 487-489 (2007). 
 
19. Nakagawa, T. et al. Cyclophilin D-dependent mitochondrial permeability 
transition regulates some necrotic but not apoptotic cell death. Nature 434, 
652-658 (2005). 
 
20. Wei, M.C. et al. Proapoptotic BAX and BAK: a requisite gateway to 
mitochondrial dysfunction and death. Science (New York, N.Y 292, 727-730 
(2001). 
 
21. Danial, N.N. & Korsmeyer, S.J. Cell death: critical control points. Cell 116, 
205-219 (2004). 
 
22. Scorrano, L. et al. A distinct pathway remodels mitochondrial cristae and 
mobilizes cytochrome c during apoptosis. Developmental cell 2, 55-67 (2002). 
 
23. Janeway, C.A., Jr. Approaching the asymptote? Evolution and revolution in 
immunology. Cold Spring Harbor symposia on quantitative biology 54 Pt 1, 1-13 
(1989). 
 
24. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C.A., Jr. A human homologue of 
the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 
394-397 (1997). 
 
138 
 
25. Medzhitov, R. & Janeway, C.A., Jr. Innate immunity: the virtues of a nonclonal 
system of recognition. Cell 91, 295-298 (1997). 
 
26. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. 
Cell 124, 783-801 (2006). 
 
27. Lopez, C.B. et al. TLR-independent induction of dendritic cell maturation and 
adaptive immunity by negative-strand RNA viruses. J Immunol 173, 6882-6889 
(2004). 
 
28. Edelmann, K.H. et al. Does Toll-like receptor 3 play a biological role in virus 
infections? Virology 322, 231-238 (2004). 
 
29. Sparwasser, T. et al. Bacterial DNA causes septic shock. Nature 386, 336-337 
(1997). 
 
30. Stockinger, S. et al. IFN regulatory factor 3-dependent induction of type I IFNs 
by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism. 
J Immunol 173, 7416-7425 (2004). 
 
31. Cortez-Gonzalez, X. et al. TLR9-independent activation of B lymphocytes by 
bacterial DNA. DNA and cell biology 25, 253-261 (2006). 
 
32. Hochrein, H. et al. Herpes simplex virus type-1 induces IFN-alpha production via 
Toll-like receptor 9-dependent and -independent pathways. Proceedings of the 
National Academy of Sciences of the United States of America 101, 11416-11421 
(2004). 
 
33. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in 
double-stranded RNA-induced innate antiviral responses. Nature immunology 5, 
730-737 (2004). 
 
34. Seth, R.B., Sun, L., Ea, C.K. & Chen, Z.J. Identification and characterization of 
MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and 
IRF 3. Cell 122, 669-682 (2005). 
 
35. Kawai, T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I 
interferon induction. Nature immunology 6, 981-988 (2005). 
 
36. Xu, L.G. et al. VISA is an adapter protein required for virus-triggered IFN-beta 
signaling. Molecular cell 19, 727-740 (2005). 
 
139 
 
37. Meylan, E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is 
targeted by hepatitis C virus. Nature 437, 1167-1172 (2005). 
 
38. Takahasi, K. et al. Nonself RNA-sensing mechanism of RIG-I helicase and 
activation of antiviral immune responses. Molecular cell 29, 428-440 (2008). 
 
39. Cui, S. et al. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor 
of RIG-I. Molecular cell 29, 169-179 (2008). 
 
40. Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition 
of RNA viruses. Nature 441, 101-105 (2006). 
 
41. Myong, S. et al. Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent 
translocase on double-stranded RNA. Science (New York, N.Y 323, 1070-1074 
(2009). 
 
42. Nallagatla, S.R. et al. 5'-triphosphate-dependent activation of PKR by RNAs with 
short stem-loops. Science 318, 1455-1458 (2007). 
 
43. Hornung, V. et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 314, 
994-997 (2006). 
 
44. Schlee, M. et al. Recognition of 5' triphosphate by RIG-I helicase requires short 
blunt double-stranded RNA as contained in panhandle of negative-strand virus. 
Immunity 31, 25-34 (2009). 
 
45. Schmidt, A. et al. 5'-triphosphate RNA requires base-paired structures to activate 
antiviral signaling via RIG-I. Proceedings of the National Academy of Sciences of 
the United States of America 106, 12067-12072 (2009). 
 
46. Kato, H. et al. Length-dependent recognition of double-stranded ribonucleic acids 
by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. 
The Journal of experimental medicine 205, 1601-1610 (2008). 
 
47. Malathi, K., Dong, B., Gale, M., Jr. & Silverman, R.H. Small self-RNA generated 
by RNase L amplifies antiviral innate immunity. Nature 448, 816-819 (2007). 
 
48. Rehwinkel, J. et al. RIG-I detects viral genomic RNA during negative-strand 
RNA virus infection. Cell 140, 397-408 (2010). 
 
49. Pichlmair, A. et al. Activation of MDA5 requires higher-order RNA structures 
generated during virus infection. Journal of virology 83, 10761-10769 (2009). 
140 
 
50. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 
805-820 (2010). 
 
51. Loo, Y.M. et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate 
immunity. Journal of virology 82, 335-345 (2008). 
 
52. Fredericksen, B.L., Keller, B.C., Fornek, J., Katze, M.G. & Gale, M., Jr. 
Establishment and maintenance of the innate antiviral response to West Nile Virus 
involves both RIG-I and MDA5 signaling through IPS-1. Journal of virology 82, 
609-616 (2008). 
 
53. Chiu, Y.H., Macmillan, J.B. & Chen, Z.J. RNA polymerase III detects cytosolic 
DNA and induces type I interferons through the RIG-I pathway. Cell 138, 
576-591 (2009). 
 
54. Ablasser, A. et al. RIG-I-dependent sensing of poly(dA:dT) through the induction 
of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10, 
1065-1072 (2009). 
 
55. Takaoka, A. et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator 
of innate immune response. Nature 448, 501-505 (2007). 
 
56. Wang, Z. et al. Regulation of innate immune responses by DAI (DLM-1/ZBP1) 
and other DNA-sensing molecules. Proceedings of the National Academy of 
Sciences of the United States of America 105, 5477-5482 (2008). 
 
57. Kaiser, W.J., Upton, J.W. & Mocarski, E.S. Receptor-interacting protein 
homotypic interaction motif-dependent control of NF-kappa B activation via the 
DNA-dependent activator of IFN regulatory factors. J Immunol 181, 6427-6434 
(2008). 
 
58. Rebsamen, M. et al. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic 
interaction motifs to activate NF-kappaB. EMBO reports 10, 916-922 (2009). 
 
59. Ishii, K.J. et al. TANK-binding kinase-1 delineates innate and adaptive immune 
responses to DNA vaccines. Nature 451, 725-729 (2008). 
 
60. Yanai, H. et al. HMGB proteins function as universal sentinels for 
nucleic-acid-mediated innate immune responses. Nature 462, 99-103 (2009). 
 
61. Unterholzner, L. et al. IFI16 is an innate immune sensor for intracellular DNA. 
Nature immunology 11, 997-1004 (2010). 
141 
 
62. Burckstummer, T. et al. An orthogonal proteomic-genomic screen identifies AIM2 
as a cytoplasmic DNA sensor for the inflammasome. Nature immunology 10, 
266-272 (2009). 
 
63. Fernandes-Alnemri, T., Yu, J.W., Datta, P., Wu, J. & Alnemri, E.S. AIM2 activates 
the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 
509-513 (2009). 
 
64. Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a 
caspase-1-activating inflammasome with ASC. Nature 458, 514-518 (2009). 
 
65. Roberts, T.L. et al. HIN-200 proteins regulate caspase activation in response to 
foreign cytoplasmic DNA. Science (New York, N.Y 323, 1057-1060 (2009). 
 
66. Kim, T. et al. Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA 
helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. 
Proceedings of the National Academy of Sciences of the United States of America 
107, 15181-15186 (2010). 
 
67. Ting, J.P., Duncan, J.A. & Lei, Y. How the noninflammasome NLRs function in 
the innate immune system. Science (New York, N.Y 327, 286-290 (2010). 
 
68. Yang, P. et al. The cytosolic nucleic acid sensor LRRFIP1 mediates the 
production of type I interferon via a beta-catenin-dependent pathway. Nature 
immunology 11, 487-494 (2010). 
 
69. Ishikawa, H. & Barber, G.N. STING is an endoplasmic reticulum adaptor that 
facilitates innate immune signalling. Nature 455, 674-678 (2008). 
 
70. Zhong, B. et al. The adaptor protein MITA links virus-sensing receptors to IRF3 
transcription factor activation. Immunity 29, 538-550 (2008). 
 
71. Sun, W. et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate 
immune signaling through dimerization. Proceedings of the National Academy of 
Sciences of the United States of America 106, 8653-8658 (2009). 
 
72. Ishikawa, H., Ma, Z. & Barber, G.N. STING regulates intracellular 
DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 
788-792 (2009). 
 
73. Dixit, E. et al. Peroxisomes are signaling platforms for antiviral innate immunity. 
Cell 141, 668-681 (2010). 
142 
 
74. Onoguchi, K. et al. Virus-infection or 5'ppp-RNA activates antiviral signal 
through redistribution of IPS-1 mediated by MFN1. PLoS pathogens 6, e1001012 
(2010). 
 
75. Zhong, B. et al. The ubiquitin ligase RNF5 regulates antiviral responses by 
mediating degradation of the adaptor protein MITA. Immunity 30, 397-407 
(2009). 
 
76. DeYoung, B.J. & Innes, R.W. Plant NBS-LRR proteins in pathogen sensing and 
host defense. Nat Immunol 7, 1243-1249 (2006). 
 
77. Ting, J.P., Willingham, S.B. & Bergstralh, D.T. NLRs at the intersection of cell 
death and immunity. Nat Rev Immunol 8, 372-379 (2008). 
 
78. Davis, B.K., Wen, H. & Ting, J.P. The Inflammasome NLRs in Immunity, 
Inflammation, and Associated Diseases. Annual review of immunology (2011). 
 
79. Jha, S. & Ting, J.P. Inflammasome-associated nucleotide-binding domain, 
leucine-rich repeat proteins and inflammatory diseases. J Immunol 183, 
7623-7629 (2009). 
80. Pedra, J.H., Cassel, S.L. & Sutterwala, F.S. Sensing pathogens and danger signals 
by the inflammasome. Current opinion in immunology 21, 10-16 (2009). 
 
81. Bao, Q. & Shi, Y. Apoptosome: a platform for the activation of initiator caspases. 
Cell death and differentiation 14, 56-65 (2007). 
 
82. Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform 
triggering activation of inflammatory caspases and processing of proIL-beta. 
Molecular cell 10, 417-426 (2002). 
 
83. Faustin, B. et al. Reconstituted NALP1 inflammasome reveals two-step 
mechanism of caspase-1 activation. Molecular cell 25, 713-724 (2007). 
 
84. Boyden, E.D. & Dietrich, W.F. Nalp1b controls mouse macrophage susceptibility 
to anthrax lethal toxin. Nature genetics 38, 240-244 (2006). 
 
85. Wu, W. et al. Resistance of human alveolar macrophages to Bacillus anthracis 
lethal toxin. J Immunol 183, 5799-5806 (2009). 
 
86. Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins 
and ATP. Nature 440, 228-232 (2006). 
 
143 
 
87. Sutterwala, F.S. et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and 
adaptive immunity through its regulation of caspase-1. Immunity 24, 317-327 
(2006). 
 
88. Marina-Garcia, N. et al. Pannexin-1-mediated intracellular delivery of muramyl 
dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of 
Nod2. J Immunol 180, 4050-4057 (2008). 
 
89. Yamasaki, K. et al. NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) 
release in response to hyaluronan, an endogenous trigger of inflammation in 
response to injury. The Journal of biological chemistry 284, 12762-12771 (2009). 
 
90. Gurcel, L., Abrami, L., Girardin, S., Tschopp, J. & van der Goot, F.G. Caspase-1 
activation of lipid metabolic pathways in response to bacterial pore-forming 
toxins promotes cell survival. Cell 126, 1135-1145 (2006). 
 
91. Craven, R.R. et al. Staphylococcus aureus alpha-hemolysin activates the 
NLRP3-inflammasome in human and mouse monocytic cells. PloS one 4, e7446 
(2009). 
 
92. Halle, A. et al. The NALP3 inflammasome is involved in the innate immune 
response to amyloid-beta. Nature immunology 9, 857-865 (2008). 
 
93. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated 
uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241 
(2006). 
 
94. Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing 
of asbestos and silica. Science (New York, N.Y 320, 674-677 (2008). 
 
95. Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 
inflammasome through phagosomal destabilization. Nature immunology 9, 
847-856 (2008). 
 
96. Eisenbarth, S.C., Colegio, O.R., O'Connor, W., Sutterwala, F.S. & Flavell, R.A. 
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of 
aluminium adjuvants. Nature 453, 1122-1126 (2008). 
 
97. Kool, M. et al. Cutting edge: alum adjuvant stimulates inflammatory dendritic 
cells through activation of the NALP3 inflammasome. J Immunol 181, 3755-3759 
(2008). 
 
144 
 
98. Li, H., Willingham, S.B., Ting, J.P. & Re, F. Cutting edge: inflammasome 
activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol 
181, 17-21 (2008). 
 
99. Chu, J. et al. Cholesterol-dependent cytolysins induce rapid release of mature 
IL-1beta from murine macrophages in a NLRP3 inflammasome and cathepsin 
B-dependent manner. Journal of leukocyte biology 86, 1227-1238 (2009). 
 
100. Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and 
activated by cholesterol crystals. Nature 464, 1357-1361 (2010). 
 
101. Rajamaki, K. et al. Cholesterol crystals activate the NLRP3 inflammasome in 
human macrophages: a novel link between cholesterol metabolism and 
inflammation. PloS one 5, e11765 (2010). 
 
102. Pelegrin, P. & Surprenant, A. Pannexin-1 couples to maitotoxin- and 
nigericin-induced interleukin-1beta release through a dye uptake-independent 
pathway. The Journal of biological chemistry 282, 2386-2394 (2007). 
 
103. Pelegrin, P. & Surprenant, A. Pannexin-1 mediates large pore formation and 
interleukin-1beta release by the ATP-gated P2X7 receptor. The EMBO journal 25, 
5071-5082 (2006). 
 
104. Tschopp, J. & Schroder, K. NLRP3 inflammasome activation: The convergence of 
multiple signalling pathways on ROS production? Nature reviews 10, 210-215 
(2010). 
 
105. Martinon, F. Signaling by ROS drives inflammasome activation. European 
journal of immunology 40, 616-619 (2010). 
 
106. Bolwell, G.P. Role of active oxygen species and NO in plant defence responses. 
Current opinion in plant biology 2, 287-294 (1999). 
 
107. Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. 
Thioredoxin-interacting protein links oxidative stress to inflammasome activation. 
Nature immunology 11, 136-140 (2010). 
 
108. Zhou, R., Yazdi, A.S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 
inflammasome activation. Nature 469, 221-225 (2011). 
 
109. Franchi, L. et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and 
interleukin 1beta in salmonella-infected macrophages. Nature immunology 7, 
145 
 
576-582 (2006). 
 
110. Mariathasan, S. et al. Differential activation of the inflammasome by caspase-1 
adaptors ASC and Ipaf. Nature 430, 213-218 (2004). 
 
111. Miao, E.A. et al. Cytoplasmic flagellin activates caspase-1 and secretion of 
interleukin 1beta via Ipaf. Nature immunology 7, 569-575 (2006). 
 
112. Suzuki, T. et al. Differential regulation of caspase-1 activation, pyroptosis, and 
autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS pathogens 3, 
e111 (2007). 
 
113. Amer, A. et al. Regulation of Legionella phagosome maturation and infection 
through flagellin and host Ipaf. The Journal of biological chemistry 281, 
35217-35223 (2006). 
 
114. Sutterwala, F.S. et al. Immune recognition of Pseudomonas aeruginosa mediated 
by the IPAF/NLRC4 inflammasome. The Journal of experimental medicine 204, 
3235-3245 (2007). 
 
115. Molofsky, A.B. et al. Cytosolic recognition of flagellin by mouse macrophages 
restricts Legionella pneumophila infection. The Journal of experimental medicine 
203, 1093-1104 (2006). 
 
116. Ren, T., Zamboni, D.S., Roy, C.R., Dietrich, W.F. & Vance, R.E. 
Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated 
macrophage immunity. PLoS pathogens 2, e18 (2006). 
 
117. Zamboni, D.S. et al. The Birc1e cytosolic pattern-recognition receptor contributes 
to the detection and control of Legionella pneumophila infection. Nature 
immunology 7, 318-325 (2006). 
 
118. Miao, E.A., Ernst, R.K., Dors, M., Mao, D.P. & Aderem, A. Pseudomonas 
aeruginosa activates caspase 1 through Ipaf. Proceedings of the National Academy 
of Sciences of the United States of America 105, 2562-2567 (2008). 
 
119. Franchi, L. et al. Critical role for Ipaf in Pseudomonas aeruginosa-induced 
caspase-1 activation. European journal of immunology 37, 3030-3039 (2007). 
 
120. Kanneganti, T.D., Lamkanfi, M. & Nunez, G. Intracellular NOD-like receptors in 
host defense and disease. Immunity 27, 549-559 (2007). 
 
146 
 
121. Philpott, D.J. & Girardin, S.E. Nod-like receptors: sentinels at host membranes. 
Current opinion in immunology 22, 428-434 (2010). 
 
122. Barnich, N., Aguirre, J.E., Reinecker, H.C., Xavier, R. & Podolsky, D.K. 
Membrane recruitment of NOD2 in intestinal epithelial cells is essential for 
nuclear factor-{kappa}B activation in muramyl dipeptide recognition. The 
Journal of cell biology 170, 21-26 (2005). 
 
123. Kufer, T.A., Kremmer, E., Adam, A.C., Philpott, D.J. & Sansonetti, P.J. The 
pattern-recognition molecule Nod1 is localized at the plasma membrane at sites of 
bacterial interaction. Cellular microbiology 10, 477-486 (2008). 
 
124. Moore, C.B. et al. NLRX1 is a regulator of mitochondrial antiviral immunity. 
Nature 451, 573-577 (2008). 
 
125. Yasukawa, K. et al. Mitofusin 2 inhibits mitochondrial antiviral signaling. Science 
signaling 2, ra47 (2009). 
 
126. Arnoult, D. et al. An N-terminal addressing sequence targets NLRX1 to the 
mitochondrial matrix. Journal of cell science 122, 3161-3168 (2009). 
 
127. Abdul-Sater, A.A. et al. Enhancement of reactive oxygen species production and 
chlamydial infection by the mitochondrial Nod-like family member, NLRX1. The 
Journal of biological chemistry (2010). 
 
128. Tattoli, I. et al. NLRX1 is a mitochondrial NOD-like receptor that amplifies 
NF-kappaB and JNK pathways by inducing reactive oxygen species production. 
EMBO reports 9, 293-300 (2008). 
 
129. Sabbah, A. et al. Activation of innate immune antiviral responses by Nod2. 
Nature immunology 10, 1073-1080 (2009). 
 
130. Allen, I.C. et al. The NLRP3 inflammasome mediates in vivo innate immunity to 
influenza A virus through recognition of viral RNA. Immunity 30, 556-565 
(2009). 
 
131. Ichinohe, T., Lee, H.K., Ogura, Y., Flavell, R. & Iwasaki, A. Inflammasome 
recognition of influenza virus is essential for adaptive immune responses. The 
Journal of experimental medicine 206, 79-87 (2009). 
 
132. Benko, S., Magalhaes, J.G., Philpott, D.J. & Girardin, S.E. NLRC5 limits the 
activation of inflammatory pathways. J Immunol 185, 1681-1691 (2010). 
147 
 
133. Cui, J. et al. NLRC5 negatively regulates the NF-kappaB and type I interferon 
signaling pathways. Cell 141, 483-496 (2010). 
 
134. Kuenzel, S. et al. The nucleotide-binding oligomerization domain-like receptor 
NLRC5 is involved in IFN-dependent antiviral immune responses. J Immunol 184, 
1990-2000 (2010). 
 
135. Meissner, T.B. et al. NLR family member NLRC5 is a transcriptional regulator of 
MHC class I genes. Proceedings of the National Academy of Sciences of the 
United States of America 107, 13794-13799 (2010). 
 
136. Neerincx, A. et al. A role for the human nucleotide-binding domain, leucine-rich 
repeat-containing family member NLRC5 in antiviral responses. The Journal of 
biological chemistry 285, 26223-26232 (2010). 
 
137. Kuenzel, S. et al. The nucleotide-binding oligomerization domain-like receptor 
NLRC5 is involved in IFN-dependent antiviral immune responses. J Immunol 184, 
1990-2000 (2009). 
 
138. Davis, B.K. et al. Cutting Edge: NLRC5-Dependent Activation of the 
Inflammasome. J Immunol (2011). 
 
139. Kumar, H. et al. NLRC5 deficiency does not influence cytokine induction by 
virus and bacteria infections. J Immunol 186, 994-1000 (2011). 
 
140. Poeck, H. et al. Recognition of RNA virus by RIG-I results in activation of 
CARD9 and inflammasome signaling for interleukin 1 beta production. Nature 
immunology 11, 63-69 (2009). 
 
141. Jounai, N. et al. The Atg5 Atg12 conjugate associates with innate antiviral 
immune responses. Proceedings of the National Academy of Sciences of the 
United States of America 104, 14050-14055 (2007). 
 
142. Tal, M.C. et al. Absence of autophagy results in reactive oxygen 
species-dependent amplification of RLR signaling. Proceedings of the National 
Academy of Sciences of the United States of America 106, 2770-2775 (2009). 
 
143. Xu, L., Xiao, N., Liu, F., Ren, H. & Gu, J. Inhibition of RIG-I and 
MDA5-dependent antiviral response by gC1qR at mitochondria. Proc Natl Acad 
Sci U S A 106, 1530-1535 (2009). 
 
144. Jia, Y. et al. Negative regulation of MAVS-mediated innate immune response by 
148 
 
PSMA7. J Immunol 183, 4241-4248 (2009). 
 
145. Komuro, A. & Horvath, C.M. RNA- and virus-independent inhibition of antiviral 
signaling by RNA helicase LGP2. Journal of virology 80, 12332-12342 (2006). 
 
146. Lin, R. et al. Negative regulation of the retinoic acid-inducible gene I-induced 
antiviral state by the ubiquitin-editing protein A20. The Journal of biological 
chemistry 281, 2095-2103 (2006). 
 
147. Friedman, C.S. et al. The tumour suppressor CYLD is a negative regulator of 
RIG-I-mediated antiviral response. EMBO reports 9, 930-936 (2008). 
 
148. You, F. et al. PCBP2 mediates degradation of the adaptor MAVS via the HECT 
ubiquitin ligase AIP4. Nature immunology 10, 1300-1308 (2009). 
 
149. Nakhaei, P. et al. The E3 ubiquitin ligase Triad3A negatively regulates the 
RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS 
pathogens 5, e1000650 (2009). 
 
150. Rothenfusser, S. et al. The RNA helicase Lgp2 inhibits TLR-independent sensing 
of viral replication by retinoic acid-inducible gene-I. J Immunol 175, 5260-5268 
(2005). 
 
151. Satoh, T. et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated 
antiviral responses. Proceedings of the National Academy of Sciences of the 
United States of America 107, 1512-1517 (2010). 
 
152. Lad, S.P. et al. Identification of MAVS splicing variants that interfere with 
RIGI/MAVS pathway signaling. Molecular immunology 45, 2277-2287 (2008). 
 
153. Shintani, T. & Klionsky, D.J. Autophagy in health and disease: a double-edged 
sword. Science (New York, N.Y 306, 990-995 (2004). 
 
154. Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132, 
27-42 (2008). 
 
155. Kanazawa, T. et al. Amino acids and insulin control autophagic proteolysis 
through different signaling pathways in relation to mTOR in isolated rat 
hepatocytes. The Journal of biological chemistry 279, 8452-8459 (2004). 
 
156. Ravikumar, B. et al. Inhibition of mTOR induces autophagy and reduces toxicity 
of polyglutamine expansions in fly and mouse models of Huntington disease. 
149 
 
Nature genetics 36, 585-595 (2004). 
 
157. Sugawara, K. et al. The crystal structure of microtubule-associated protein light 
chain 3, a mammalian homologue of Saccharomyces cerevisiae Atg8. Genes Cells 
9, 611-618 (2004). 
 
158. Suzuki, N.N., Yoshimoto, K., Fujioka, Y., Ohsumi, Y. & Inagaki, F. The crystal 
structure of plant ATG12 and its biological implication in autophagy. Autophagy 1, 
119-126 (2005). 
 
159. Geng, J. & Klionsky, D.J. The Atg8 and Atg12 ubiquitin-like conjugation systems 
in macroautophagy. 'Protein modifications: beyond the usual suspects' review 
series. EMBO reports 9, 859-864 (2008). 
 
160. Klionsky, D.J. et al. Guidelines for the use and interpretation of assays for 
monitoring autophagy in higher eukaryotes. Autophagy 4, 151-175 (2008). 
 
161. Lee, H.K., Lund, J.M., Ramanathan, B., Mizushima, N. & Iwasaki, A. 
Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 
(New York, N.Y 315, 1398-1401 (2007). 
 
162. Yousefi, S. et al. Calpain-mediated cleavage of Atg5 switches autophagy to 
apoptosis. Nature cell biology 8, 1124-1132 (2006). 
 
163. Reggiori, F., Shintani, T., Nair, U. & Klionsky, D.J. Atg9 cycles between 
mitochondria and the pre-autophagosomal structure in yeasts. Autophagy 1, 
101-109 (2005). 
 
164. Takahashi, Y. et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates 
autophagy and tumorigenesis. Nature cell biology 9, 1142-1151 (2007). 
 
165. Lee, I.H. et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation 
of autophagy. Proceedings of the National Academy of Sciences of the United 
States of America 105, 3374-3379 (2008). 
 
166. Skaug, B., Jiang, X. & Chen, Z.J. The role of ubiquitin in NF-kappaB regulatory 
pathways. Annual review of biochemistry 78, 769-796 (2009). 
 
167. Isaacson, M.K. & Ploegh, H.L. Ubiquitination, ubiquitin-like modifiers, and 
deubiquitination in viral infection. Cell host & microbe 5, 559-570 (2009). 
 
168. Gack, M.U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for 
150 
 
RIG-I-mediated antiviral activity. Nature 446, 916-920 (2007). 
 
169. Gack, M.U., Nistal-Villan, E., Inn, K.S., Garcia-Sastre, A. & Jung, J.U. 
Phosphorylation-mediated negative regulation of RIG-I antiviral activity. Journal 
of virology 84, 3220-3229 (2010). 
 
170. Kayagaki, N. et al. DUBA: a deubiquitinase that regulates type I interferon 
production. Science (New York, N.Y 318, 1628-1632 (2007). 
 
171. Arimoto, K. et al. Polyubiquitin conjugation to NEMO by triparite motif protein 
23 (TRIM23) is critical in antiviral defense. Proceedings of the National Academy 
of Sciences of the United States of America 107, 15856-15861 (2010). 
 
172. Zeng, W. et al. Reconstitution of the RIG-I pathway reveals a signaling role of 
unanchored polyubiquitin chains in innate immunity. Cell 141, 315-330 (2010). 
 
173. Lei, Y. et al. MAVS-mediated apoptosis and its inhibition by viral proteins. PloS 
one 4, e5466 (2009). 
 
174. Besch, R. et al. Proapoptotic signaling induced by RIG-I and MDA-5 results in 
type I interferon-independent apoptosis in human melanoma cells. J Clin Invest 
119, 2399-2411 (2009). 
 
175. Sun, Q. et al. The specific and essential role of MAVS in antiviral innate immune 
responses. Immunity 24, 633-642 (2006). 
 
176. Cuconati, A. & White, E. Viral homologs of BCL-2: role of apoptosis in the 
regulation of virus infection. Genes & development 16, 2465-2478 (2002). 
 
177. Bouchier-Hayes, L. & Martin, S.J. CARD games in apoptosis and immunity. 
EMBO reports 3, 616-621 (2002). 
 
178. Zou, H., Henzel, W.J., Liu, X., Lutschg, A. & Wang, X. Apaf-1, a human protein 
homologous to C. elegans CED-4, participates in cytochrome c-dependent 
activation of caspase-3. Cell 90, 405-413 (1997). 
 
179. Ting, J.P. et al. The NLR gene family: a standard nomenclature. Immunity 28, 
285-287 (2008). 
 
180. Inohara, N. et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear 
factor-kappaB. The Journal of biological chemistry 274, 14560-14567 (1999). 
 
151 
 
181. Ogura, Y. et al. Nod2, a Nod1/Apaf-1 family member that is restricted to 
monocytes and activates NF-kappaB. The Journal of biological chemistry 276, 
4812-4818 (2001). 
 
182. Sadasivam, S. et al. Caspase-1 activator Ipaf is a p53-inducible gene involved in 
apoptosis. Oncogene 24, 627-636 (2005). 
 
183. Poyet, J.L. et al. Identification of Ipaf, a human caspase-1-activating protein 
related to Apaf-1. The Journal of biological chemistry 276, 28309-28313 (2001). 
 
184. Potter, J.A., Randall, R.E. & Taylor, G.L. Crystal structure of human 
IPS-1/MAVS/VISA/Cardif caspase activation recruitment domain. BMC 
structural biology 8, 11 (2008). 
 
185. Li, X.D., Sun, L., Seth, R.B., Pineda, G. & Chen, Z.J. Hepatitis C virus protease 
NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to 
evade innate immunity. Proceedings of the National Academy of Sciences of the 
United States of America 102, 17717-17722 (2005). 
 
186. Yang, Y. et al. Disruption of innate immunity due to mitochondrial targeting of a 
picornaviral protease precursor. Proceedings of the National Academy of Sciences 
of the United States of America 104, 7253-7258 (2007). 
 
187. Griffin, D.E. & Hardwick, J.M. Regulators of apoptosis on the road to persistent 
alphavirus infection. Annual review of microbiology 51, 565-592 (1997). 
 
188. Chen, C.Y. et al. Open reading frame 8a of the human severe acute respiratory 
syndrome coronavirus not only promotes viral replication but also induces 
apoptosis. The Journal of infectious diseases 196, 405-415 (2007). 
 
189. Tan, Y.X. et al. Induction of apoptosis by the severe acute respiratory syndrome 
coronavirus 7a protein is dependent on its interaction with the Bcl-XL protein. 
Journal of virology 81, 6346-6355 (2007). 
 
190. Fouchier, R.A. et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 
423, 240 (2003). 
 
191. Drosten, C. et al. Identification of a novel coronavirus in patients with severe 
acute respiratory syndrome. The New England journal of medicine 348, 
1967-1976 (2003). 
 
192. Ksiazek, T.G. et al. A novel coronavirus associated with severe acute respiratory 
152 
 
syndrome. The New England journal of medicine 348, 1953-1966 (2003). 
 
193. Chan-Yeung, M. & Xu, R.H. SARS: epidemiology. Respirology (Carlton, Vic 8 
Suppl, S9-14 (2003). 
 
194. Rota, P.A. et al. Characterization of a novel coronavirus associated with severe 
acute respiratory syndrome. Science (New York, N.Y 300, 1394-1399 (2003). 
 
195. Marra, M.A. et al. The Genome sequence of the SARS-associated coronavirus. 
Science (New York, N.Y 300, 1399-1404 (2003). 
 
196. Peiris, J.S. et al. Clinical progression and viral load in a community outbreak of 
coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 
1767-1772 (2003). 
 
197. Frieman, M., Heise, M. & Baric, R. SARS coronavirus and innate immunity. 
Virus research 133, 101-112 (2008). 
 
198. Schaecher, S.R., Touchette, E., Schriewer, J., Buller, R.M. & Pekosz, A. Severe 
acute respiratory syndrome coronavirus gene 7 products contribute to 
virus-induced apoptosis. Journal of virology 81, 11054-11068 (2007). 
 
199. Ye, Z., Wong, C.K., Li, P. & Xie, Y. A SARS-CoV protein, ORF-6, induces 
caspase-3 mediated, ER stress and JNK-dependent apoptosis. Biochimica et 
biophysica acta (2008). 
 
200. Lau, Y.L. & Peiris, J.S. Pathogenesis of severe acute respiratory syndrome. 
Current opinion in immunology 17, 404-410 (2005). 
 
201. Nicholls, J.M. et al. Time course and cellular localization of SARS-CoV 
nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS medicine 3, e27 
(2006). 
 
202. Adrain, C. & Martin, S.J. The mitochondrial apoptosome: a killer unleashed by 
the cytochrome seas. Trends in biochemical sciences 26, 390-397 (2001). 
 
203. Lamkanfi, M., Festjens, N., Declercq, W., Vanden Berghe, T. & Vandenabeele, P. 
Caspases in cell survival, proliferation and differentiation. Cell death and 
differentiation 14, 44-55 (2007). 
 
204. Hacker, G. The morphology of apoptosis. Cell and tissue research 301, 5-17 
(2000). 
153 
 
205. Heylbroeck, C. et al. The IRF-3 transcription factor mediates Sendai 
virus-induced apoptosis. Journal of virology 74, 3781-3792 (2000). 
 
206. Zamzami, N. et al. Sequential reduction of mitochondrial transmembrane 
potential and generation of reactive oxygen species in early programmed cell 
death. The Journal of experimental medicine 182, 367-377 (1995). 
 
207. Zamzami, N. et al. Reduction in mitochondrial potential constitutes an early 
irreversible step of programmed lymphocyte death in vivo. The Journal of 
experimental medicine 181, 1661-1672 (1995). 
 
208. Chawla-Sarkar, M. et al. Apoptosis and interferons: role of interferon-stimulated 
genes as mediators of apoptosis. Apoptosis 8, 237-249 (2003). 
 
209. Yoneyama, M. et al. Shared and unique functions of the DExD/H-box helicases 
RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175, 
2851-2858 (2005). 
 
210. Silverman, N. & Maniatis, T. NF-kappaB signaling pathways in mammalian and 
insect innate immunity. Genes & development 15, 2321-2342 (2001). 
 
211. Miagkov, A.V. et al. NF-kappaB activation provides the potential link between 
inflammation and hyperplasia in the arthritic joint. Proceedings of the National 
Academy of Sciences of the United States of America 95, 13859-13864 (1998). 
 
212. Holm, G.H. et al. Retinoic acid-inducible gene-I and interferon-beta promoter 
stimulator-1 augment proapoptotic responses following mammalian reovirus 
infection via interferon regulatory factor-3. The Journal of biological chemistry 
282, 21953-21961 (2007). 
 
213. Peters, K., Chattopadhyay, S. & Sen, G.C. IRF-3 activation by Sendai virus 
infection is required for cellular apoptosis and avoidance of persistence. Journal 
of virology 82, 3500-3508 (2008). 
 
214. Ivanov, K.A. et al. Major genetic marker of nidoviruses encodes a replicative 
endoribonuclease. Proceedings of the National Academy of Sciences of the United 
States of America 101, 12694-12699 (2004). 
 
215. Green, D.R. Apoptotic pathways: ten minutes to dead. Cell 121, 671-674 (2005). 
 
216. Reeves, M.B., Davies, A.A., McSharry, B.P., Wilkinson, G.W. & Sinclair, J.H. 
Complex I binding by a virally encoded RNA regulates mitochondria-induced cell 
154 
 
death. Science (New York, N.Y 316, 1345-1348 (2007). 
 
217. van Deventer, H.W. et al. C-C chemokine receptor 5 on pulmonary fibrocytes 
facilitates migration and promotes metastasis via matrix metalloproteinase 9. The 
American journal of pathology 173, 253-264 (2008). 
 
218. Rehwinkel, J. & Reis e Sousa, C. RIGorous detection: exposing virus through 
RNA sensing. Science (New York, N.Y 327, 284-286 (2010). 
 
219. Harton, J.A., Linhoff, M.W., Zhang, J. & Ting, J.P. Cutting edge: CATERPILLER: 
a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, 
and leucine-rich repeat domains. J Immunol 169, 4088-4093 (2002). 
 
220. Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821-832 (2010). 
 
221. Rajan, J.V., Rodriguez, D., Miao, E.A. & Aderem, A. The NLRP3 inflammasome 
detects EMCV and VSV infection. Journal of virology (2011). 
 
222. Thomas, P.G. et al. The intracellular sensor NLRP3 mediates key innate and 
healing responses to influenza A virus via the regulation of caspase-1. Immunity 
30, 566-575 (2009). 
 
223. Sanjuan, M.A. & Green, D.R. Eating for good health: linking autophagy and 
phagocytosis in host defense. Autophagy 4, 607-611 (2008). 
 
224. Virgin, H.W. & Levine, B. Autophagy genes in immunity. Nature immunology 10, 
461-470 (2009). 
 
225. Chen, X., Smith, L.M. & Bradbury, E.M. Site-specific mass tagging with stable 
isotopes in proteins for accurate and efficient protein identification. Analytical 
chemistry 72, 1134-1143 (2000). 
 
226. Ong, S.E. et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a 
simple and accurate approach to expression proteomics. Mol Cell Proteomics 1, 
376-386 (2002). 
 
227. Ye, Z. & Ting, J.P. NLR, the nucleotide-binding domain leucine-rich repeat 
containing gene family. Current opinion in immunology 20, 3-9 (2008). 
 
228. Kunze, G. et al. The N terminus of bacterial elongation factor Tu elicits innate 
immunity in Arabidopsis plants. The Plant cell 16, 3496-3507 (2004). 
 
155 
 
229. Zipfel, C. et al. Perception of the bacterial PAMP EF-Tu by the receptor EFR 
restricts Agrobacterium-mediated transformation. Cell 125, 749-760 (2006). 
 
230. Shelly, S., Lukinova, N., Bambina, S., Berman, A. & Cherry, S. Autophagy is an 
essential component of Drosophila immunity against vesicular stomatitis virus. 
Immunity 30, 588-598 (2009). 
 
231. Mizushima, N., Yoshimori, T. & Levine, B. Methods in mammalian autophagy 
research. Cell 140, 313-326 (2010). 
 
232. Kabeya, Y. et al. LC3, a mammalian homologue of yeast Apg8p, is localized in 
autophagosome membranes after processing. The EMBO journal 19, 5720-5728 
(2000). 
 
233. Chan, D.C. Mitochondrial fusion and fission in mammals. Annual review of cell 
and developmental biology 22, 79-99 (2006). 
 
234. Wells, J., Henkler, F., Leversha, M. & Koshy, R. A mitochondrial elongation 
factor-like protein is over-expressed in tumours and differentially expressed in 
normal tissues. FEBS letters 358, 119-125 (1995). 
 
235. Valente, L. et al. Infantile encephalopathy and defective mitochondrial DNA 
translation in patients with mutations of mitochondrial elongation factors EFG1 
and EFTu. American journal of human genetics 80, 44-58 (2007). 
 
236. Suzuki, H., Ueda, T., Taguchi, H. & Takeuchi, N. Chaperone properties of 
mammalian mitochondrial translation elongation factor Tu. The Journal of 
biological chemistry 282, 4076-4084 (2007). 
 
237. Zhou, R., Yazdi, A.S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 
inflammasome activation. Nature (2010). 
 
238. Chen, Z. et al. GB virus B disrupts RIG-I signaling by NS3/4A-mediated 
cleavage of the adaptor protein MAVS. Journal of virology 81, 964-976 (2007). 
 
239. Mibayashi, M. et al. Inhibition of retinoic acid-inducible gene I-mediated 
induction of beta interferon by the NS1 protein of influenza A virus. Journal of 
virology 81, 514-524 (2007). 
 
240. Opitz, B. et al. IFNbeta induction by influenza A virus is mediated by RIG-I 
which is regulated by the viral NS1 protein. Cellular microbiology 9, 930-938 
(2007). 
156 
 
241. Guo, Z. et al. NS1 protein of influenza A virus inhibits the function of 
intracytoplasmic pathogen sensor, RIG-I. American journal of respiratory cell and 
molecular biology 36, 263-269 (2007). 
 
242. Graef, K.M. et al. The PB2 subunit of the influenza virus RNA polymerase affects 
virulence by interacting with the mitochondrial antiviral signaling protein and 
inhibiting expression of beta interferon. Journal of virology 84, 8433-8445 
(2010). 
 
243. Iwai, A. et al. Influenza A virus polymerase inhibits type I interferon induction by 
binding to interferon beta promoter stimulator 1. The Journal of biological 
chemistry 285, 32064-32074 (2010). 
 
244. Ling, Z., Tran, K.C. & Teng, M.N. Human respiratory syncytial virus 
nonstructural protein NS2 antagonizes the activation of beta interferon 
transcription by interacting with RIG-I. Journal of virology 83, 3734-3742 (2009). 
 
245. Fan, L., Briese, T. & Lipkin, W.I. Z proteins of New World arenaviruses bind 
RIG-I and interfere with type I interferon induction. Journal of virology 84, 
1785-1791 (2010). 
 
246. Zhou, S. et al. Induction and inhibition of type I interferon responses by distinct 
components of lymphocytic choriomeningitis virus. Journal of virology 84, 
9452-9462 (2010). 
 
247. Andrejeva, J. et al. The V proteins of paramyxoviruses bind the IFN-inducible 
RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. 
Proceedings of the National Academy of Sciences of the United States of America 
101, 17264-17269 (2004). 
 
248. Childs, K.S., Andrejeva, J., Randall, R.E. & Goodbourn, S. Mechanism of mda-5 
Inhibition by paramyxovirus V proteins. Journal of virology 83, 1465-1473 
(2009). 
 
249. Wei, C. et al. The hepatitis B virus X protein disrupts innate immunity by 
downregulating mitochondrial antiviral signaling protein. J Immunol 185, 
1158-1168 (2010). 
 
250. Drahos, J. & Racaniello, V.R. Cleavage of IPS-1 in cells infected with human 
rhinovirus. Journal of virology 83, 11581-11587 (2009). 
 
251. Li, H.M. et al. IPS-1 is crucial for DAP3-mediated anoikis induction by caspase-8 
157 
 
activation. Cell death and differentiation 16, 1615-1621 (2009). 
 
252. Yu, C.Y., Chiang, R.L., Chang, T.H., Liao, C.L. & Lin, Y.L. The interferon 
stimulator mitochondrial antiviral signaling protein facilitates cell death by 
disrupting the mitochondrial membrane potential and by activating caspases. 
Journal of virology 84, 2421-2431 (2010). 
 
253. Lamkanfi, M. & Dixit, V.M. Manipulation of host cell death pathways during 
microbial infections. Cell host & microbe 8, 44-54 (2010). 
 
254. Straus, S.E., Sneller, M., Lenardo, M.J., Puck, J.M. & Strober, W. An inherited 
disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. 
Annals of internal medicine 130, 591-601 (1999). 
 
255. Muzio, M. et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is 
recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell 85, 
817-827 (1996). 
 
256. Youle, R.J. & Strasser, A. The BCL-2 protein family: opposing activities that 
mediate cell death. Nat Rev Mol Cell Biol 9, 47-59 (2008). 
 
257. Chen, Y.B. et al. Alternate functions of viral regulators of cell death. Cell death 
and differentiation 13, 1318-1324 (2006). 
 
258. Thome, M. et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis 
induced by death receptors. Nature 386, 517-521 (1997). 
 
259. Rahman, M.M. & McFadden, G. Modulation of tumor necrosis factor by 
microbial pathogens. PLoS pathogens 2, e4 (2006). 
 
260. Hu, F.Q., Smith, C.A. & Pickup, D.J. Cowpox virus contains two copies of an 
early gene encoding a soluble secreted form of the type II TNF receptor. Virology 
204, 343-356 (1994). 
 
261. Loparev, V.N. et al. A third distinct tumor necrosis factor receptor of 
orthopoxviruses. Proceedings of the National Academy of Sciences of the United 
States of America 95, 3786-3791 (1998). 
 
262. Saraiva, M. & Alcami, A. CrmE, a novel soluble tumor necrosis factor receptor 
encoded by poxviruses. Journal of virology 75, 226-233 (2001). 
 
263. Smith, C.A. et al. Cowpox virus genome encodes a second soluble homologue of 
158 
 
cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. 
Virology 223, 132-147 (1996). 
 
264. White, E., Cipriani, R., Sabbatini, P. & Denton, A. Adenovirus E1B 19-kilodalton 
protein overcomes the cytotoxicity of E1A proteins. Journal of virology 65, 
2968-2978 (1991). 
 
265. Galluzzi, L., Brenner, C., Morselli, E., Touat, Z. & Kroemer, G. Viral control of 
mitochondrial apoptosis. PLoS pathogens 4, e1000018 (2008). 
 
266. Jacotot, E. et al. Control of mitochondrial membrane permeabilization by adenine 
nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. The 
Journal of experimental medicine 193, 509-519 (2001). 
 
267. Mateyak, M.K. & Kinzy, T.G. eEF1A: thinking outside the ribosome. The Journal 
of biological chemistry 285, 21209-21213 (2010). 
 
268. Kim, H.K. et al. Mitochondrial alterations in human gastric carcinoma cell line. 
American journal of physiology 293, C761-771 (2007). 
 
269. Sertel, S. et al. Factors determining sensitivity or resistance of tumor cell lines 
towards artesunate. Chemico-biological interactions 185, 42-52 (2010). 
 
270. Rabinowitz, J.D. & White, E. Autophagy and metabolism. Science (New York, N.Y 
330, 1344-1348 (2010). 
 
271. Gonen, H., Dickman, D., Schwartz, A.L. & Ciechanover, A. Protein synthesis 
elongation factor EF-1 alpha is an isopeptidase essential for ubiquitin-dependent 
degradation of certain proteolytic substrates. Advances in experimental medicine 
and biology 389, 209-219 (1996). 
 
272. Gonen, H. et al. Protein synthesis elongation factor EF-1 alpha is essential for 
ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may 
be substituted for by the bacterial elongation factor EF-Tu. Proceedings of the 
National Academy of Sciences of the United States of America 91, 7648-7652 
(1994). 
 
273. Yang, F., Demma, M., Warren, V., Dharmawardhane, S. & Condeelis, J. 
Identification of an actin-binding protein from Dictyostelium as elongation factor 
1a. Nature 347, 494-496 (1990). 
 
274. Demma, M., Warren, V., Hock, R., Dharmawardhane, S. & Condeelis, J. Isolation 
159 
 
of an abundant 50,000-dalton actin filament bundling protein from Dictyostelium 
amoebae. The Journal of biological chemistry 265, 2286-2291 (1990). 
 
275. Gross, S.R. & Kinzy, T.G. Translation elongation factor 1A is essential for 
regulation of the actin cytoskeleton and cell morphology. Nature structural & 
molecular biology 12, 772-778 (2005). 
 
276. Blackwell, J.L. & Brinton, M.A. Translation elongation factor-1 alpha interacts 
with the 3' stem-loop region of West Nile virus genomic RNA. Journal of virology 
71, 6433-6444 (1997). 
 
277. Davis, W.G., Blackwell, J.L., Shi, P.Y. & Brinton, M.A. Interaction between the 
cellular protein eEF1A and the 3'-terminal stem-loop of West Nile virus genomic 
RNA facilitates viral minus-strand RNA synthesis. Journal of virology 81, 
10172-10187 (2007). 
 
278. Scott, I. & Norris, K.L. The mitochondrial antiviral signaling protein, MAVS, is 
cleaved during apoptosis. Biochem Biophys Res Commun 375, 101-106 (2008). 
 
279. Barretto, N. et al. Deubiquitinating activity of the SARS-CoV papain-like 
protease. Advances in experimental medicine and biology 581, 37-41 (2006). 
 
280. Barretto, N. et al. The papain-like protease of severe acute respiratory syndrome 
coronavirus has deubiquitinating activity. Journal of virology 79, 15189-15198 
(2005). 
 
281. Lindner, H.A. et al. The papain-like protease from the severe acute respiratory 
syndrome coronavirus is a deubiquitinating enzyme. Journal of virology 79, 
15199-15208 (2005). 
 
282. Ratia, K. et al. Severe acute respiratory syndrome coronavirus papain-like 
protease: structure of a viral deubiquitinating enzyme. Proceedings of the 
National Academy of Sciences of the United States of America 103, 5717-5722 
(2006). 
 
283. Chen, T. & Cao, X. Stress for maintaining memory: HSP70 as a mobile 
messenger for innate and adaptive immunity. European journal of immunology 40, 
1541-1544 (2010). 
 
284. Salminen, A., Paimela, T., Suuronen, T. & Kaarniranta, K. Innate immunity meets 
with cellular stress at the IKK complex: regulation of the IKK complex by HSP70 
and HSP90. Immunology letters 117, 9-15 (2008). 
160 
 
285. Gotoh, T., Terada, K., Oyadomari, S. & Mori, M. hsp70-DnaJ chaperone pair 
prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of 
Bax to mitochondria. Cell death and differentiation 11, 390-402 (2004). 
 
 
